[{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"上海","City":"上海","ReimbursementRatio":"0.9","InsuranceType":"(职工)","ReimbursementTreatment":"\"在职职工门诊急诊医疗费用：在职职工一年内门诊急诊就医或者到定点零售药店配药所发生的费用，先由其个人医疗帐户当年计入资金支付。不足部分由个人支付至门急诊自负段标准计1500元，超过部分按照下列规定支付：\n　　（一）44岁以下人员，在一级医疗机构门诊急诊的，由附加基金支付65%；在二级医疗机构门诊急诊的，由附加基金支付60%；在三级医疗机构门诊急诊的，由附加基金支付50%。\n　　（二）45岁以上人员，在一级医疗机构门诊急诊的，由附加基金支付75%；在二级医疗机构门诊急诊的，由附加基金支付70%；在三级医疗机构门诊急诊的，由附加基金支付60%。其中，1955年12月31日前出生、2000年12月31日前参加工作的，超过门急诊自负段标准部分的医疗费用，在一级医疗机构门诊急诊的，由附加基金支付75%；在二、三级医疗机构门诊急诊的，由附加基金支付70%。\n\n退休人员门诊急诊医疗费用：退休人员一年内门诊急诊就医或者到定点零售药店配药所发生的除本办法第二十六条、第二十八条规定以外的费用，先由其个人医疗帐户当年计入资金支付。不足部分由个人支付至门急诊自负段标准计700元，超过部分按照下列规定支付(不含到定点零售药店配药所发生的费用)：\n　　（一）69岁以下人员，在一级医疗机构门诊急诊的，由附加基金支付80%；在二级医疗机构门诊急诊的，由附加基金支付75%；在三级医疗机构门诊急诊的，由附加基金支付70%。其中，1955年12月31日前出生、2000年12月31日前参加工作并于2001年1月1日后办理退休手续的人员，超过门急诊自负段标准部分的医疗费用，在一级医疗机构门诊急诊的，由附加基金支付85%；在二级医疗机构门诊急诊的，由附加基金支付80%；在三级医疗机构门诊急诊的，由附加基金支付75%。\n　　（二）70岁以上人员，在一级医疗机构门诊急诊的，由附加基金支付85%；在二级医疗机构门诊急诊的，由附加基金支付80%；在三级医疗机构门诊急诊的，由附加基金支付75%。\n　　\n住院：起付线：在职职工1500，退休人员1200，退休老人700；报销比例：在职职工85%，退休人员92%\n住院/急诊观察+门诊大病/家庭病床合计限额57万，最高限额以上的医疗费用由地方附加医疗保险附加基金支付80%，个人自负20%\"","OutpatientStartPayLine":"在职1500，退休700-300","OutpatientEndPayLine":"不设封顶线","HospitalizationStartPayLine":"在职1500元，退休700-1200元","HospitalizationEndPayLine":"住院/急诊观察+门诊大病/家庭病床合计57万","PolicyLink":"","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"\"门诊急诊（含家庭病床）居民医保基金支付比例为：在社区卫生服务中心（或者一级医疗机构）门诊急诊的，支付70％；在二级医疗机构门诊急诊的，支付60％；在三级医疗机构门诊急诊的，支付50％。\n住院医疗待遇：居民医保基金支付比例为：60周岁及以上人员、以及城镇重残人员，在社区卫生服务中心（或者一级医疗机构）住院的支付90％，在二级医疗机构住院的支付80％，在三级医疗机构住院的支付70％；60周岁以下人员，在社区卫生服务中心（或者一级医疗机构）住院的支付80％，在二级医疗机构住院的支付75％，在三级医疗机构住院的支付60％。\n在基本医疗保险报销后，个人自负部分大病二次报销60%，低保、低收入家庭成员报销65%\"","OutpatientStartPayLineTwo":"60周岁及以上人员、城镇重残人员以及中小学生和婴幼儿为300元；超过18周岁、不满60周岁人员为500元。","OutpatientEndPayLineTwo":"不设封顶线","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"不设封顶线","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"\"职工门诊大病\n居民大病二次报销\"","ReimbursementTreatmentThree":"\"一.职工在门诊进行重症尿毒症透析、恶性肿瘤治疗（化学治疗、内分泌特异治疗、放射治疗、同位素治疗、介入治疗、中医治疗）、部分精神病病种治疗（精神分裂症、中重度抑郁症、躁狂症、强迫症、精神发育迟缓伴发精神障碍、癫痫伴发精神障碍、偏执性精神病）（以下统称“门诊大病”）所发生的医疗费用，在职职工的，由统筹基金支付85%；退休人员的，由统筹基金支付92%。其余部分由其个人医疗帐户历年结余资金支付，仍不足支付的，由职工自负。\n二、参保居民罹患上述大病后，在本市基本医疗保险定点医疗机构发生、符合本市基本医疗保险报销范围的费用，在基本医疗保险报销后，参保居民在基本医疗保险政策范围内个人自负的费用，纳入城乡居民大病保险支付范围，由大病保险资金报销60%，本市低保、低收入家庭成员报销65%。城乡居民中已参加上海市中小学生、婴幼儿住院医疗互助基金的，应先扣除互助基金支付部分。\"","OutpatientStartPayLineThree":"不设起付标准","OutpatientEndPayLineThree":"不设封顶线","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"安徽","City":"合肥","ReimbursementRatio":"0.7","InsuranceType":"(职工)","ReimbursementTreatment":"一级医院，起付线200，小于6万，报销94%，6-30万内报销97%，大于30万，不报。二级医院起付线400，小于6万，报销92%，6-30万报销96%，30万封顶。三级起付线600，小于6万，报销90%，6-30万报销95%，30万封顶。","OutpatientStartPayLine":"200-600","OutpatientEndPayLine":"30万","HospitalizationStartPayLine":"一级200     二级400     三级600","HospitalizationEndPayLine":"30万","PolicyLink":"http://ybj.hefei.gov.cn/zcwj/zcwj/14817903.html","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"在社区卫生服务中心门诊发生医疗费，统筹基金支付80%，最高限额20或50元/年；居民一级医院住院：医保范围内费用超过200元(起付标准)以上部分报销90%;二级医院住院：医保范围内费用超过400元(起付标准)以上部分报销85%; 三级医院住院：医保范围内费用超过600元(起付标准)以上部分报销80%；省属三级住院：医保范围内费用超过1000元（起付标准）以上部分报销75%","OutpatientStartPayLineTwo":"不设起伏标准","OutpatientEndPayLineTwo":"普通160元/年；>60岁男/55岁女 240元/年","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"30万","PolicyLinkTwo":"http://ybj.hefei.gov.cn/zcwj/zcwj/14817903.html","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"职工报销比例同住院；居民50%报销","OutpatientStartPayLineThree":"1.5万","OutpatientEndPayLineThree":"30万","PolicyLinkThree":"http://ybj.hefei.gov.cn/zcwj/zcwj/14817903.html","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"安徽","City":"芜湖","ReimbursementRatio":"0.7","InsuranceType":"(职工)","ReimbursementTreatment":"住院报销<1万元部分 在职人员三级医院85%，二级医院88%，一级医院90%；退休人员再增加2%。1万-3万元部分，在职人员三级医院88%，二级医院90%，一级医院92%；退休人员再增加2%。3万元以上部分不区分医院级别均为90%。","OutpatientStartPayLine":"普通门诊医疗费用由个人账户支付，统筹基金不支付","OutpatientEndPayLine":"普通门诊医疗费用由个人账户支付，统筹基金不支付","HospitalizationStartPayLine":"社区300；一级700；二级800；三级900","HospitalizationEndPayLine":"基本医疗保险统筹基金3万元，基本医疗保险统筹基金和医疗救助基金累计实际支付限额为30万元","PolicyLink":"芜湖市城镇职工医疗保险政策","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"普通门诊自费。住院报销，220元缴费标准，一级二级三级医院报销比例分别为：（起付线至10000元以下）70% ，65%，55%；（10000元及以上） 72%，67%，65%；260元缴费标准，一级二级三级医院报销比例分别为：（起付线至10000元以下）80%， 75%， 65%；（10000元及以上） 82%，77%，75%；同时对不同额度的单次住院医药费用实行分段保底补偿。","OutpatientStartPayLineTwo":"50元","OutpatientEndPayLineTwo":"80元缴费标准200元；260元缴费标准400元","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"30万","PolicyLinkTwo":"芜湖市市区居民基本医疗保险有关政策规定","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工、居民","ReimbursementTreatmentThree":"\"职工门慢：同等条件下住院比例报销；\n居民门特：医保执行同级医院住院报销规定。\n同时，居民享受2016年城镇大病医疗补充保险的起付标准为2万元（个人负担合规医疗费用累计超过部分），起付标准以上(元) 分段支付比例\n（0-20000含) 50%，（20000-100000含) 60%，（100000-200000含) 70%，（200000以上） 80%。\n\"","OutpatientStartPayLineThree":"居民：一级100 元   二级300 元   三级500元；职工不设起付标准","OutpatientEndPayLineThree":"居民同住院最高支付限额；职工4万元","PolicyLinkThree":"芜湖职工、居民基本医疗保险政策；2016年芜湖市城镇大病医疗补充保险实施办法","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"安徽","City":"马鞍山","ReimbursementRatio":"0.7","InsuranceType":"(职工)","ReimbursementTreatment":"门诊全部由职工个户支付","OutpatientStartPayLine":"无","OutpatientEndPayLine":"无","HospitalizationStartPayLine":"一级医院200，二级400，三级600","HospitalizationEndPayLine":"30万","PolicyLink":"","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"乡镇、社区，20-50元内报销80%，100元封顶；二级以上医院，300以上600以内报销40%，封顶线是1500.","OutpatientStartPayLineTwo":"不设","OutpatientEndPayLineTwo":"100-1500","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"30万","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"起付线1万-5万，报销60%，5万-10万，报销65%，10-20万报销80%","OutpatientStartPayLineThree":"1万","OutpatientEndPayLineThree":"30万","PolicyLinkThree":"马鞍山基本医疗管理办法","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"江苏","City":"镇江","ReimbursementRatio":"0.7","InsuranceType":"(职工)","ReimbursementTreatment":"\"门诊统筹：职工报销定点医疗机构：90%；一级：75%；二级：70%；三级50%。\n住院：社区，1万以内职工报销85%，退休报销90%；社区，1万-5万职工报销90%，退休报销92.5。二级以上医疗机构，1万以内职工报销80%，退休报销90%；二级以上医疗机构，1万-5万，职工90%，退休95%\"","OutpatientStartPayLine":"在职为年缴费工资总额10%，退休为年度退休总额的5%","OutpatientEndPayLine":"无","HospitalizationStartPayLine":"","HospitalizationEndPayLine":"无","PolicyLink":"","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"首诊社区报销50%","OutpatientStartPayLineTwo":"","OutpatientEndPayLineTwo":"个人缴费标准的3倍","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"本市上年居民人均可支配收入的8倍","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"\"职工大病：5万-30万，报销95%；30万-50万：报销96%；50万以上，报销98%；\n居民门慢：高血压、糖尿病、前列腺增生、红斑狼疮、肾衰，社区报销50%；精神病、乙肝、癫痫、结核病、再障贫血，二级及以上报销50%；\n门特：终末期肾病透析重性精神病、耐多药结核、终末期肾病、恶性肿瘤、血友病、器官移植排异、先心、甲亢、儿童苯丙酮尿症：社区报销70%，二级及以上报销50%\"","OutpatientStartPayLineThree":"职工大病：5万元","OutpatientEndPayLineThree":"\"居民门慢：社区，个人缴费标准的8倍；二级及以上，个人缴费标准的15倍\n居民门特：二级及以上，个人缴费标准的15倍\"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"江苏","City":"淮安","ReimbursementRatio":"0.7","InsuranceType":"(职工)","ReimbursementTreatment":"\"门诊费用走个人账户，不统筹。\n住院：\n一级医院，400元-2万元，在职报销90%，退休报销95%；2万元-6万元，在职报销95%，退休报销97.5%；6万元以上，在职和退休均报销90%。\n二级医院，600元-2万元，在职报销90%，退休报销95%；2万元-6万元，在职报销95%，退休报销97.5%；6万元以上，在职和退休均报销90%。\n三级医院，1000元-2万元，在职报销90%，退休报销95%；2万元-6万元，在职报销95%，退休报销97.5%；6万元以上，在职和退休均报销90%。\"","OutpatientStartPayLine":"","OutpatientEndPayLine":"","HospitalizationStartPayLine":"一级400元，二级600元，三级1000元","HospitalizationEndPayLine":"无","PolicyLink":"","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"\"门诊：参保人员一个统筹年度内在首诊医疗卫生机构发生的医保甲类药品（含基本药物）、一般诊疗费和其他符合规定的普通门诊（急诊）医疗费用和产前检查医疗费用，按50%补偿（其中一般诊疗费补偿70%），年度内最高补偿限额为300元。未在首诊医疗机构所发生的门诊医药费用不予补偿(除急诊急救外)。纳入家庭医生签约，补偿最高400元。\n住院：一级医院报销85%，二级医院报销75%，三级医院报销65%\"","OutpatientStartPayLineTwo":"","OutpatientEndPayLineTwo":"年度内最高补偿限额为300元，未在首诊医疗机构所发生的的门诊医药费用不予补偿（除急诊急救外）。纳入家庭医生签约，补偿最高400元","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"24万元","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"\"职工：报销同住院；\n居民：大病保险：1.5-6万元，报销50%，6-10万元，报销70%，10万元以上，报销85%。22种大病，按病种付费报销70%\"","OutpatientStartPayLineThree":"\"职工：精神类疾病：300元，其他门特：750元\n居民大病保险住院：1.5万元\"","OutpatientEndPayLineThree":"职工：恶性肿瘤门诊放化疗、系统性红斑狼疮、肾衰竭透析、器官移植排异、慢性肝炎（含肝硬化）：最高支付限额；血友病（轻型）：2万元；血友病（中重型）：8万元；再生障碍性贫血：1.5万元；支架术后抗凝、冠状动脉大桥后抗凝一年：1万元；恶性肿瘤内分泌治疗：8000元；冠心病、高血压（极高危）、中度糖尿病、帕金森病、恶性肿瘤术后、精神类疾病：3000元；儿童脑瘫：1800元；结核病：2000元。","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"江苏","City":"盐城","ReimbursementRatio":"60%-70%","InsuranceType":"(职工)","ReimbursementTreatment":"\"职工门诊：零差率基层医疗机构报销70%，其他医疗机构报销50%；\n职工住院：1万元以下，二、三级医院报销80%；一级及以下医院报销85%，基本药物基层医疗机构报销90%。\n1万-5万元，二、三级医院报销85%；一级及以下医院报销90%，基本药物基层医疗机构报销95%。\n5万-7万元，二、三级医院报销90%；一级及以下医院和基本药物基层医疗机构报销95%。\n7万元以上，报销90%。\n退休人员个人负担比例减半。\"","OutpatientStartPayLine":"500元（低保、特困、重残0起付线）","OutpatientEndPayLine":"2500元","HospitalizationStartPayLine":"\"二级综合及以上医院：800元，递减100元，不低于500元；\n一级及其他二级医院：600元，递减100元，不低于400元；\n基本药物基层医院：300元；\n转市外住院：1000元\"","HospitalizationEndPayLine":"","PolicyLink":"","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"\"居民门诊：报销50%\n居民住院：一级医院，300元-1万元，报80%，一万元以上报75%；二级医院，500元-一万元，报70%，一万元以上报65%；三级医院，1000元-一万元，报60%，一万元以上报55%；转外，1000元-1万元，报55%，一万元以上报40%。\"","OutpatientStartPayLineTwo":"","OutpatientEndPayLineTwo":"1500元","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"\"职工：在医保范围内凭发票报销80%，无上限。门慢18种：社区报90%，二级及以上医院报销80%；门诊大病24中，二级及以上报80%，一级及以下报90%。\n居民：门慢13种，一级70%，二级60%，三级50%；门特14种，一级、二级70%，三级66%。大病，7000-5万元，报50%，5-10万元，报60%，10-20万元，报70%，20万元以上，报80%。\"","OutpatientStartPayLineThree":"300元","OutpatientEndPayLineThree":"\"职工：门慢18种，在职：1200元；退休：1500元\n居民：门慢13种，3000元；门特14种，6万元\"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"江苏","City":"南京","ReimbursementRatio":"0.7","InsuranceType":"(职工)","ReimbursementTreatment":"\"门诊统筹： 社区医疗机构报销比例，在职70%，退休75%，建国前老人100%；其他医疗机构报销比例，在职60%，退休65%，建国前老人95%.\n住院报销：在职 一级医院97%，二级医院95%，三级医院90%；退休 一级医院98%，二级医院97%，三级医院93%。\"","OutpatientStartPayLine":"职工1200；退休1000；建国前老工人200","OutpatientEndPayLine":"职工2000；退休3000；建国前老工人4000","HospitalizationStartPayLine":"一级300   二级500   三级1000","HospitalizationEndPayLine":"不封顶","PolicyLink":"南京城镇职工医保","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"\"1.“居民”看门诊200元以内的费用由个人承担.在社区医院就诊基金支付50%，在其他医院就诊基金支付30%;80周岁以上居民，在社区医院就诊基金支付55%，在其他医院就诊基金支付35%.\n2.住院待遇-老年居民和其他居民：一级报销90%，二级报销85%，三级报销65%。学生儿童一级报销95%，二级报销90%，三级报销80%.80周岁以上：一级报销95%，二级报销90%，三级报销70%。\"","OutpatientStartPayLineTwo":"200","OutpatientEndPayLineTwo":"普通居民年度基金支付限额300。80周岁以上330元。","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"统筹基金年度支付限额30万；逐年增加1万，最高增加到36万。","PolicyLinkTwo":"南京市城镇居民基本医疗保险政策","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"职工：70%居民60%","OutpatientStartPayLineThree":"无","OutpatientEndPayLineThree":"无","PolicyLinkThree":"单独支付","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"江苏","City":"常州","ReimbursementRatio":"0.7","InsuranceType":"(职工)","ReimbursementTreatment":"\"1.普通门诊医疗费用由医保基金补贴70%，按规定办理转诊手续在二、三级医疗机构支付比例：60%，50%。未办理转诊：二三级医疗机构支付比例：50%，40%。\n2.住院待遇，未退休（退职）人员支付90%、退休（退职）人员支付95%。\"","OutpatientStartPayLine":"1200元","OutpatientEndPayLine":"在职4000  退休5000     建国前工人6000","HospitalizationStartPayLine":"在职：一级400二级600，三级1000元。  退休建国前工人：：一级320二级480，三级800元。","HospitalizationEndPayLine":"15万","PolicyLink":"常州职工基本医疗保险政策解读","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"门诊：首诊50%，二三级：40%。 住院：一、二级、老年非从业居民：85%；未成年及大学生：95%。四院新北区二院阳湖园区及其他三级：老年非从业居民：75%；未成年及大学生：85%。","OutpatientStartPayLineTwo":"200元","OutpatientEndPayLineTwo":"1500元","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"25万，缴满5年增加5万","PolicyLinkTwo":"常州\\常州居民医保.docx","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"职工：70%居民60%","OutpatientStartPayLineThree":"无","OutpatientEndPayLineThree":"无","PolicyLinkThree":"2021年度常州市市本级城乡居民基本医疗保险宣传提纲 ；常州市市本级职工基本医疗保险宣传提纲","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"江苏","City":"徐州","ReimbursementRatio":"0.75","InsuranceType":"(职工)","ReimbursementTreatment":"参保人员在实行基本药物零差率销售的基层医疗卫生机构（含爱心医院）就医，超过起付标准所发生的政策范围内费用，门诊统筹基金按75%的比例予以补助；在其他基层医疗机构和A级定点零售药店，按70%补助；在二级医院（含县级医院，下同），按60%补助；在三级医院，按50%补助。低保、特困、重度残疾人员、70周岁以上（含70周岁）退休人员，在上述比例基础上提高10个百分点；69周岁以下（含69周岁）退休人员提高5个百分点。            住院报销：在职 1万一下一级医院94%，二级医院92%，三级医院85%；，1-5万： 一级医院96%，二级医院94%，三级医院90%；5万以上：一级医院98%，二级医院96%，三级医院92%。","OutpatientStartPayLine":"1500元","OutpatientEndPayLine":"1200元","HospitalizationStartPayLine":"市内住院治疗的起付标准为：三级医疗机构1000元，二级医疗机构500元，一级医疗机构及社区卫生服务机构200元。","HospitalizationEndPayLine":"10万元","PolicyLink":"关于统一全市城镇职工医疗保险待遇标准的通知","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"门诊统筹：甲类药物（含基本药物）。基层医疗机构：50%，社区卫生服务中心60%。村卫生室：80%。居民住院：一级90%，二级：80%，三级：70%。","OutpatientStartPayLineTwo":"起付：30","OutpatientEndPayLineTwo":"限额600，纳入家庭医生签约的900元。","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"20万","PolicyLinkTwo":"徐州城乡居民医保待遇","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"职工：70%居民60%","OutpatientStartPayLineThree":"无","OutpatientEndPayLineThree":"2万","PolicyLinkThree":"徐州关于贯彻落实国家医保谈判药品“双通道”管理机制有关事项的通知","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"江苏","City":"泰州","ReimbursementRatio":"0.7","InsuranceType":"(职工)","ReimbursementTreatment":"住院待遇，起付线-1.5万元，一级95%，二级91%，三级91%；1.5万元-9万元，一级96%，二级95%，三级95%；9万元以上：一级、二级、三级均为90%","OutpatientStartPayLine":"30元","OutpatientEndPayLine":"市区医院：500元乡镇卫生院150元。","HospitalizationStartPayLine":"一级400元，二级600元，三级800元","HospitalizationEndPayLine":"无","PolicyLink":"2020泰州市职工基本医疗保险政策宣传","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"住院待遇：起付线-6万元，一级80%，二级70%，三级63%；6-20万元，一级、二级、三级均为63%","OutpatientStartPayLineTwo":"30元","OutpatientEndPayLineTwo":"市区医院：500元乡镇卫生院150元。","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"20万","PolicyLinkTwo":"2021泰州市职工基本医疗保险政策宣传","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"职工：70%居民60%","OutpatientStartPayLineThree":"无","OutpatientEndPayLineThree":"无","PolicyLinkThree":"单独支付政策","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"江苏","City":"苏州","ReimbursementRatio":"0.7","InsuranceType":"(职工)","ReimbursementTreatment":"\"普通门诊：职工报销60%，基层80%；退休报销70%，基层90%。\n住院：4万元以下的部分，按在职职工90%、退休人员95%的比例结付；4万元以上的部分，统一按95%的比例结付\n\"","OutpatientStartPayLine":"个人账户用完后，职工600元、退休400元。","OutpatientEndPayLine":"职工4000元；退休4800元","HospitalizationStartPayLine":"市级及市级以上医院：在职职工（含灵活就业参保人员、“协保”人员、参加职工医疗保险的领取失业保险金人员，下同）800元，退休人员600元；区（县）级医院、专科医院：在职职工600元，退休人员400元；乡镇等基层医院：在职职工300元，退休人员200元。","HospitalizationEndPayLine":"基本医疗保险统筹基金20万元。住院和门特累计20万以上的部分，由大额医疗费用社会共济基金结付95%，自付5%。","PolicyLink":"苏州\\苏州职工医保待遇.docx","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"\"门诊报销比例：居民 签约社区医院及乡镇医院60%，非签约的社区医院及乡镇医院40%，区（县）级医院专科医院40%，市级及以上医院35%。学生少儿60%。\n居民住院报销：乡镇等基层医院，起付线至4万元，报销75%；4万元至10万元，报销80%；10万元至20万元，报销90%。区（县）级医院、专科医院，起付线至4万元，报销75%，4万-10万元，报销80%，10万-20万元，报销90%。市级及以上医院，起付线至4万元，报销75%，4万-10万元，报销80%，10万-20万元，报销90%\n\"","OutpatientStartPayLineTwo":"不设起付标准","OutpatientEndPayLineTwo":"2000元","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"20万","PolicyLinkTwo":"苏州居民医保待遇","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"先按个人负担进行自付，职工：90%，居民80%。","OutpatientStartPayLineThree":"不设起付标准","OutpatientEndPayLineThree":"单独支付总治疗费10万，超过后进入乙类报销","PolicyLinkThree":"单独支付","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"浙江","City":"杭州","ReimbursementRatio":"","InsuranceType":"(职工)","ReimbursementTreatment":"在三级医疗机构发生的医疗费，在职人员76%，退休人员82%；在其他医疗机构发生的医疗费，在职人员80%，退休人员86%；在社区卫生服务机构发生的医疗费，在职人员86%，退休人员92%","OutpatientStartPayLine":"在职1000元，退休300元","OutpatientEndPayLine":"无封顶线","HospitalizationStartPayLine":"社区300元，其他医疗机构500元，三级800元","HospitalizationEndPayLine":"无封顶线","PolicyLink":"杭政[2013]8号","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"\"1.少儿医保和其他城乡居民和大学生医保的统筹基金支付均不设最高限额。 \n2.承担一次住院起付标准，具体为：三级医疗机构800元，其他医疗机构500元，社区卫生服务机构300元。 \n3.起付标准以上部分医疗费，统筹基金承担的比例按以下规定支付：  \n（1）少儿医保和其他城乡居民医保住院起付标准大于25万元（含），在三级、其他医疗机构和社区卫生服务机构发生的医疗费，基金均承担70%。  \n（2）大学生医保住院起付标准以上至25万元（含），在三级医疗机构发生的医疗费，基金承担70%；在其他医疗机构发生的医疗费，基金承担75%；在社区卫生服务机构发生的医疗费，基金承担80%。  \n25万元以上部分医疗费，由统筹基金支付80%。  \n（三十七）在一个结算年度内，参保人员发生的符合医保开支范围的普通门诊医疗费按以下规定结算：  \n1.先由个人承担一个门诊起付标准的医疗费用，具体为300元。其中，其他城乡居民医保一档和二档的参保人员自愿选择定点在居住地所在社区卫生服务机构就诊的，其门诊医疗费不设起付标准。  \n2.门诊起付标准以上部分医疗费，统筹基金承担的比例为：  \n（1）居民一档（少儿医保和大学生）医保的参保人员：在三级医疗机构发生的医疗费，基金承担40%；在其他医疗机构发生的医疗费，基金承担50%；在社区卫生服务机构发生的医疗费，基金承担70%。  \n（2）其他城乡居民医保二档的参保人员：在三级医疗机构发生的医疗费，基金承担30%；在其他医疗机构发生的医疗费，基金承担50%；在社区卫生服务机构发生的医疗费，基金承担60%。\"","OutpatientStartPayLineTwo":"300","OutpatientEndPayLineTwo":"无封顶线","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"无封顶线","PolicyLinkTwo":"杭政[2013]8号","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工+城乡居民","ReimbursementTreatmentThree":"\"规定病种门诊医疗费按照住院待遇结算，但不设住院起付标准。住院待遇：1、住院起付标准以上至4万元（含），三级医院，在职人员82%，退休人员86%；医院其他，在职人员84%，退休人员88%；社区医院，在职人员88%，退休人员92%。2、4万元至36万元（含），三级医院，在职人员88%，退休人员92%；其他医院，在职人员90%，退休人员94%；社区医院，在职人员92%，退休人员96%。3、36万元以上，在职和退休人员均为90%\n门诊慢病：起付线300元，职工报销80%；居民报销50%\n大病保险：起付线2万元，2-20万元，报销60%；20-45万元，报销70%\"","OutpatientStartPayLineThree":"无","OutpatientEndPayLineThree":"无","PolicyLinkThree":"杭政[2013]8号","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"浙江","City":"宁波","ReimbursementRatio":"","InsuranceType":"(职工)","ReimbursementTreatment":"职工门诊：三级70%，其他75%；社区80%  ；住院：80%-90%","OutpatientStartPayLine":"1500","OutpatientEndPayLine":"10000","HospitalizationStartPayLine":"一级800，二级1000；三级1200","HospitalizationEndPayLine":"无","PolicyLink":"","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"A档门诊社区60%；二级35%；三级30%. B档分别是50%，35%，20%                                   A档住院社区85%，小于4万70%，大于4万75%；B档统一65%","OutpatientStartPayLineTwo":"无","OutpatientEndPayLineTwo":"A档4000   B档3000","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"A档30万      B档20万","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"","ReimbursementTreatmentThree":"门诊慢病：社区60%，二级40%，三级35%","OutpatientStartPayLineThree":"0","OutpatientEndPayLineThree":"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"浙江","City":"嘉兴","ReimbursementRatio":"","InsuranceType":"(职工)","ReimbursementTreatment":"门诊：三级50%，其他60%，社区80%；住院：三级80%，二级85%，社区90%","OutpatientStartPayLine":"500","OutpatientEndPayLine":"6000","HospitalizationStartPayLine":"三级800       二级500       社区301","HospitalizationEndPayLine":"20万","PolicyLink":"","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"门诊：社区50%，二级机构20%，其他机构10%              住院：一级医院80%，二级75%，三级65%，","OutpatientStartPayLineTwo":"无","OutpatientEndPayLineTwo":"800元","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"20","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"","ReimbursementTreatmentThree":"","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"浙江","City":"湖州","ReimbursementRatio":"","InsuranceType":"(职工)","ReimbursementTreatment":"门诊二三级机构50%，一级60%                                                 住院：80%-90%","OutpatientStartPayLine":"0","OutpatientEndPayLine":"在职960        退休1080","HospitalizationStartPayLine":"一级300，二级600，三级800元","HospitalizationEndPayLine":"无","PolicyLink":"","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"门诊：一级及以下55%，三级20%，二级30%                                               住院：一级85%，三级60%，二级75%","OutpatientStartPayLineTwo":"0","OutpatientEndPayLineTwo":"1200元","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"8倍人均收入","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"","ReimbursementTreatmentThree":"","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"浙江","City":"温州","ReimbursementRatio":"","InsuranceType":"(职工)","ReimbursementTreatment":"门诊三级60%，二级70%，一级80%                                                        住院：在职95%，退休90%","OutpatientStartPayLine":"退休400，在职601","OutpatientEndPayLine":"10001","HospitalizationStartPayLine":"一级200，二级300，三级及以上600","HospitalizationEndPayLine":"上年度社平工资6倍","PolicyLink":"","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"门诊：三级35%，二级40%，三级50%； 住院三级70%，二级80%，一级90%","OutpatientStartPayLineTwo":"100","OutpatientEndPayLineTwo":"1500","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"20万","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"","ReimbursementTreatmentThree":"","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"浙江","City":"丽水","ReimbursementRatio":"","InsuranceType":"(职工)","ReimbursementTreatment":"门诊：社区50%，其他40%，住院：15万以下社区92%，二级87%，三级83%；15万以上90%","OutpatientStartPayLine":"0","OutpatientEndPayLine":"5000，慢病根据基本提高1000-5000不等","HospitalizationStartPayLine":"1000","HospitalizationEndPayLine":"30万","PolicyLink":"","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"门诊：市内社区70%，市内等级医院及慢病药店50%，市内其他机构40%                                                住院：支付额10万以下社区84%，二级79%，三级70%，10万以上70%","OutpatientStartPayLineTwo":"300","OutpatientEndPayLineTwo":"3000","HospitalizationStartPayLineTwo":"100000%","HospitalizationEndPayLineTwo":"18万","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"","ReimbursementTreatmentThree":"","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"浙江","City":"衢州","ReimbursementRatio":"","InsuranceType":"(职工)","ReimbursementTreatment":"门诊：一级70%，二级60%，三级50%；住院：一级87%，二级84%，三级84%","OutpatientStartPayLine":"300","OutpatientEndPayLine":"3000","HospitalizationStartPayLine":"800元","HospitalizationEndPayLine":"35万","PolicyLink":"","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"门诊：一级50%，二级30%；三级20%                                                住院：一级85%，二级75%。三级哦65%","OutpatientStartPayLineTwo":"100","OutpatientEndPayLineTwo":"1800","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"15万","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"","ReimbursementTreatmentThree":"","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"浙江","City":"金华","ReimbursementRatio":"","InsuranceType":"(职工)","ReimbursementTreatment":"住院：三级医院85%，退休90%；二级及以下88%，退休92%；基层卫生95%                 慢病门诊80%","OutpatientStartPayLine":"0","OutpatientEndPayLine":"慢病5000","HospitalizationStartPayLine":"三家1200，三乙1000，二级及以下800，社区500","HospitalizationEndPayLine":"30万","PolicyLink":"","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"\"门诊慢病60%\n住院：三级医院75%，二级及以下80%，基层卫生90%\"","OutpatientStartPayLineTwo":"0","OutpatientEndPayLineTwo":"2000","HospitalizationStartPayLineTwo":"0%","HospitalizationEndPayLineTwo":"20万","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工+居民","ReimbursementTreatmentThree":"居民报销60%，职工报销80%","OutpatientStartPayLineThree":"0","OutpatientEndPayLineThree":"职工5000，居民2000","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"浙江","City":"绍兴","ReimbursementRatio":"0.97","InsuranceType":"(职工)","ReimbursementTreatment":"\"类风关享受职工医保门诊慢性病待遇：\n1、在参保地（或长期居住地）内基层医疗卫生机构普通门诊（含急诊）发生的政策范围内费用，报销比例在职工基本医疗保险现行政策规定基础上再提高5个百分点。即基层医疗机构在职80%，退休85%。2、自2021年7月1日起，慢性病病种门诊费用中职工医保参保人员普通门诊最高支付限额内，符合基本医疗保险基金支付范围的个人自付部分（包括普通门诊起付标准），纳入大病保险支付范围。\"","OutpatientStartPayLine":"400元","OutpatientEndPayLine":"5000元","HospitalizationStartPayLine":"基层300元；二级以下800元；三级1200元，门诊规定病种400元","HospitalizationEndPayLine":"无封顶线","PolicyLink":"","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"\"类风关享受居民医保门诊慢性病：\n1、在定点医药机构慢性病门诊发生的政策范围内费用，起付标准以上部分，统筹基金按下列比例报销：在市内基层医疗卫生机构医疗的，报销60%，其中肺结核报销70%；在市内其他定点医疗机构医疗的，报销15%；在指定定点零售药店购药的，报销15%。参保人员在定点医药机构慢性病门诊(包括其他疾病门急诊)累计净报销限额为 1000元。\n2、一年内，城乡居民医保参保人员在定点医药机构慢性病门诊(包括其他疾病门急诊)起付线50元，累计净报销限额为1000元。上年度有效签约的参保人员，经民政部门认定的特困人员、低保对象、低保边缘对象、因病致贫对象、享受基本生活费的困境儿童，持有《中华人民共和国残疾人证》且残疾等级在二级及以上的人员，重点优抚对象，在指定定点零售药店购买规定慢性病药品的，报销40%。上述四类人员在定点医药机构慢性病门诊(包括其他疾病门急诊)累计净报销限额再提高200元，也就是说年度内可以净报销1200元。　　\n3、城乡居民医保参保人员患有高血压、糖尿病等12种常见慢性病的，在绍兴市内二级定点医疗机构慢性病门诊发生符合浙江省指定慢性病药品目录的药品费用，政策范围内报销比例为50%。\n4、自2021年7月1日起，慢性病病种门诊费用中居民医保参保人员普通门诊累计净报销限额内，符合基本医疗保险基金支付范围的个人自付部分（包括普通门诊起付标准），纳入大病保险支付范围。\"","OutpatientStartPayLineTwo":"50元","OutpatientEndPayLineTwo":"1000元","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"28万","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"","ReimbursementTreatmentThree":"\"2021年3月10日起，\n1、一个医保年度内，参保人员住院和门诊规定病种经基本医疗保险政策规定报销后个人自付及转外就医承担的自理比例费用，\n2、慢性病病种门诊费用中，职工医保普通门诊最高支付限额内、居民医保普通门诊累计净报销限额内，符合医保支付范围内的个人自付部分\n3、符合规定的PET-CT费用\n以上累计超过2.5万元部分，大病保险基金报销70%，最高支付限额40万元。\n\n一个医保年度内，参保人员使用特殊药品发生的累计费用，8000元以上至40万元部分，大病保险基金报销70%。（困难人群特殊药品起付线4000，报销比例80%）\"","OutpatientStartPayLineThree":"2.5万元","OutpatientEndPayLineThree":"40万元","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"浙江","City":"台州","ReimbursementRatio":"0.97","InsuranceType":"(职工)","ReimbursementTreatment":"\"门诊：先纳入个人账户当年资金支付，超过个人账户当年资金额度部分走统筹。基层86%，市内一级80%，市内二级75%，市内三级70%，市内药店60%；市外一级及以下40%，市外二级及以上55%，市外一级80%，市外二级75%，市外三级70%。\n住院及门诊特殊病：\n基层和市内一级：在职，600元-5万元，报销86%；5万-市平6倍上浮35万，报销96%。退休，600元-5万元，报销91%，5万、市平6倍上浮35万，报销96%。\n市内二级：在职，800元-5万元，报销83%；5万-市平6倍上浮35万，报销93%。退休，800元-5万元，报销88%，5万、市平6倍上浮35万，报销93%.\n市内三级：在职，800元-5万元，报销80%；5万-市平6倍上浮35万，报销90%。退休，800元-5万元，报销85%，5万、市平6倍上浮35万，报销90%\n市外一级及以下：在职和退休，1000元-市平6倍上浮35万，均报销55%。\n市外二级及以上：在职，600元-5万元，报销70%；5万-市平6倍上浮35万，报销80%。退休，600元-5万元，报销75%；5万-市平6倍上浮35万，报销80%。\n市外二级：在职，800-5万元，报销83%；5万-市平6倍上浮35万，报销93%。退休，800-5万元，报销88%；5万-市平6倍上浮35万，报销93%。\n市外三级：在职，800-5万元，报销80%；5万-市平6倍上浮35万，报销90%。退休，800-5万元，报销85%；5万-市平6倍上浮35万，报销90%。\"","OutpatientStartPayLine":"无","OutpatientEndPayLine":"在职人员 10000 元、退休人员 12000 元","HospitalizationStartPayLine":"600-1000","HospitalizationEndPayLine":"上一年度全市在岗职工平均工资的 6 倍再上浮 35 万元","PolicyLink":"","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"\"居民门诊慢性病：市内三级10%、市内二级20%、基层一级60%、市内药店50%。年度可报费用限额：900 元（与基层卫生医疗机构家庭医生签约的参保人员为 1200 元）2021年7月1日起，城乡居民高血压、糖尿病在二级基层医疗机构门诊费用报销比例提高到50%，与家庭签约医生签约的支付限额提高到1400元/人▪年，未签约的提高到1100元/人▪年\n住院： 一级及以下，报销80%；二级报销75%；三级报销70%。台州市外，一级及以下，报销40%；二级及以上，报销50%。\"","OutpatientStartPayLineTwo":"无","OutpatientEndPayLineTwo":"1100元，基层签约1400元","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"上一年度市城乡居民人均可支配收入水平的 6 倍","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工和居民","ReimbursementTreatmentThree":"\"一个医保年度内，参保人员住院、特殊病种门诊合规医疗费用统筹基金支付后累计个人负担部分及大病保险特殊用药费用，\n2万元以上部分，\n由大病保险基金承担75%，不设封顶线。\n困难群众起付线降低一半，支付比例提高到85%。\"","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"浙江","City":"舟山","ReimbursementRatio":"0.97","InsuranceType":"(职工)","ReimbursementTreatment":"职工门慢基层医院报销65%","OutpatientStartPayLine":"无","OutpatientEndPayLine":"无封顶线","HospitalizationStartPayLine":"\"市内：三级800元，二级500元，二级以下300元；\n市外：三级1000元，二级800元，二级以下600元\"","HospitalizationEndPayLine":"无封顶线","PolicyLink":"","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"城镇居民糖尿病门慢基层60%","OutpatientStartPayLineTwo":"无","OutpatientEndPayLineTwo":"无封顶线","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"无封顶线","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工和居民","ReimbursementTreatmentThree":"\"一个医保年度内，参保人员个人发生的住院和规定(慢性病)病种门诊等费用中按规定需由个人支付的自理、自付费用，以及使用浙江省大病保险特殊药品的费用，超过大病保险年度起付标准部分，纳入大病保险支付范围。大病保险不设置年度最高支付限额。\n2021年1月起，一个医保年度内，参保人员发生的合规医疗费用，经基本医疗保险按规定报销后剩余费用（含浙江省大病保险特殊药品、诊疗项目费用），个人自负2.5万元大病保险起付线后部分，支付比例提高到70%；其中医疗救助对象大病保险起付线为1.25万元，支付比例提高到80%。\"","OutpatientStartPayLineThree":"2.5万","OutpatientEndPayLineThree":"无封顶线","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"内蒙","City":"呼和浩特","ReimbursementRatio":"","InsuranceType":"(职工)","ReimbursementTreatment":"\"’-门诊统筹：三级医院统筹基金支付比例为60%，二级及以下医院统筹基金支付比例为80%。\n-住院报销：在职人员，起付线~2万元 三甲医院报销88%、三乙医院报销90%，其他医疗机构92%；20001元-5万， 三甲医院报销90%、三乙医院报销92%，其他医疗机构95%； 5万以上，三甲医院报销95%、三乙医院报销96%，其他医疗机构98%。退休人员在职工基础上增加一个百分点。\n-参保人员大额补充医疗保险按以下比例赔付。\n（一）住院医疗费基本医疗保险统筹基金年度内累计支付4万元至8万元（含8万元）的个人按比例负担部分，大额补充医疗保险支付比例为50%。\n（二）住院医疗费基本医疗保险统筹基金年度内累计支付8万元至19万元（含19万元）的个人按比例负担部分和超过19万元以上符合基本医疗保险规定范围的医疗费，大额补充医疗保险支付比例为95%。\n（三）甲类特殊慢性病门诊治疗基本医疗保险统筹基金年度内累计支付2万元至8万元（含8万元）的个人按比例负担部分，大额补充医疗保险支付比例为50%；基本医疗保险统筹基金年度内累计支付8万元至19万元（含19万元）的个人按比例负担部分和超过19万元以上符合基本医疗保险规定范围的医疗费，大额补充医疗保险支付比例为95%。\n（四）住院治疗、本条第三项甲类特殊慢性病门诊治疗使用乙类药品、特检特治、特殊材料按规定个人负担部分，大额补充医疗保险支付比例为50%。\n（五）住院医疗费基本医疗保险统筹基金年度内累计支付4万元在本条一、二项使用基本医疗保险规定范围外且临床治疗必需的自费药品、特殊材料超限价费用年度累计1万元以上的，大额补充医疗保险支付比例为40%。\n（六）城镇职工大额补充医疗保险年度内累计支付限额为20万元。\"","OutpatientStartPayLine":"1000元","OutpatientEndPayLine":"4000元","HospitalizationStartPayLine":"\"三级甲等医院首次1000元，第二次700元，第三次及以上0元\n三级乙等医院首次800元，第二次560元，第三次及以上0元\n二级医院首次500元，第二次350元，第三次及以上0元\n二级以下医院首次300元，第二次210元，第三次及以上0元\"","HospitalizationEndPayLine":"基本19万，城镇职工大额补充医疗保险年度内累计支付限额为20万元","PolicyLink":"\"呼和浩特市城镇职工基本医疗保险政策须知\n呼和浩特市城镇职工大额补充医疗保险办法\"","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"\"居民门诊：1.所有参保人员在定点乡镇卫生院、社区卫生服务中心门、急诊就医的，每季度门、急诊费用累计超过100元以上的部分按65%支付，每季度支付限额为150元;在二级定点医疗机构门、急诊就医的，每季度门、急诊费用累计超过200元以上的部分按60%支付， 60周岁（含）以上的参保人员每季度支付限额为600元，60周岁以下的每季度支付限额为500元；在三级定点医疗机构门、急诊就医的，年度门、急诊费用累计超过1200元以上的部分按50%支付，60周岁（含）以上的参保人员年度支付限额为2400元，60周岁以下的年度支付限额为2000元。\n居民住院： 起付线-1万元， 三甲70%，三乙75%，二级80%，一级85%。 1万元-3万元， 三甲75%，三乙78%，二级85%，一级90%。 3万元以上， 三甲78%，三乙80%，二级90%，一级95%。\n城镇居民大病补充保险年度起付标准为年度累计个人负担费用14000元；合规医疗费用按60%支付。\"","OutpatientStartPayLineTwo":"一级100，二级200，三级1200","OutpatientEndPayLineTwo":"一级150元/季；二级60周岁以上600元/季，60岁以下500元/季；三级60周岁以上2400元/年，60岁以下2000元/年","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"基本13万，大病补充：儿童、学生等15万，具体居民10万","PolicyLinkTwo":"\"呼和浩特市城乡居民门诊统筹实施办法\n呼和浩特市城乡居民基本医疗保险 门诊特殊慢性病实施办法\n呼和浩特市城乡居民大病补充保险实施办法\"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工、居民","ReimbursementTreatmentThree":"\"门诊特殊药品报销政策\n职工:80%\n居民:65%\"","OutpatientStartPayLineThree":"\"职工1000元\n居民：400元\"","OutpatientEndPayLineThree":"参照住院","PolicyLinkThree":"\"《关于规范和完善门诊特殊药品使用管理的通知》\n关于转发《关于完善内蒙古自治区门诊特殊用药管理工作的通知》\"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"北京","City":"北京","ReimbursementRatio":"","InsuranceType":"(职工)","ReimbursementTreatment":"","OutpatientStartPayLine":"","OutpatientEndPayLine":"","HospitalizationStartPayLine":"","HospitalizationEndPayLine":"","PolicyLink":"","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"","OutpatientStartPayLineTwo":"","OutpatientEndPayLineTwo":"","HospitalizationStartPayLineTwo":"0%","HospitalizationEndPayLineTwo":"","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"","ReimbursementTreatmentThree":"","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"吉林","City":"长春","ReimbursementRatio":"0.9","InsuranceType":"(职工)","ReimbursementTreatment":"特药职工先行自付20%，后进入统筹报销比例区级91%，市级88%，省级85%；住院退休区级93%，市级90%，省级87% 。","OutpatientStartPayLine":"","OutpatientEndPayLine":"","HospitalizationStartPayLine":"三级(省级)1200元 三级( 市级)700元 二级(县区)400元，一级200元","HospitalizationEndPayLine":"基本医疗保险20万/年；大病补充50万/年，公务员补助4万/年","PolicyLink":"关于切实做好国家基本医疗保险、工伤保险和生育保险药品目录执行工作的通知","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"\"住院成年居民：特药先行自付30%，后进入统筹支付。在一级及以下，起付线以上—3万，80%；3万元—6万元，85%；6万以上90%\n在二级医疗机构，起付线以上—3万，70%；3万元—6万元，75%；6万以上80%。（未成年分别为：80%、85%、90%）\n在三级（原市级）医疗机构，起付线以上—3万，60%；3万元—6万元，65%；6万以上70%。（未成年分别为：70%、75%、80%）\n在三级（原省级）医疗机构，起付线以上—3万，55%；3万元—6万元，60%；6万以上65%。（未成年分别为：65%、70%、75%）\n\"","OutpatientStartPayLineTwo":"","OutpatientEndPayLineTwo":"","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"20万元/年大额30万","PolicyLinkTwo":"长春市城乡居民基本医疗保险实施办法","InsuranceTypeThree":"http://xxgk.jl.gov.cn/zsjg/fgw/xxgkmlqy/202111/t20211123_8297201.html","CrowdType":"职工、居民","ReimbursementTreatmentThree":"居民先行自付30%、职工先行自付20%，进入统筹报销待遇","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"关于加强国家医保谈判药品配备使用完善“双通道药品”管理机制的通知 (jl.gov.cn)","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"吉林","City":"吉林市","ReimbursementRatio":"","InsuranceType":"(职工)","ReimbursementTreatment":"特药职工先行自付比例20%，后按乙类报销","OutpatientStartPayLine":"职工没有门诊统筹待遇，用个人账户支付","OutpatientEndPayLine":"职工没有门诊统筹待遇","HospitalizationStartPayLine":"一级（含以下）定点医疗机构为400元，二级定点医疗机构为800元，三级定点医疗机构为1100元。","HospitalizationEndPayLine":"9万+41万大额","PolicyLink":"关于加强国家医保谈判药品配备使用完善“双通道药品”管理机制的通知 (jl.gov.cn)","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"\"特药居民先行自付比例30%。住院成年居民：在一级及以下，起付线以上—3万，80%；3万元—6万元，85%；6万以上90%\n在二级医疗机构，起付线以上—3万，70%；3万元—6万元，75%；6万以上80%。（未成年分别为：80%、85%、90%）\n在三级（原市级）医疗机构，起付线以上—3万，60%；3万元—6万元，65%；6万以上70%。（未成年分别为：70%、75%、80%）\n在三级（原省级）医疗机构，起付线以上—3万，55%；3万元—6万元，60%；6万以上65%。（未成年分别为：65%、70%、75%）\n\"","OutpatientStartPayLineTwo":"按住院起付线","OutpatientEndPayLineTwo":"同住院","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"20万元/年","PolicyLinkTwo":"关于加强国家医保谈判药品配备使用完善“双通道药品”管理机制的通知 (jl.gov.cn)","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工、居民","ReimbursementTreatmentThree":"居民先行自付30%、职工先行自付20%，进入统筹报销待遇","OutpatientStartPayLineThree":"门诊特殊疾病全年只缴纳一次性住院起付线，享受住院统筹基金支付待遇","OutpatientEndPayLineThree":"统筹基金限额","PolicyLinkThree":"关于加强国家医保谈判药品配备使用完善“双通道药品”管理机制的通知 (jl.gov.cn)","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"天津","City":"天津","ReimbursementRatio":"0.95","InsuranceType":"(职工)","ReimbursementTreatment":"门诊报销：一级医院报销75%，二级是65%，三级是55%。药店按照外配处方医院报销比例报销。住院报销， 5.5万元以下职工85%，退休90%；5.5万-15万，报销80%.15万-35万职工大额医疗救助报销80%。","OutpatientStartPayLine":"在职800；退休 650-800","OutpatientEndPayLine":"最高9000","HospitalizationStartPayLine":"一级医院800 二级医院1100 三级医院1700","HospitalizationEndPayLine":"35万","PolicyLink":"市医保局财政局关于做好城乡居民基本医疗保障有关工作的通知、2020年度居民基本医疗保险宣传提纲、天津医保最新医保待遇","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"门诊报销比例：一级二级55%，新增三级报销政策，报销比例为50%。住院待遇：学生儿童一级85%、二级80%、三级75%。成年居民一级医院（高档85%、中档80%、低档75%）二级（高档80%、中档75%、低档70%）三级（高档75%、中档70%、抵挡65%）","OutpatientStartPayLineTwo":"600","OutpatientEndPayLineTwo":"4000","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"180000","PolicyLinkTwo":"市医保局财政局关于做好城乡居民基本医疗保障有关工作的通知、2020年度居民基本医疗保险宣传提纲、天津医保最新医保待遇","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"按照三级医疗机构门诊统筹报销比例执行55%","OutpatientStartPayLineThree":"职工起付线按照上一年市职工平均工资1%；居民600","OutpatientEndPayLineThree":"门诊保障机制一药一标准13870元","PolicyLinkThree":"《天津市医保局市卫生健康委关于持续做好国家医保谈判药品供应保障和分类管理工作的通知》","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"山东","City":"青岛","ReimbursementRatio":"根据不同参保人群/医院级别划分","InsuranceType":"(职工)","ReimbursementTreatment":"\"门统：职工60%，使用基药提高10个百分点；\n\n住院：三级0-4万报86%；4万以上报95%；二级0-4万88%；4万以上报95%；一级0-4万报90%;4万以上95%；\"","OutpatientStartPayLine":"0","OutpatientEndPayLine":"1120元","HospitalizationStartPayLine":"一级200；二级500；三级800；","HospitalizationEndPayLine":"20万","PolicyLink":"","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"\"门统：居民一档50%；居民二档40%；少年50%；大学生80%；\n\n住院：0-18万-\n居民一档：三级报70%；二级报80%；一级报85%\n居民二档和少年：三级报55%；二级报75%；一级报85%；\n大学生级报80%；二级报85%；一级报90%\"","OutpatientStartPayLineTwo":"0","OutpatientEndPayLineTwo":"居民一档720元；居民二档和少年400元；大学生暂无封顶；","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"18万","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"\"职工：三级医院86%；二级88%；一级90%；超限额以上部分1-3级医院可报50%；社区可报70%;\n\n居民：三级医院一档65%；二档55%；少年和大学生80%；\n二级医院一档70%；二档65%；少年和大学生85%；\n一级医院一档80%；二档80%；少年和大学生90%；居民超限额以上不予支付\"","OutpatientStartPayLineThree":"\"职工：三级800元；二级500元；一级200元’；社区200元\n\n居民：与职工相同\n\"","OutpatientEndPayLineThree":"4000元","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"山东","City":"济南","ReimbursementRatio":"根据不同参保人群/医院级别划分","InsuranceType":"(职工)","ReimbursementTreatment":"\"普通门统:\n社区报80%；二级及一级报60%；三级报40%;\n\n住院：三级起付线-1万元报85%；1万-40万报88%；40万-60万报90%；二级及以下起付线-1万报90%；1万-40万报93%；40万-60万报90%\"","OutpatientStartPayLine":"社区400元；二级及一级700元；三级1200元","OutpatientEndPayLine":"3000元","HospitalizationStartPayLine":"三级医院：第一次住院1000元；第二次500元；第三次0元；二级及一级医院:第一次400；第二次200；第三次0元；","HospitalizationEndPayLine":"60万","PolicyLink":"2021年济南市职工医保待遇标准","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"\"普通门统：\n50%\n\"","OutpatientStartPayLineTwo":"0","OutpatientEndPayLineTwo":"400元","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"25万元（含个人按一定比例负担部分）","PolicyLinkTwo":"2021年济南市居民医保待遇标准","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"\"职工：二级以下医院-起付线-1万报销90%；1-40万报销93%；40-60万报90%\n三级医院-起付线-1万元报85%；1万-40万报88%；40-60万报90%\n\n居民：无类风关病种\"","OutpatientStartPayLineThree":"\"职工：社区0元；二级及一级300元；三级600元；省部三级800元；\n\n\"","OutpatientEndPayLineThree":"职工：60万与住院合并；","PolicyLinkThree":"2021年济南市职工/居民医保待遇标准","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"山东","City":"烟台","ReimbursementRatio":"","InsuranceType":"(职工)","ReimbursementTreatment":"住院：一级起付200以上-25万报90%；二级起付500以上报90%；三级起付800以上报85%，800-1w报90%","OutpatientStartPayLine":"普通门诊由个人账户支付，统筹基金不支付","OutpatientEndPayLine":"普通门诊由个人账户支付，统筹基金不支付","HospitalizationStartPayLine":"一级200；二级500；三级800；","HospitalizationEndPayLine":"25万","PolicyLink":"根据不同参保人群/医院级别划分","InsuranceTypeTwo":"(城镇居民)","ReimbursementTreatmentTwo":"\"普通门诊：50%\n门统50%；\n住院：一级基层90%；非基层70%；二级一档58%；二档72%；三级一档45%；二档60%；\"","OutpatientStartPayLineTwo":"0","OutpatientEndPayLineTwo":"居民一档18万；二档22万","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"居民一档18万；二档22万","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"\"职工：恶性肿瘤、糖尿病并发症甲、精神障碍，甲类病种报85%；\n乙类：起付300以上报80%;\n\n居民：甲类一档40%；二档60%；乙类一档35%；二档50%；\n\n\n\n\n\"","OutpatientStartPayLineThree":"\"职工：300元\n\n居民：甲类300；乙类300\"","OutpatientEndPayLineThree":"\"职工单病种3000元\n\n居民一档800；二档1200\"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"山东","City":"潍坊","ReimbursementRatio":"根据不同参保人群/医院级别划分","InsuranceType":"(职工)","ReimbursementTreatment":"仅在签约基层医疗机构有普通门诊统筹，50%报销比例。在职住院报销：社区96%，一级医院92%，二级医院90%，三级医院88%；退休住院报销：社区98%，一级医院96%，二级医院95%，三级医院94%。","OutpatientStartPayLine":"仅在签约基层医疗机构有普通门诊统筹，起付20元","OutpatientEndPayLine":"500元","HospitalizationStartPayLine":"社区400元，一级医院500元，二级医院700元，三级医院900元","HospitalizationEndPayLine":"基本医保6万，大额24万，重特大疾病50万","PolicyLink":"潍坊市城镇职工医疗保险实施办法","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"基层医疗机构有普通门诊统筹，无起付标准，报销比例50%；城镇居民基本医疗保险统筹基金年度最高支付限额为18万元。其中，年度内统筹基金支付额度超出6万元时，超出部分统一按80%的比例支付，最高支付12万元。住院报销比例 一档缴费二档缴费分别为：一级医院85%，90%；二级医院70%，80%；三级医院55%，65%。","OutpatientStartPayLineTwo":"基层医疗机构有普通门诊统筹，无起付标准","OutpatientEndPayLineTwo":"450元","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"18万","PolicyLinkTwo":"潍坊市城镇居民基本医疗保险有关政策","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/城乡居民","ReimbursementTreatmentThree":"报销比例居民： 一档缴费60%，二档缴费70%；职工医保报销 70%。","OutpatientStartPayLineThree":"居民：一级医院200，二级医院600，三级医院900元；职工起付线同一次住院标准","OutpatientEndPayLineThree":"职工：5000元；居民：4000元","PolicyLinkThree":"潍坊市城镇居民基本医疗保险有关政策；潍坊市城镇职工医疗保险实施办法","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"山东","City":"淄博","ReimbursementRatio":"根据不同参保人群/医院级别划分","InsuranceType":"(职工)","ReimbursementTreatment":"城镇职工门诊统筹需要签约，从社区医院转诊，报销比例50%。住院报销比例：根据医疗费金额不同，三级医院，在职74%-90%，退休87%-95%；二级医院在职78%-90%，退休89%-95%；一级医院在职82%-90%，90%-95%。","OutpatientStartPayLine":"无起付标准","OutpatientEndPayLine":"1200元","HospitalizationStartPayLine":"一级医院300元，二级医院500元，三级医院700元","HospitalizationEndPayLine":"基本医保90万；大额医疗救助42万","PolicyLink":"淄博城镇职工基本医疗保险政策","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"城乡居民门诊统筹需要签约，社区转诊报销比例30%。住院报销待遇，一类缴费标准的参保人，一级医院75%-85%，二级医院70%，三级医院55%。二类缴费标准的参保人报销比例降低5个点。","OutpatientStartPayLineTwo":"50元","OutpatientEndPayLineTwo":"900元","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"20万","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/城乡居民","ReimbursementTreatmentThree":"\"职工70%’\n居民55%\"","OutpatientStartPayLineThree":"三级职工500；居民1000","OutpatientEndPayLineThree":"\"职工：4500；\n居民4500\"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"山东","City":"临沂","ReimbursementRatio":"根据不同参保人群/医院级别划分","InsuranceType":"(职工)","ReimbursementTreatment":"社区、乡镇报50%","OutpatientStartPayLine":"个人账户","OutpatientEndPayLine":"300元","HospitalizationStartPayLine":"一级200；二级500；三级1000；其中市内二、三级中医定点分别400；900","HospitalizationEndPayLine":"15万","PolicyLink":"","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"0.55","OutpatientStartPayLineTwo":"1000","OutpatientEndPayLineTwo":"15万","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"15万","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"甲类70%；乙类60%","OutpatientStartPayLineThree":"0","OutpatientEndPayLineThree":"8000","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"山西","City":"太原市","ReimbursementRatio":"0.95","InsuranceType":"(职工)","ReimbursementTreatment":"特药管理，不设起付标准，职工60%，省直职工70%，离休70%。","OutpatientStartPayLine":"不设起付标准","OutpatientEndPayLine":"累计住院费用后达到当年医保基金最高支付限额限制，省直职工50万，职工及离休40万","HospitalizationStartPayLine":"不设起付标准","HospitalizationEndPayLine":"省直职工50万，职工40万，离休职工40万（基本医疗封顶线为8万元，大病封顶线为32万，一年最多可报销40万元）","PolicyLink":"《山西省医保局办公室关于进一步完善国家谈判药品使用管理的通知》（晋医保办发【2021】5号）《太原市基本医疗保险大额门诊特殊药品就医管理实施细则》（并医险中心字【2020】16号）","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"特药管理，不设起付标准，居民50%。","OutpatientStartPayLineTwo":"不设起付标准","OutpatientEndPayLineTwo":"累计住院费用后达到当年医保基金最高支付限额限制，居民47万","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"14万","PolicyLinkTwo":"《山西省医保局办公室关于进一步完善国家谈判药品使用管理的通知》（晋医保办发【2021】5号）《关于规范完善国家医保谈判药品使用管理的通知》（晋医保发【2019】66号）《太原市基本医疗保险大额门诊特殊药品就医管理实施细则》（并医险中心字【2020】16号）","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工、居民","ReimbursementTreatmentThree":"特药管理，不设起付标准，职工60%，省直职工70%，离休70%，居民50%","OutpatientStartPayLineThree":"不设起付标准","OutpatientEndPayLineThree":"累计住院费用后达到当年医保基金最高支付限额限制，省直职工50万，职工及离休40万，居民47万","PolicyLinkThree":"《山西省医保局办公室关于进一步完善国家谈判药品使用管理的通知》（晋医保办发【2021】5号）《关于规范完善国家医保谈判药品使用管理的通知》（晋医保发【2019】66号）《太原市基本医疗保险大额门诊特殊药品就医管理实施细则》（并医险中心字【2020】16号）","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"河北省","City":"石家庄市","ReimbursementRatio":"根据不同参保人群/医院级别划分","InsuranceType":"(职工)","ReimbursementTreatment":"\"门诊：\n乙类药品先行自付5%。一级及以下医疗机构80%，二级70%，三级60%。\n住院：\n1、在职\n【县区住院】一级及以下医疗机构支付比例为92%，二级90%。\n【市区住院】一级医疗机构支付比例90%，二级85%，市属三级医疗机构83%，省属三级医疗机构80%。\n2、退休\n支付比例比在职职工提高3%。\"","OutpatientStartPayLine":"一级及以下医疗机构700元，二级1000元；三级1500元。","OutpatientEndPayLine":"在职1500元/年，退休2500元/年。","HospitalizationStartPayLine":"\"1、在职：\n【县区住院】一级及以下医疗机构每次起付线200元，二级医每次起付线300元。\n【市区住院】一级医疗机构每次起付线200元，二级700元，市属三级医疗机构900元，省属三级医疗机构1200元。\n2、退休：\n起付标准在在职职工基础上降低100元。\"","HospitalizationEndPayLine":"25万元/年","PolicyLink":"关于印发石家庄市城镇职工基本医疗保险实施办法的通知（石政规〔2019〕7号）","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"\"门诊：\n乙类先行自付10%，40元/人/年包干使用。\n住院：\n乙类先行自付10%。\n【县区住院】\n一级及以下医院90，二级80%。\n【市区住院】\n一级医院支付比例为85%，二级医院基70%，市属三级医院65%，省属三级医院60%。\"","OutpatientStartPayLineTwo":"40元/人/年包干使用。","OutpatientEndPayLineTwo":"40元/人/年包干使用。","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"20万元/年","PolicyLinkTwo":"关于印发石家庄市城乡居民基本医疗保险实施办法的通知（石政发〔2016〕59号）","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"\"职工：一级及以下医疗机构90%；二级医疗机构85%；三级医疗机构80%。]\n居民：报销比例60%\"","OutpatientStartPayLineThree":"\"职工200元/年\n居民200元/年\"","OutpatientEndPayLineThree":"\"职工：2000元/年\n居民：800元/年\"","PolicyLinkThree":"\"2017.1.24 - 关于城镇职工基本医疗保险有关问题的通知（石人社字〔2017〕8号）\n2019.12.4 - 关于印发石家庄市城镇职工基本医疗保险实施办法的通知（石政规〔2019〕7号）\"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"河北省","City":"保定","ReimbursementRatio":"根据不同参保人群/医院级别划分","InsuranceType":"(职工)","ReimbursementTreatment":"\"乙类药品先行自付比例5%。\n在职：第一次住院85%，第二次87%，第三次及以上89%。\n退休：第一次住院88%，第二次90%，第三次92%。\"","OutpatientStartPayLine":"普通门诊由个人账户支付费用","OutpatientEndPayLine":"普通门诊由个人账户支付费用","HospitalizationStartPayLine":"一个医疗保险业务年度内，一级医院第一次住院起付标准金为500 元，第二次400 元，第三次及以上300 元；二级医院分别为900 元、800元、700 元；三级医院分别为1200 元、1100 元、1000 元。中医院的住院起付标准金执行一级医院标。","HospitalizationEndPayLine":"9万元","PolicyLink":"关于印发《保定市城镇基本医疗保险生育保险市级统筹实施细则》的通知 （保人社字〔2015〕19号）","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"\"门诊：\n每人每年40元，由参保家庭户共享使用，可结转，不能冲抵参保缴费。\n\n住院：\n【参保县域内】\n乡镇卫生院（社区卫生服务中心）90%，一级及二级医疗机构75%，三级60%。\n【参保县域外统筹市域内】\n二级及以下医疗机构70%，三级55%。\n【统筹市域外】医疗机构50%。\n用中医药治疗的医药和诊疗费用支付比例提高5个百分。对学生儿童（含大学生）一级及以上医疗机构支付比例提高10个百分点。\"","OutpatientStartPayLineTwo":"无","OutpatientEndPayLineTwo":"40元/人/年","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"20万元/年","PolicyLinkTwo":"关于印发《保定市城乡居民基本医疗保险实施办法》的通知（保政发〔2018〕25号）","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"\"职工：80%\n居民：60%\"","OutpatientStartPayLineThree":"\"职工：500元/年\n居民：成人800元/年，学生儿童500元/年\"","OutpatientEndPayLineThree":"\"职工：3100元/年\n居民：1500元/年\"","PolicyLinkThree":"\"关于印发《保定市城乡居民基本医疗保险门诊特殊疾病管理办法》的通知（保医保发〔2019〕48 号）\n关于印发《保定市城镇职工基本医疗保险门诊特殊疾病管理办法》的通知（保医保发〔2019〕47 号）\"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"河北省","City":"邯郸市","ReimbursementRatio":"根据不同参保人群/医院级别划分","InsuranceType":"(职工)","ReimbursementTreatment":"\"门诊：普通门诊由个人账户支付费用\n住院：\n乙类药品先行自付比例5%。\n在职职工在一级及其以下医疗机构92%、二级医疗机构90%、三级医疗机构88%。退休人员相应提高三个百分点。\"","OutpatientStartPayLine":"普通门诊由个人账户支付费用","OutpatientEndPayLine":"普通门诊由个人账户支付费用","HospitalizationStartPayLine":"\"首次住院的起付标准为：三级定点医疗机构900元、二级定点医疗机构600元、一级定点医疗机构300元。\n参保人员在一个年度内多次住院的，第二次住院的起付标准减半计算；第三次及以上住院的起付标准为三级定点医疗\n机构300元，二级定点医疗机构200元，一级定点医疗机构100元。\"","HospitalizationEndPayLine":"8万元/年","PolicyLink":"关于印发邯郸市城镇职工基本医疗保险市级统筹实施细则的通知（市政府〔2014〕91号）","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"\"门诊：50%\n住院：\n乙类药品先行自付比例5%。\n乡镇卫生院、社区卫生服务中心90%;一级医疗机构85%;县统筹区内二级医疗机构77%，县统筹区外二级医疗机构72%;三级医疗机构65%;转外医疗机构50%。住院使用中药(汤剂，目录内中药饮片)支付比例100%。\"","OutpatientStartPayLineTwo":"不设起付线","OutpatientEndPayLineTwo":"75元/年","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"15万元/年","PolicyLinkTwo":"关于印发《邯郸市城乡居民基本医疗保险实施办法》（试行）的通知","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"\"职工：60%\n居民：60%\"","OutpatientStartPayLineThree":"\"职工：无。\n居民：400元，可累计计算，一年只收一次。\"","OutpatientEndPayLineThree":"\"职工：3000元/年\n居民：3000元/年\"","PolicyLinkThree":"\"关于印发《邯郸市城乡居民基本医疗保险长期门诊慢性病暂行管理办法》的通知（邯人社规〔2017〕4号）\n关于落实城乡居民基本医疗保险门诊特殊病医疗保险待遇的通知（邯人社规〔2017〕94号）\n关于印发《邯郸市本级城镇参保职工长期慢性病医疗管理办法》的通知（邯人社〔2011〕39号）\n关于调整市本级城镇职工基本医疗保险尿毒症等特殊病相关政策的通知（邯人社办〔2013〕90号）\"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"河北省","City":"唐山","ReimbursementRatio":"根据不同参保人群/医院级别划分","InsuranceType":"(职工)","ReimbursementTreatment":"\"门诊：普通门诊由个人账户支付费用\n住院：\n乙类药品先行自付比例5%。\n在职职工在一级及其以下医疗机构92%、二级医疗机构90%、三级医疗机构88%。退休人员相应提高三个百分点。\"","OutpatientStartPayLine":"普通门诊由个人账户支付费用","OutpatientEndPayLine":"普通门诊由个人账户支付费用","HospitalizationStartPayLine":"\"首次住院的起付标准为：三级定点医疗机构900元、二级定点医疗机构600元、一级定点医疗机构300元。\n参保人员在一个年度内多次住院的，第二次住院的起付标准减半计算；第三次及以上住院的起付标准为三级定点医疗\n机构300元，二级定点医疗机构200元，一级定点医疗机构100元。\"","HospitalizationEndPayLine":"8万元/年","PolicyLink":"关于印发邯郸市城镇职工基本医疗保险市级统筹实施细则的通知（市政府〔2014〕91号）","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"\"门诊：50%\n住院：\n乙类药品先行自付比例5%。\n乡镇卫生院、社区卫生服务中心90%;一级医疗机构85%;县统筹区内二级医疗机构77%，县统筹区外二级医疗机构72%;三级医疗机构65%;转外医疗机构50%。住院使用中药(汤剂，目录内中药饮片)支付比例100%。\"","OutpatientStartPayLineTwo":"不设起付线","OutpatientEndPayLineTwo":"75元/年","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"15万元/年","PolicyLinkTwo":"关于印发《邯郸市城乡居民基本医疗保险实施办法》（试行）的通知","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"\"职工：80%\n居民：65%\"","OutpatientStartPayLineThree":"\"职工：390元/年\n居民：480元/年\"","OutpatientEndPayLineThree":"\"职工：3000元/年\n居民：2000元/年\"","PolicyLinkThree":"\"2021.4.21 - 关于调整基本医疗保险有关规定的通知（唐医保字〔2021〕39号）\n2017.12.29 - 关于印发唐山市城镇职工基本医疗保险实施办法的通知（唐政发〔2017〕25号）\n2016.12.5 - 于印发唐山市城乡居民基本医疗保险门诊特殊疾病管理办法的通知（唐人社发〔2016〕19号）\"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"河北省","City":"秦皇岛","ReimbursementRatio":"1","InsuranceType":"(职工)","ReimbursementTreatment":"普通门诊统筹基金的起付标准为100元。起付标准以上合规医疗费用在职职工支付比例为50%，退休职工支付比例为60%，省外异地就医降低5%，最高支付限额为每人每年2000元。乙类按95%计入基本医疗保险支付范围，住院待遇：在职一级95%，二级92%，三级87%；退休一级96%，二级95%，三级92%。","OutpatientStartPayLine":"100元","OutpatientEndPayLine":"2000元","HospitalizationStartPayLine":"\"一级医疗机构 400元；\n二级医疗机构 600元；\n三级医疗机构 800元；\n\"","HospitalizationEndPayLine":"职工基本医疗保险统筹基金最高支付限额为每人每年15万元（职工大病保险基金年度最高支付限额为50万元）","PolicyLink":"秦皇岛市市本级职工大病保险实施细则","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"\"一、门诊报销比例50%；\n二、参保居民在省内及京津直接定点医疗机构就医政策范围内基金支付比例：一级定点医疗机构（含乡镇卫生院、社区卫生服务中心）90%；二级定点医疗机构75%；三级定点医疗机构60%。在省外医保定点医疗机构异地就医基金支付比例：一级定点医疗机构（含乡镇卫生院、社区卫生服务中心）70%；二级定点医疗机构60%；三级定点医疗机构50%。\"","OutpatientStartPayLineTwo":"50元","OutpatientEndPayLineTwo":"65","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"基金最高支付限额为每人每年15万元。（大病保险为每人每年40万元）","PolicyLinkTwo":"秦皇岛市城镇居民基本医疗保险市级统筹实施细则、秦皇岛市城乡居民大病保险市级统筹实施细则","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"药品自付比例10%，1.职工医保：符合门诊慢特病病种支付范围的医疗费用，不设起付线，谈判药、集采药按相关政策执行后，甲类、乙类医疗费用报销比例统一确定为80%，退休人员增加3%，省外异地就医降低5%；2.居民：起付线100元，统筹基金支付90%","OutpatientStartPayLineThree":"1、职工不设起付标准；2、居民100元","OutpatientEndPayLineThree":"职工2000元/年；居民800元","PolicyLinkThree":"秦皇岛市医疗保障局秦皇岛市人力资源和社会保障局关于非肿瘤类谈判药品自付比例调整的通知（秦医保〔2021〕34号）","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"河南","City":"郑州","ReimbursementRatio":"根据不同参保人群/医院级别划分","InsuranceType":"(职工)","ReimbursementTreatment":"\"门诊：普通门诊由个人账户支付费用。\n住院：\n在职，社区卫生服务机构95%，一类医疗机构95%，二类医疗机构90%，三类医疗机构88%；\n退休，社区卫生服务机构97%，一类医疗机构97%，二类医疗机构95%，三类医疗机构93%。\"","OutpatientStartPayLine":"普通门诊由个人账户支付费用","OutpatientEndPayLine":"普通门诊由个人账户支付费用","HospitalizationStartPayLine":"\"社区卫生服务机构（包括乡镇卫生院，下同）200元，一类医疗机构300元，二类医疗机构600元，三类医疗机构900元。\n同一自然年度内出院后再次住院，起付标准降低50%。\"","HospitalizationEndPayLine":"15万元/年","PolicyLink":"郑州市人民政府办公厅关于印发郑州市职工基本医疗保险办法的通知（郑政办〔2018〕3号）","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"\"门诊：\n市级(或二类)45%、县级(或一类)55%、乡镇卫生院、社区卫生服务中心(站、所)、村卫生室65%。\n住院：\n社区卫生服务中心（含乡镇卫生院）住院，报销比例：150元-1000元80%，1000元以上90%；\n县区级医疗机构住院，报销比例：600元-3000元65%，3000元以上75%；\n市级医疗机构住院，报销比例：1200-5000元60%，5000元以上70%；\n省级医疗机构住院，报销比例：2000-8000元55%6；8000元以上65%。\"","OutpatientStartPayLineTwo":"不设起付线","OutpatientEndPayLineTwo":"150元/年","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"15万元/年","PolicyLinkTwo":"\"郑州市人民政府办公厅关于印发郑州市城乡居民基本医疗保险办法(试行)的通知（郑政办〔2016 〕78 号）\n《关于做好2019年城乡居民基本医疗保障工作的通知》（郑医保〔2019〕8号）\"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"\"职工85%，居民80%\n\"","OutpatientStartPayLineThree":"\"职工：不设起付线\n居民：不设起付线\"","OutpatientEndPayLineThree":"1盒/4周","PolicyLinkThree":"\"2021.4.28 - 关于调整河南省基本医疗保险门诊特定药品范围的通知（豫医保〔2021〕1号）\n2021.5.8 - 关于进一步规范河南省省直职工基本医疗保险门诊特定药品和重特大疾病用药管理的通知（豫医保中心〔2021〕17号）\"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"河南","City":"南阳","ReimbursementRatio":"根据不同参保人群/医院级别划分","InsuranceType":"(职工)","ReimbursementTreatment":"市域内，一级、二级、三级医疗机构合规费用支付比例分别为88%、83%、78%，对退休人员的支付比例在上述标准的基础上提高5%；市域外，支付比例较市域内相应级别医院降低10%。参加大额补充医疗保险的人员，在一个自然年度内发生的合规医疗费用，超过基本医保最高支付限额以上部分，职工大额补充医疗保险报销为90%。","OutpatientStartPayLine":"职工暂未开展门诊统筹","OutpatientEndPayLine":"职工暂未开展门诊统筹","HospitalizationStartPayLine":"市域内每次住院起付标准600元；市域外省内每次住院1500元，省外每次住院2000元。","HospitalizationEndPayLine":"职工医保基本医疗保险统筹基金最高支付6万元(不含生育津贴)，大额医疗保险基金最高支付54万元","PolicyLink":"南阳市基本医疗保险和生育保险市级统筹实施细则（暂行）》","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"乡级(乡镇卫生院或社区医疗机构)合规费用支付比例200-1000元(含下限不含上限，下同)的为75%;1000-2000元为80%，2000元以上为90%;县级(二级或相当规模以下医院)合规费用支付比例500-1500元为63%，1500-5000元为73%，5000元以上为85%;市级(二级或相当规模以下医院)合规费用支付比例600-3000元为55%，3000-6000元为65%，6000元以上为75%，市级(三级医院)合规费用支付比例1200-4000元为53%，4000-9000元为65%，9000元以上为75%。省级(二级或相当规模以下医院)合规费用支付比例1200-5000元为50%，5000元以上为70%，省级(三级医院)及省外合规费用支付比例2000-9000元为50%，9000元以上为60%。对80岁以上参保的城乡居民住院医疗费政策范围内支付比例在原有基础上提高5%","OutpatientStartPayLineTwo":"无","OutpatientEndPayLineTwo":"300元/年","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"城乡居民医保基本医疗保险统筹基金最高支付15万元，城乡居民大病保险最高支付40万元","PolicyLinkTwo":"南阳市人民政府办公室关于印发南阳市城乡居民基本医疗保险实施办法(试行)的通知（正宛政办[2016]91）","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"\"职工85%，居民80%\n\"","OutpatientStartPayLineThree":"\"职工：不设起付线\n居民：不设起付线\"","OutpatientEndPayLineThree":"1盒/4周","PolicyLinkThree":"\"2021.4.28 - 关于调整河南省基本医疗保险门诊特定药品范围的通知（豫医保〔2021〕1号）\n2021.5.8 - 关于进一步规范河南省省直职工基本医疗保险门诊特定药品和重特大疾病用药管理的通知（豫医保中心〔2021〕17号）\"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"河南","City":"焦作","ReimbursementRatio":"","InsuranceType":"(职工)","ReimbursementTreatment":"住院报销比例三级综合医疗机构80%，二级医疗机构85%，一级医疗机构90%；","OutpatientStartPayLine":"住院报销比例三级综合医疗机构80%，二级医疗机构85%，一级医疗机构90%；","OutpatientEndPayLine":"住院报销比例三级综合医疗机构80%，二级医疗机构85%，一级医疗机构90%；","HospitalizationStartPayLine":"住院报销比例三级综合医疗机构80%，二级医疗机构85%，一级医疗机构90%；","HospitalizationEndPayLine":"住院报销比例三级综合医疗机构80%，二级医疗机构85%，一级医疗机构90%；","PolicyLink":"住院报销比例三级综合医疗机构80%，二级医疗机构85%，一级医疗机构90%；","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"参保居民发生的住院医疗费用且由城镇居民基本医疗保险统筹基金支付的，其起付标准、统筹基金支付比例为：一级医疗机构200元、85%；二级医疗机构600元、75%；三级医疗机构800元、70%；经批准转统筹区外定点医疗机构800元、60%。门诊报销不设起付线，按55%比例报销，一年内累计报销额度为300元","OutpatientStartPayLineTwo":"不设起付线","OutpatientEndPayLineTwo":"300元","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"6万元","PolicyLinkTwo":"焦作市城镇医疗保险筹资标准及报销政策","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"\"职工85%，居民80%\n\"","OutpatientStartPayLineThree":"\"职工：不设起付线\n居民：不设起付线\"","OutpatientEndPayLineThree":"1盒/4周","PolicyLinkThree":"\"2021.4.28 - 关于调整河南省基本医疗保险门诊特定药品范围的通知（豫医保〔2021〕1号）\n2021.5.8 - 关于进一步规范河南省省直职工基本医疗保险门诊特定药品和重特大疾病用药管理的通知（豫医保中心〔2021〕17号）\"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"辽宁","City":"沈阳","ReimbursementRatio":"","InsuranceType":"(职工)","ReimbursementTreatment":"\"门诊报销统筹基金支付比例在职职工为60%，退休人员为65%。\n住院在职人员一级94%，区属二级93%，市属二级93%，三级88%，特大型三级86%；住院退休人员再增加3%..\"","OutpatientStartPayLine":"20元","OutpatientEndPayLine":"150/月","HospitalizationStartPayLine":"一级300，区属二级400，市属二级500，三级800，特大型三级1200","HospitalizationEndPayLine":"基本医疗保险15万元；大额医疗费用补助45万元；","PolicyLink":"沈阳市城镇职工门诊统筹就医指南；沈阳市城镇职工基本医疗保险参保就医指南","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"\"统筹基金支付比例为55%，起付标准和最高支付限额标准累计计算。\n居民医保住院支付比例：基层卫生医疗机构90%、一级85%、二级80%、三级75%、特三级70%。其中，成年居民在特三级定点医疗机构一个自然年度内单次住院发生的起付标准以上部分实行分段支付，1.5万元及以下部分支付比例为60%，1.5万元以上部分支付比例为70%。\"","OutpatientStartPayLineTwo":"40元/季度","OutpatientEndPayLineTwo":"150元/季度","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"15万元","PolicyLinkTwo":"沈阳市城乡居民基本医疗保险实施细则（沈医保发【2019】139号）","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/城乡居民","ReimbursementTreatmentThree":"\"职工医保统筹基金支付比例：在职报销75%，退休报销85%。\n居民医保统筹基金支付比例为：基层卫生医疗机构（包括一级乡镇卫生院及社区卫生服务机构）85%；一级医疗机构80%；二级医疗机构70%；三级医疗机构60%；特三级医疗机构55%。\"","OutpatientStartPayLineThree":"不设起付标准","OutpatientEndPayLineThree":"类风湿性关节炎：职工：350元/月；居民2600元/年","PolicyLinkThree":"沈阳市基本医保门诊规定病种及待遇标准表；沈阳市城镇职工基本医疗保险门诊规定病种管理办法;沈阳市城乡居民医疗保险门诊规定病种管理办法","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"辽宁","City":"大连","ReimbursementRatio":"","InsuranceType":"(职工)","ReimbursementTreatment":"\"（一）支付比例。参保人员在定点社区卫生服务机构和一级定点医疗机构就诊的，门诊统筹基金支付45%；在统筹地区外，异地安置人员在安置地所选定点医疗机构就诊的支付30%。\n（二）最高支付限额。门诊统筹基金支付参保人员普通门诊医疗费用年度内按季度设定最高支付限额，每季度最高支付限额为180元。限额不滚存、不累计。\"","OutpatientStartPayLine":"不设起付标准","OutpatientEndPayLine":"180元/季度","HospitalizationStartPayLine":"三级医院为1200元或850元，二级医院及专科医院为500元，一级医院为300元。转诊异地住院治疗，起付标准为1500元。","HospitalizationEndPayLine":"25万+35万元","PolicyLink":"\"大连市职工基本医疗保险门诊医疗费用统筹办法（大人社发[2013]222号）；\n大连市职工基本医疗保险规定\"","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"\"门诊：统筹基金支付比例为50%。\n住院：1.未成年居民、大学生按照三级医院、二级及专科医院、一级医院、基层医疗机构及护理院分别为70%、80%、85%和90%;\n　　2.成年居民在三级甲等医院住院发生的起付标准以上保内医疗费用实行分段支付：2万元及以下的部分支付比例为50%、2万元以上的部分支付比例为65%;在其他三级医院、二级及专科医院、一级医院、基层医疗机构及护理院支付比例分别为65%、75%、80%和85%.\"","OutpatientStartPayLineTwo":"30元/季度","OutpatientEndPayLineTwo":"未成年人和大学生为100元/季度，成年人为50元/季度","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"未成年居民、大学生为20万元；成年居民为15万元。","PolicyLinkTwo":"大连市城镇居民基本医疗保险实施办法","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"职工：85%报销比例；居民:未成年人大学生75%，成年人65%","OutpatientStartPayLineThree":"职工300元；居民不设起付标准","OutpatientEndPayLineThree":"类风关：职工1800元/年；居民1200元/年，","PolicyLinkThree":"\"\n大连市职工基本医疗保险门诊规定病种管理办法\n大连市城镇居民基本医疗保险实施办法\"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"辽宁","City":"鞍山","ReimbursementRatio":"","InsuranceType":"(职工)","ReimbursementTreatment":"在职职工住院基金支付三级医院80%，二级医院82%，一级医院85%，退休职工再增加5%。","OutpatientStartPayLine":"个人帐户主要用于支付门诊医疗费用；统筹基金不支付普通门诊费用","OutpatientEndPayLine":"个人帐户主要用于支付门诊医疗费用；统筹基金不支付普通门诊费用","HospitalizationStartPayLine":"三级700元，二级500元，一级300元","HospitalizationEndPayLine":"基本医疗保险6万；超限额补充医疗保险每年最高报销50万元","PolicyLink":"鞍山市城镇职工基本医疗保险制度改革试行方案","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"\"居民门诊医疗费首次起付标准为40元，年度内第二次以后（含第二次）起付标准减半均为20元，年度门诊医疗费起付标准累计不超过200元。门诊年度统筹基金累计最高支付限额为400元，每次统筹基金最高支付限额为100元。低于起付标准和超过最高支付限额的医疗费由个人支付。起付标准以上、最高限额以下的医疗费，由门诊统筹金按50%比例支付，其余部分由个人支付。\n居民住院报销起付标准以上至10000元，特三级60%，三级65%，二级75%，一级80%；超出10000元以上部分，特三级65%，三级70%，二级80%，一级80%\"","OutpatientStartPayLineTwo":"40元","OutpatientEndPayLineTwo":"400元/年","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"基本医疗保险6万元；超出部分大病保险支付，大病保险不设限额。","PolicyLinkTwo":"鞍山市城乡居民医疗保险实施细则","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/城乡居民","ReimbursementTreatmentThree":"按照住院报销比例","OutpatientStartPayLineThree":"不设起付标准","OutpatientEndPayLineThree":"职工：类风关150元/月","PolicyLinkThree":"鞍人社发 【2010】 35号；鞍人社发【2011】33号，鞍山市城乡居民医疗保险实施细则","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"辽宁","City":"本溪","ReimbursementRatio":"","InsuranceType":"(职工)","ReimbursementTreatment":"\"在三级定点医院就医的，在职职工统筹基金支付比例为85%，退休人员为90%；\n（二）在二级及以下定点医院就医的，在职职工统筹基金支付比例为87%，退休人员为92%；\"","OutpatientStartPayLine":"个人帐户主要用于支付门诊医疗费用；统筹基金不支付普通门诊费用","OutpatientEndPayLine":"个人帐户主要用于支付门诊医疗费用；统筹基金不支付普通门诊费用","HospitalizationStartPayLine":"\"三级甲等医院800元/人次；三级乙等医院600元/人次；二级甲等医院500元/人次（本钢南芬医院、北钢医院400元/人次）；二级乙等医院400元/人次；一级及以下医院300元/人次。\n2．在一个年度内多次住院的，起付标准依次降低100元，但最低不低于300元/人次。\"","HospitalizationEndPayLine":"基本医疗保险6万元 ；大额医疗补充保险统筹基金24万元","PolicyLink":"\"本溪市城镇职工基本医疗保险制度实施方案\n本人社发【2018】17号\"","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"\"门诊：在村卫生室、乡镇卫生院、社区卫生服务中心和大中专院校门诊就医的，基金按50%比例支付，在县域内二级医疗机构门诊就医的，基金按20%比例支付。\n住院：参保居民在本市定点医院住院的社区卫生服务中心及乡镇卫生院85%。二级及二级以下医院75%；三级医院55%。其中，大中小学生在三级医院住院基金按照65%比例支付。\"","OutpatientStartPayLineTwo":"普通门诊合规医疗费用基金支付起付标准为每人每年100元","OutpatientEndPayLineTwo":"300元/年","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"基本医疗保险6万元；大额医疗补充保险12万","PolicyLinkTwo":"\"本溪市城镇居民基本医疗保险\n实施细则\n\"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"","ReimbursementTreatmentThree":"","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"黑龙江","City":"哈尔滨","ReimbursementRatio":"0.6","InsuranceType":"(职工)","ReimbursementTreatment":"个人自付 40% 后，统筹基金按照规定比例支付","OutpatientStartPayLine":"","OutpatientEndPayLine":"","HospitalizationStartPayLine":"社区200元、一级240元、二级480元、三级720元。","HospitalizationEndPayLine":"15万/年+大病35万/年","PolicyLink":"\"关于调整哈尔滨市城镇基本医疗保险生育保险待遇标准的通知，《黑龙江省基本医疗保险、工伤保险\n和生育保险药品目录》\"","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"个人自付 40% 后，统筹基金按照规定比例支付","OutpatientStartPayLineTwo":"","OutpatientEndPayLineTwo":"","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"18万/年","PolicyLinkTwo":"\"《关于做好2019年城乡居民基本医疗保障工作的通知》 《黑龙江省基本医疗保险、工伤保险\n和生育保险药品目录》\n\"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工、居民","ReimbursementTreatmentThree":"个人自付 40% 后，统筹基金按照规定比例支付","OutpatientStartPayLineThree":"特药门诊治疗不设起付线","OutpatientEndPayLineThree":"同住院","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"黑龙江","City":"大庆","ReimbursementRatio":"55-70%","InsuranceType":"(职工)","ReimbursementTreatment":"一、谈判药品先行自付30%后住院按85%报销，门诊按85%报销","OutpatientStartPayLine":"","OutpatientEndPayLine":"","HospitalizationStartPayLine":"1.市内三级甲等医院800元，其他三级医院600元；2. 市内区级医院、厂矿医院和民营医院400元；3.市内乡镇卫生院和 社区卫生服务中心200元；4.当年多次住院的，起付标准依次递减 100元，递减到200元为止","HospitalizationEndPayLine":"基本医保10万元/年，大额医疗保险基金年度最高支付限额17万元","PolicyLink":"_","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"特药先行自付45%，住院按55%、60%，门诊按80%","OutpatientStartPayLineTwo":"不设起付标准","OutpatientEndPayLineTwo":"同住院","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"15万元","PolicyLinkTwo":"大庆市城镇居民基本医疗保险管理办法的通知","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工、居民","ReimbursementTreatmentThree":"一、居民：1、参保人员发生的门诊慢性病费用，起付标准为300元，核销比例为60%。2参保人员认定两种（含两种）以上门诊慢性病的，按照病种补助标准最高一种疾病的定额标准执行。3、 门诊慢性病报销费用支出与其他统筹基金支出累计计算，累计支出之和不超过统筹基金年度最高支付限额。二、职工：1、门诊指定慢性疾病费用报销的年度起付标准为600元，参加基本医疗保险的，报销70%。2、各病种年度定额标准不含起付标准和自付比例费用，年度内超门诊指定慢性疾病定额以上费用不予报销。享受待遇年度指自然年度。3、 参保人员认定为两种门诊指定慢性疾病的，报销金额在较高的一种疾病定额基础上增加500元；认定为三种（含三种）以上门诊指定慢性疾病的，在最高一种疾病定额基础上增加2000元。4、 门诊指定慢性疾病统筹基金支出与其他统筹基金支出累计计算，累计支出之和不超过本人统筹基金年度最高支付限额。也可选择特药待遇报销","OutpatientStartPayLineThree":"职工600元；居民300元","OutpatientEndPayLineThree":"居民：1500元/年、职工：2000元","PolicyLinkThree":"\"大庆市城镇职工医疗保险门诊指定慢性疾病及门诊大病管理办法；大庆市城镇居民基本医疗保险管理办法的通知 \n\"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"黑龙江","City":"齐齐哈尔","ReimbursementRatio":"","InsuranceType":"(职工)","ReimbursementTreatment":"住院55%，门诊55%","OutpatientStartPayLine":"统筹基金不支付普通门诊费用","OutpatientEndPayLine":"统筹基金不支付普通门诊费用","HospitalizationStartPayLine":"1.市内三级甲等医院800元，其他三级医院600元；2. 市内区级医院、厂矿医院和民营医院400元；3.市内乡镇卫生院和 社区卫生服务中心200元；4.当年多次住院的，起付标准依次递减 100元，递减到200元为止","HospitalizationEndPayLine":"基本医保10万元/年，大额医疗保险基金年度最高支付限额17万元","PolicyLink":"","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"住院50%，门诊50%","OutpatientStartPayLineTwo":"不设起付标准","OutpatientEndPayLineTwo":"门诊统筹报销比例为70%，年度最高支付限额为100元","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"15万元","PolicyLinkTwo":"大庆市城镇居民基本医疗保险管理办法的通知","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工、居民","ReimbursementTreatmentThree":"职工：80%报销封顶4800元/年。居民：60%报销封顶2400元/年，","OutpatientStartPayLineThree":"不设起付标准","OutpatientEndPayLineThree":"居民：2400元/年、职工：4800元","PolicyLinkThree":"齐齐哈尔市医疗保障局关于规范基本医疗保险门诊慢性病和门诊特殊疾病（治疗）的通知","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"黑龙江","City":"牡丹江","ReimbursementRatio":"0.6","InsuranceType":"(职工)","ReimbursementTreatment":"\"住院60%*90%，\n门诊60%*85%\"","OutpatientStartPayLine":"统筹基金不支付普通门诊费用","OutpatientEndPayLine":"统筹基金不支付普通门诊费用","HospitalizationStartPayLine":"1.市内三级甲等医院800元，其他三级医院600元；2. 市内区级医院、厂矿医院和民营医院400元；3.市内乡镇卫生院和 社区卫生服务中心200元；4.当年多次住院的，起付标准依次递减 100元，递减到200元为止","HospitalizationEndPayLine":"基本医保10万元/年，大额医疗保险基金年度最高支付限额17万元","PolicyLink":"关于加强牡丹江市基本医疗保险特殊药品管理工作的通知","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"\"住院60%*50%，\n门诊60%*65%\"","OutpatientStartPayLineTwo":"不设起付标准","OutpatientEndPayLineTwo":"同住院","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"15万元","PolicyLinkTwo":"大庆市城镇居民基本医疗保险管理办法的通知","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工、居民","ReimbursementTreatmentThree":"按特药待遇报销","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"否","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"广东","City":"深圳","ReimbursementRatio":"一档（职工）：100%","InsuranceType":"(职工)","ReimbursementTreatment":"1 门诊：基本医疗保险一档参保人个人账户用于支付参保人门诊基本医疗费用、地方补充医疗费用、在定点零售药店凭本市市内定点医疗机构医生开具的处方购买医疗保险目录范围内药品的费用，个人账户不足支付部分由个人自付。基本医疗保险一档参保人连续参保满一年，在同一医疗保险年度内个人自付的门诊基本医疗费用和地方补充医疗费用超过本市上年度在岗职工平均工资5%的，超过部分由基本医疗保险大病统筹基金或地方补充医疗保险基金按规定支付70%，参保人年满70周岁以上的支付80%。   基本医疗保险一档参保人在本市定点社康中心发生的基本医疗费用和地方补充医疗费用，70%由其个人账户支付，30%由基本医疗保险大病统筹基金、地方补充医疗保险基金按规定支付                               2 住院：基本医疗保险一档参保人按8%缴交基本医疗保险费的支付比例为90%；","OutpatientStartPayLine":"基本医疗保险一档参保人连续参保满一年，在同一医疗保险年度内个人自付的门诊基本医疗费用和地方补充医疗费用超过本市上年度在岗职工平均工资5%的，","OutpatientEndPayLine":"\"基本医疗保险统筹基金支付限额：1. 连续参保时间不满6个月的，为本市上年度在岗职工平均工资的1倍；2 连续参保时间满6个月不满12个月的，为本市上年度在岗职工平均工资的2倍；\n　3 连续参保时间满12个月不满24个月的，为本市上年度在岗职工平均工资的3倍；4 连续参保时间满24个月不满36个月的，为本市上年度在岗职工平均工资的4倍；5 连续参保时间满36个月不满72个月的，为本市上年度在岗职工平均工资的5倍；6 连续参保时间满72个月以上的，为本市上年度在岗职工平均工资的6倍。   地补限额：1 连续参保时间不满6个月的，为1万元；\n2 连续参保时间满6个月不满12个月的，为5万元；3 连续参保时间满12个月不满24个月的，为10万元；\n4 连续参保时间满24个月不满36个月的，为15万元； 5 连续参保时间满36个月不满72个月的，为20万元； 6 连续参保时间满72个月以上的，为100万元。\n\n\"","HospitalizationStartPayLine":"起付线按照医院级别设定，市内一级以下医院为100元，二级医院为200元，三级医院为300元；市外医疗机构已按规定办理转诊或备案的为400元，未按规定办理转诊或备案的为1000元。","HospitalizationEndPayLine":"\"基本医疗保险统筹基金支付限额：1. 连续参保时间不满6个月的，为本市上年度在岗职工平均工资的1倍；2 连续参保时间满6个月不满12个月的，为本市上年度在岗职工平均工资的2倍；\n　3 连续参保时间满12个月不满24个月的，为本市上年度在岗职工平均工资的3倍；4 连续参保时间满24个月不满36个月的，为本市上年度在岗职工平均工资的4倍；5 连续参保时间满36个月不满72个月的，为本市上年度在岗职工平均工资的5倍；6 连续参保时间满72个月以上的，为本市上年度在岗职工平均工资的6倍。   地补限额：1 连续参保时间不满6个月的，为1万元；\n2 连续参保时间满6个月不满12个月的，为5万元；3 连续参保时间满12个月不满24个月的，为10万元；\n4 连续参保时间满24个月不满36个月的，为15万元； 5 连续参保时间满36个月不满72个月的，为20万元； 6 连续参保时间满72个月以上的，为100万元。\n\n\"","PolicyLink":"深圳市社会医疗保险办法","InsuranceTypeTwo":"(二档、三档)","ReimbursementTreatmentTwo":"\"属于基本医疗保险药品目录中甲类药品和乙类药品的，分别由社区门诊统筹基金按80%和60%的比例支付；\n参保人因病情需要经结算医院同意转诊到其他医疗机构发生的门诊医疗费用，或因工外出、出差在非结算医院发生的急诊抢救门诊医疗费用，由社区门诊统筹基金按前款规定支付标准的90%报销；其他情形在非结算医院发生的门诊医疗费用社区门诊统筹基金不予报销。\n社区门诊统筹基金在一个医疗保险年度内支付给每位基本医疗保险二档、三档参保人的门诊医疗费用，总额最高不得超过1000元。\n\"","OutpatientStartPayLineTwo":"不设起付线","OutpatientEndPayLineTwo":"1000元/年","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"\"基本医疗保险统筹基金支付限额：1. 连续参保时间不满6个月的，为本市上年度在岗职工平均工资的1倍；2 连续参保时间满6个月不满12个月的，为本市上年度在岗职工平均工资的2倍；\n　3 连续参保时间满12个月不满24个月的，为本市上年度在岗职工平均工资的3倍；4 连续参保时间满24个月不满36个月的，为本市上年度在岗职工平均工资的4倍；5 连续参保时间满36个月不满72个月的，为本市上年度在岗职工平均工资的5倍；6 连续参保时间满72个月以上的，为本市上年度在岗职工平均工资的6倍。   地补限额：1 连续参保时间不满6个月的，为1万元；\n2 连续参保时间满6个月不满12个月的，为5万元；3 连续参保时间满12个月不满24个月的，为10万元；\n4 连续参保时间满24个月不满36个月的，为15万元； 5 连续参保时间满36个月不满72个月的，为20万元； 6 连续参保时间满72个月以上的，为100万元。\n\n\"","PolicyLinkTwo":"深圳市社会医疗保险办法","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"","ReimbursementTreatmentThree":"0.9","OutpatientStartPayLineThree":"不设起付线","OutpatientEndPayLineThree":"1万元/年","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"广东","City":"深圳","ReimbursementRatio":"一档（职工）：100%","InsuranceType":"(职工)","ReimbursementTreatment":"1 门诊：基本医疗保险一档参保人个人账户用于支付参保人门诊基本医疗费用、地方补充医疗费用、在定点零售药店凭本市市内定点医疗机构医生开具的处方购买医疗保险目录范围内药品的费用，个人账户不足支付部分由个人自付。基本医疗保险一档参保人连续参保满一年，在同一医疗保险年度内个人自付的门诊基本医疗费用和地方补充医疗费用超过本市上年度在岗职工平均工资5%的，超过部分由基本医疗保险大病统筹基金或地方补充医疗保险基金按规定支付70%，参保人年满70周岁以上的支付80%。   基本医疗保险一档参保人在本市定点社康中心发生的基本医疗费用和地方补充医疗费用，70%由其个人账户支付，30%由基本医疗保险大病统筹基金、地方补充医疗保险基金按规定支付                               2 住院：基本医疗保险一档参保人按8%缴交基本医疗保险费的支付比例为90%；","OutpatientStartPayLine":"基本医疗保险一档参保人连续参保满一年，在同一医疗保险年度内个人自付的门诊基本医疗费用和地方补充医疗费用超过本市上年度在岗职工平均工资5%的，","OutpatientEndPayLine":"\"基本医疗保险统筹基金支付限额：1. 连续参保时间不满6个月的，为本市上年度在岗职工平均工资的1倍；2 连续参保时间满6个月不满12个月的，为本市上年度在岗职工平均工资的2倍；\n　3 连续参保时间满12个月不满24个月的，为本市上年度在岗职工平均工资的3倍；4 连续参保时间满24个月不满36个月的，为本市上年度在岗职工平均工资的4倍；5 连续参保时间满36个月不满72个月的，为本市上年度在岗职工平均工资的5倍；6 连续参保时间满72个月以上的，为本市上年度在岗职工平均工资的6倍。   地补限额：1 连续参保时间不满6个月的，为1万元；\n2 连续参保时间满6个月不满12个月的，为5万元；3 连续参保时间满12个月不满24个月的，为10万元；\n4 连续参保时间满24个月不满36个月的，为15万元； 5 连续参保时间满36个月不满72个月的，为20万元； 6 连续参保时间满72个月以上的，为100万元。\n\n\"","HospitalizationStartPayLine":"起付线按照医院级别设定，市内一级以下医院为100元，二级医院为200元，三级医院为300元；市外医疗机构已按规定办理转诊或备案的为400元，未按规定办理转诊或备案的为1000元。","HospitalizationEndPayLine":"\"基本医疗保险统筹基金支付限额：1. 连续参保时间不满6个月的，为本市上年度在岗职工平均工资的1倍；2 连续参保时间满6个月不满12个月的，为本市上年度在岗职工平均工资的2倍；\n　3 连续参保时间满12个月不满24个月的，为本市上年度在岗职工平均工资的3倍；4 连续参保时间满24个月不满36个月的，为本市上年度在岗职工平均工资的4倍；5 连续参保时间满36个月不满72个月的，为本市上年度在岗职工平均工资的5倍；6 连续参保时间满72个月以上的，为本市上年度在岗职工平均工资的6倍。   地补限额：1 连续参保时间不满6个月的，为1万元；\n2 连续参保时间满6个月不满12个月的，为5万元；3 连续参保时间满12个月不满24个月的，为10万元；\n4 连续参保时间满24个月不满36个月的，为15万元； 5 连续参保时间满36个月不满72个月的，为20万元； 6 连续参保时间满72个月以上的，为100万元。\n\n\"","PolicyLink":"深圳市社会医疗保险办法","InsuranceTypeTwo":"(二档、三档)","ReimbursementTreatmentTwo":"\"属于基本医疗保险药品目录中甲类药品和乙类药品的，分别由社区门诊统筹基金按80%和60%的比例支付；\n参保人因病情需要经结算医院同意转诊到其他医疗机构发生的门诊医疗费用，或因工外出、出差在非结算医院发生的急诊抢救门诊医疗费用，由社区门诊统筹基金按前款规定支付标准的90%报销；其他情形在非结算医院发生的门诊医疗费用社区门诊统筹基金不予报销。\n社区门诊统筹基金在一个医疗保险年度内支付给每位基本医疗保险二档、三档参保人的门诊医疗费用，总额最高不得超过1000元。\n\"","OutpatientStartPayLineTwo":"不设起付线","OutpatientEndPayLineTwo":"1000元/年","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"\"基本医疗保险统筹基金支付限额：1. 连续参保时间不满6个月的，为本市上年度在岗职工平均工资的1倍；2 连续参保时间满6个月不满12个月的，为本市上年度在岗职工平均工资的2倍；\n　3 连续参保时间满12个月不满24个月的，为本市上年度在岗职工平均工资的3倍；4 连续参保时间满24个月不满36个月的，为本市上年度在岗职工平均工资的4倍；5 连续参保时间满36个月不满72个月的，为本市上年度在岗职工平均工资的5倍；6 连续参保时间满72个月以上的，为本市上年度在岗职工平均工资的6倍。   地补限额：1 连续参保时间不满6个月的，为1万元；\n2 连续参保时间满6个月不满12个月的，为5万元；3 连续参保时间满12个月不满24个月的，为10万元；\n4 连续参保时间满24个月不满36个月的，为15万元； 5 连续参保时间满36个月不满72个月的，为20万元； 6 连续参保时间满72个月以上的，为100万元。\n\n\"","PolicyLinkTwo":"深圳市社会医疗保险办法","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"","ReimbursementTreatmentThree":"0.9","OutpatientStartPayLineThree":"不设起付线","OutpatientEndPayLineThree":"计入年度支付限额约53万+100万（补充医疗保险）","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"广东","City":"佛山","ReimbursementRatio":"0.9","InsuranceType":"一档、二档（有个帐）","ReimbursementTreatment":"\"门诊：属于《广东省基本医疗保险、工伤保险和生育保险药品目录（2010年版）》中规定的药品费用和纳入报销范围的常规基本医疗服务项目）所发生的费用，由统筹基金按以下规定支付：\n一类医疗机构90％。\n二类医疗机构70％。\n三类医疗机构40％。甲类药品100％核报；乙类药品及医院制剂60％核报\n住院：参保人在市内定点医疗机构发生的起付标准以上纳入统筹基金支付范围的医疗费用，由统筹基金根据医院类别支付至最高支付限额：一类医疗机构95％，二类医疗机构90％，三类医疗机构85％（恶性肿瘤手术治疗、心脑疾病手术治疗以及肝、肾和骨髓移植手术治疗住院的基金支付90％）。\n2.参保人在市内定点医疗机构住院，实行按病种付费结算的，在总费用标准（详见附件1）内，个人实际负担费用分别为：一类医疗机构10％，二类医疗机构20％，三类医疗机构35％。个人实际自付部分进入大病支付范围。\n\"","OutpatientStartPayLine":"不设起付线","OutpatientEndPayLine":"不设封顶线线","HospitalizationStartPayLine":"三类医疗机构1200元/次，二类医疗机构600元/次，一类医疗机构300元/次。","HospitalizationEndPayLine":"30万元","PolicyLink":"佛府办〔2016〕60号","InsuranceTypeTwo":"","ReimbursementTreatmentTwo":"","OutpatientStartPayLineTwo":"","OutpatientEndPayLineTwo":"","HospitalizationStartPayLineTwo":"0%","HospitalizationEndPayLineTwo":"","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"城乡一体化","ReimbursementTreatmentThree":"一级医疗机构95%，二级医疗机构90%，三级医疗机构85%","OutpatientStartPayLineThree":"不设起付标准","OutpatientEndPayLineThree":"1万元/年","PolicyLinkThree":"佛府办〔2016〕60号","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"广东","City":"东莞","ReimbursementRatio":"0.8","InsuranceType":"城乡统筹","ReimbursementTreatment":"社区门诊基金按70%支付，转诊诊定点医院60%支付，三级定点医疗机构50%支付。住院：一级定点医疗机构不足或等于5万，支付95%，5万以上不足10万，75%，10万以上少于15万，55%，15万以上，45%，二级各段减少5%，三级减少10%，市外三级减少15%","OutpatientStartPayLine":"不设起付线","OutpatientEndPayLine":"无封顶线","HospitalizationStartPayLine":"市内：三级医院1300，二级医院800，一级及以下医院500，市外三级医院2000，二级医院1500，一级及以下1000。","HospitalizationEndPayLine":"参保时间<6个月1万，6个月<1年2万，1年<2年5万，2年<3年10万，3年以上30万","PolicyLink":"东莞市社会基本医疗保险规定","InsuranceTypeTwo":"","ReimbursementTreatmentTwo":"","OutpatientStartPayLineTwo":"","OutpatientEndPayLineTwo":"","HospitalizationStartPayLineTwo":"0%","HospitalizationEndPayLineTwo":"","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工居民","ReimbursementTreatmentThree":"0.75","OutpatientStartPayLineThree":"不设起付线","OutpatientEndPayLineThree":"8500元/年","PolicyLinkThree":"东莞市社会基本医疗保险规定；东莞市补充医疗保险实施细则","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"广东","City":"惠州","ReimbursementRatio":"0.95","InsuranceType":"(职工)","ReimbursementTreatment":"门诊：一级医院报销比例80%，二级医院60%，三级医院55%，经定点门诊转诊支付比例分别减少10%，每次限额140元以下。住院：连续缴费6个月后，在定点医疗机构或经批准转院，支付比例95%，自行到市外就医，支付70%，缴费不到6个月，支付50%","OutpatientStartPayLine":"不设起付线","OutpatientEndPayLine":"1000","HospitalizationStartPayLine":"一级医院200，二级400，三级800，本市行政区域外医院1200","HospitalizationEndPayLine":"60万","PolicyLink":"惠州社会医疗保险 办法","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"门诊：A档单次支付比例55%，B档单次75%。住院：A档：一级医院：95%，二级医院：75%，三级医院：65%；B档：一级医院：95%，二级医院：85%，三级医院：75%","OutpatientStartPayLineTwo":"不设起付线","OutpatientEndPayLineTwo":"A档：500/年，50/次，B档：800，70/次","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"A档：40万，B档：50万","PolicyLinkTwo":"惠州社会医疗保险 办法","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工居民","ReimbursementTreatmentThree":"职工95%，居民55%","OutpatientStartPayLineThree":"不设起付线","OutpatientEndPayLineThree":"4000元/年","PolicyLinkThree":"惠州社会医疗保险 办法","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"广东","City":"汕头","ReimbursementRatio":"0.9","InsuranceType":"(职工)","ReimbursementTreatment":"门诊：普通门诊基本医疗费按70％的比例支付；其他门诊基本医疗费用按50％的比例支付。。住院：参保人个人支付的比例：三级医疗机构为20%，二级医疗机构为15%，一级及以下医疗机构为10%；参保人属退休人员的，个人支付的比例为前述规定比例的80%。","OutpatientStartPayLine":"不设起付钱","OutpatientEndPayLine":"20元/月","HospitalizationStartPayLine":"一级300元二级500元三级1千元","HospitalizationEndPayLine":"连续参保12个月以下的，年度累计支付限额10万；参保12月以上的，年度40万元","PolicyLink":"汕头市人民政府关于进一步完善我市职工基本医疗保险制度有关问题的通知（汕府办〔2018〕21号）","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"\"门诊：普通门诊基本医疗费用按70％的比例支付；其他门诊基本医疗费用按50％的比例支付。住院：一档：一级定点医疗机构为85%，二级定点医疗机构为70%，三级定点医疗机构为50%，非定点医疗机构40%。\n　　（二）二档：一级定点医疗机构为85%，二级定点医疗机构为75%，三级定点医疗机构为60%，非定点医疗机构50%。\n\"","OutpatientStartPayLineTwo":"不设起付钱","OutpatientEndPayLineTwo":"120元/年，180元/年（特困）","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"\"居民：（一）连续参保缴费时间在12个月以下的，年度累计最高支付限额为10万元；（二）连续参保缴费时间在12个月以上的，年度累计最高支付限额为20万元。参保人门诊特定病种、门（急）诊抢救无效死亡、设立家庭病床、住院等发生的基本医疗费用。\n\"","PolicyLinkTwo":"汕头市城镇居民基本医疗保险暂行规定","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工居民","ReimbursementTreatmentThree":"0.7","OutpatientStartPayLineThree":"不设起付线","OutpatientEndPayLineThree":"职工1200元/月，居民1000元/月","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"广东","City":"湛江","ReimbursementRatio":"0.9","InsuranceType":"(职工)","ReimbursementTreatment":"\"门诊：60%\n住院：一级医疗机构88%，二级医疗机构85%，三级医疗机构82%比例支付\"","OutpatientStartPayLine":"暂无","OutpatientEndPayLine":"1600","HospitalizationStartPayLine":"一级医疗机构500元，二级医疗机构700元，三级医疗机构900元。","HospitalizationEndPayLine":"\"1）统筹基金10万，\n2）大病补助40万\"","PolicyLink":"湛人社【2013】81号","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"\"门诊：60%\n住院：一级医疗机构80%，二级医疗机构70%，三级医疗机构50%比例支付\"","OutpatientStartPayLineTwo":"20","OutpatientEndPayLineTwo":"300","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"基本医疗保险加大病保险年支付限额60万","PolicyLinkTwo":"\"湛人社【2015】464号\n湛人社【2016】514号\"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工+城乡居民","ReimbursementTreatmentThree":"类风关。统筹基金支付比例：职工：一级88%，二级85%，三级82%；居民：一级医疗机构80%，二级医疗机构70%，三级医疗机构50%","OutpatientStartPayLineThree":"职工：不设起付线；居民：不设起付线","OutpatientEndPayLineThree":"最高支付限额为：职工：4000元/年；居民：3200元/年","PolicyLinkThree":"职工门慢：湛人社【2015】107号；居民：湛人社【2016】525号","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"广东","City":"广州","ReimbursementRatio":"","InsuranceType":"(职工)","ReimbursementTreatment":"\"职工门诊报销比例： 在基层选定医疗机构就医统筹基金的支付比例为80%；经基层选定医疗机构转诊后30日内在其他选定医疗机构和指定专科医疗机构就医统筹基金的支付比例为55%；未经基层选定医疗机构转诊到其他选定医疗机构和指定专科医疗机构就医统筹基金的支付比例为45%。    职工住院报销比例：  职工：一级定点医疗机构为90%，二级定点医疗机构为85%，三级定点医疗机构为80%；\n　　\"","OutpatientStartPayLine":"不设起付线","OutpatientEndPayLine":"统筹基金每月最高支付限额为300元。每月最高支付限额当月有效，不滚存、不累计。","HospitalizationStartPayLine":"\"职工：一级定点医疗机构为400元，二级定点医疗机构为800元，三级定点医疗机构为1600元；\n\"","HospitalizationEndPayLine":"在一个职工医保年度内，职工社会医疗保险统筹基金对参保人员住院、指定单病种、门诊特定项目、门诊指定慢性病及普通门诊就医发生的符合规定范围内的医疗费用，累计最高支付限额为上年度本市在岗职工年平均工资的6倍。","PolicyLink":"穗医保规字〔2019〕12号","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"门诊：居民在基层选定医疗机构门诊就医按60%比例支付                              住院：一级医疗机构85%，二级医疗机构70%，三级医疗机构55%比例支付","OutpatientStartPayLineTwo":"不设起付线","OutpatientEndPayLineTwo":"不超过600元","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"统筹基金年度累计最高支付限额为缴费基数的6倍","PolicyLinkTwo":"穗府办（2014）47号","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工+居民","ReimbursementTreatmentThree":"基层85%，其他医疗机构65%","OutpatientStartPayLineThree":"0","OutpatientEndPayLineThree":"按参保患者相应的住院基本医疗费用的支付比例执行，不纳入普通门诊统筹、相应门特医保统筹基金最高支付限额，直接计入医保基金年度累计最高支付限额计算","PolicyLinkThree":"广州市印发广州市建立国家医保谈判药品“双通道”管理机制实施细则的通知2022.1.10","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"广东","City":"珠海","ReimbursementRatio":"(基本医疗保险)","InsuranceType":"门诊 ： 参保人在选定的门诊统筹定点医疗机构就医所发生的下列门诊费用由门诊统筹基金支付70%，个人自付30%：住院:职工基本医疗保险一档、二档参保人，在职人员支付92%，退休人员支付94%；","ReimbursementTreatment":"不设起付线","OutpatientStartPayLine":"社保年度内转诊及急诊待遇支付限额合计为1500元（含自付部分）","OutpatientEndPayLine":"\"1.一级医院300元 2.二级医院500元3.三级医院1000元。\n\"","HospitalizationStartPayLine":"连续参保缴费时间1年以上的，40万/年；补充高额医疗费用：40-60万/年，最高补充20万/年；","HospitalizationEndPayLine":"珠海市医疗保险住院费用年度最高支付限额有关问题的通知珠人社[2017]155号","PolicyLink":"","InsuranceTypeTwo":"","ReimbursementTreatmentTwo":"","OutpatientStartPayLineTwo":"","OutpatientEndPayLineTwo":"","HospitalizationStartPayLineTwo":"0%","HospitalizationEndPayLineTwo":"","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"基本医疗保险","ReimbursementTreatmentThree":"中额门特：类风关，支付比例70%","OutpatientStartPayLineThree":"不设起付线","OutpatientEndPayLineThree":"1中6000，2种8000，3种10000","PolicyLinkThree":"2020珠海市基本医疗保险门诊特定病种目录","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"广东","City":"中山","ReimbursementRatio":"0.7","InsuranceType":"(职工)","ReimbursementTreatment":"一级以下定点医疗机构支付95%，二级定点医疗机构支付92%，三级定点医疗机构支付90%，其余部分由个人自付。","OutpatientStartPayLine":"不设","OutpatientEndPayLine":"统账结合职工基本医疗保险、单建统筹职工基本医疗保险年度最高支付限额分别为本市上上年度职工年平均工资的0.04倍、0.03倍；年度最高支付限额取整至个位数。","HospitalizationStartPayLine":"一级以下定点医疗机构400元/次，二级定点医疗机构600元/次，三级定点医疗机构800元/次。","HospitalizationEndPayLine":"\"　（一）参保人连续缴纳统账结合职工基本医疗保险不满1年、1年以上的，年度最高支付限额分别为本市上上年度职工年平均工资的4倍、12倍。退休人员统账结合职工基本医疗保险年度最高支付限额为本市上上年度职工年平均工资的12倍。\n\n　　（二）参保人连续缴纳单建统筹职工基本医疗保险不满1年、1年以上的，年度最高支付限额分别为本市上上年度职工年平均工资的2倍、8倍。退休人员单建统筹职工基本医疗保险年度最高支付限额为本市上上年度职工年平均工资的8倍。\"","PolicyLink":"中山市人民政府关于印发中山市职工医疗保险办法的通知2021.10.15","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"一级以下定点医疗机构支付92%，二级定点医疗机构支付90%，三级定点医疗机构支付80%，其余部分由个人自付。","OutpatientStartPayLineTwo":"一级以下定点医疗机构600元/次，二级定点医疗机构800元/次，三级定点医疗机构1000元/次","OutpatientEndPayLineTwo":"城乡居民基本医疗保险年度最高支付限额为本市上上年度城乡居民人均可支配收入的8倍。","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"城乡居民基本医疗保险年度最高支付限额为本市上上年度城乡居民人均可支配收入的8倍。","PolicyLinkTwo":"中山市人民政府关于印发中山市城乡居民医疗保险办法的通知2021.10.15","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工居民","ReimbursementTreatmentThree":"二类门特：类风关，报销70%","OutpatientStartPayLineThree":"不设","OutpatientEndPayLineThree":"8000","PolicyLinkThree":"2020年中山市门特病种名称、种类及待遇表","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"广东","City":"江门","ReimbursementRatio":"职工门特四类：1.本市一级及以下定点医疗机构基金支付比例为60%。居民四类门特：1.本市一级及以下定点医疗机构基金支付比例为60%。50%。","InsuranceType":"(职工)","ReimbursementTreatment":"职工住院：1级支付93%，二级90%，单机83%，非定点64%","OutpatientStartPayLine":"0","OutpatientEndPayLine":"基层50元/月，非基层40元/月","HospitalizationStartPayLine":"1档：1级：500元；2级：600元；3级900元；","HospitalizationEndPayLine":"60万","PolicyLink":"2021年度江门市基本医疗保险待遇标准","InsuranceTypeTwo":"居民","ReimbursementTreatmentTwo":"住院：一级85%，二级80%，三级65%，非定点40%","OutpatientStartPayLineTwo":"0","OutpatientEndPayLineTwo":"基层360元/年","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"30万","PolicyLinkTwo":"2021年度江门市基本医疗保险待遇标准","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工居民","ReimbursementTreatmentThree":"\"职工门特四类：类风关，1.本市一级及以下定点医疗机构基金支付比例为60%。居民四类门特：1.本市一级及以下定点医疗机构基金支付比例为60%。50%。\n3.非定点医疗机构基金支付比例为30%。\n2.其他定点医疗机构基金支付比例为\n2.其他定点医疗机构基金支付比例为50%。\n3.非定点医疗机构基金支付比例为30%。\"","OutpatientStartPayLineThree":"无","OutpatientEndPayLineThree":"职工：180元/月；居民：180元/月","PolicyLinkThree":"2021年度江门市基本医疗保险待遇标准","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"江西","City":"南昌","ReimbursementRatio":"0.7","InsuranceType":"(职工)","ReimbursementTreatment":"70%报销比例双通道药品不设起付线和个人先行自付比例，年度累计药品费用，与基本医保、大病保险基金最高支付限额合并计算（门诊保障待遇同该要求一致）。","OutpatientStartPayLine":"无","OutpatientEndPayLine":"双通道药品不设起付线和个人先行自付比例，年度累计药品费用，与基本医保、大病保险基金最高支付限额合并计算","HospitalizationStartPayLine":"双通道药品不设起付线和个人先行自付比例，年度累计药品费用，与基本医保、大病保险基金最高支付限额合并计算（门诊保障待遇同该要求一致）。","HospitalizationEndPayLine":"10万","PolicyLink":"《江西省双通道谈判药品管理暂行办法》","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"60%报销比例，双通道药品不设起付线和个人先行自付比例，年度累计药品费用，与基本医保、大病保险基金最高支付限额合并计算（门诊保障待遇同该要求一致）。","OutpatientStartPayLineTwo":"双通道药品不设起付线和个人先行自付比例，年度累计药品费用，与基本医保、大病保险基金最高支付限额合并计算（门诊保障待遇同该要求一致）","OutpatientEndPayLineTwo":"双通道药品不设起付线和个人先行自付比例，年度累计药品费用，与基本医保、大病保险基金最高支付限额合并计算（门诊保障待遇同该要求一致）","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"10万","PolicyLinkTwo":"《江西省双通道谈判药品管理暂行办法》","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"\"城镇职工和城镇居民所有门诊特殊病种待遇纳入住院统筹基金最高支付限额及大病保险最高支付限额范围内；居民门诊特殊慢性病实行定点医疗机构管理，支付比例参照住院支付比例执行。\n参保居民年度最高支付限额按照住院统筹基金（含大病医疗保险）年度最高支付限额执行。\n\"","OutpatientStartPayLineThree":"职工：不设起付标准；居民执行住院医疗起付标准","OutpatientEndPayLineThree":"职工：10万；居民10万","PolicyLinkThree":"南昌市城镇职工基本医疗保险市级统筹实施意见；南昌市城乡居民基本医疗保险暂行办法","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"海南","City":"海口","ReimbursementRatio":"按住院","InsuranceType":"(职工)","ReimbursementTreatment":"住院：在一级医疗机构就医的报销90% ;在二级医疗机构就医的报销88%；在三级医疗机构就医的报销85%。退休all90%","OutpatientStartPayLine":"一级及以下定点医疗机构年度起付标准为10元；二级定点医疗机构年度起付标准为50元；三级定点医疗机构年度起付标准为100元.与门慢、门特、住院合并计算。","OutpatientEndPayLine":"统筹基金不支付普通门诊","HospitalizationStartPayLine":"在职800；退休600","HospitalizationEndPayLine":"最高支付限额为26万元/年 。但因患重大疾病最高支付额50万","PolicyLink":"海口市城镇从业人员基本医疗保险、《海南省城镇从业人员基本医疗保险普通门诊共济保障管理办法（试行）》的通知","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"参保居民发生起付标准以上、最高支付标准以下的门诊医疗费用，由 统筹基金和参保居民分别按比例分担：一级及以下定点医疗机构，统筹基金支 付比例为60%，个人支付比例为40%;二级定点医疗机构，统筹基金支付比例为 50%，个人支付比例为50%。每日最高支付限额为40元。","OutpatientStartPayLineTwo":"50元/年，门慢、门特、住院合并计算。","OutpatientEndPayLineTwo":"300元（超过限额，统筹基金不予支付；未达到，可结转下年度用于支付住院医疗费用）","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"15万/年","PolicyLinkTwo":"海南省城乡居民基本医疗保险普通门诊统筹管理办法（试行）","InsuranceTypeThree":"门慢门特","CrowdType":"从业/居民","ReimbursementTreatmentThree":"国谈（门特品种）不占所申请疾病的定额标准。按住院比例结算，计入个人年度医保统筹基金最高支付限额。","OutpatientStartPayLineThree":"不设","OutpatientEndPayLineThree":"按住院","PolicyLinkThree":"海南省医疗保障局关于调整基本医疗保险门诊慢性特殊疾病有关规定的通知琼医保规[2021]7号2021.09.01","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"湖北","City":"武汉","ReimbursementRatio":"乙类药品报销90%","InsuranceType":"(职工)","ReimbursementTreatment":"住院：（一）年度累计基本医疗保险内费用在10万以内，医保基金比例分别为： 　　1、社区、一级医院基金支付92%（在职）936%（退休）； 　　2、二级医院基金支付89%（在职）912%（退休）； 　　3、三级医院基金支付86%（在职）888%（退休）； 　　4、享受低保待遇的残疾人，统筹基金支付比例提高2%。 　　（二）年度累计基本医疗保险内费用10—20万，医保基金支付96%， 　　（三）年度累计基本医疗保险内费用在20—24万，医保基金支付98%。","OutpatientStartPayLine":"普通门诊统筹基金不支付","OutpatientEndPayLine":"普通门诊统筹基金不支付","HospitalizationStartPayLine":"社区卫生服务中心200元；一级医院400元；二级医院600元；三级医院800元。在一个保险年度内，参保人员两次及以上住院的，住院起付标准减半（社区卫生服务中心除外）。享受低保待遇的残疾人，免收住院起付标准费用。","HospitalizationEndPayLine":"24万","PolicyLink":"武汉市城镇职工基本医疗保险办法；城镇职工基本医疗保险政策指南","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"\"门诊报销50%；\n住院：在社区卫生服务中心、一级医院住院，医保基金支付80%，个人承担20%；\n　　在二级医院住院，医保基金支付70%，个人承担30%；\n　　在三级医院住院，医保基金支付60%，个人承担40%。\n　　享受低保待遇的残疾人，统筹基金支付比例在现行基础上提高2%。\"","OutpatientStartPayLineTwo":"200","OutpatientEndPayLineTwo":"1000","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"13万","PolicyLinkTwo":"武汉市城镇居民基本医疗保险办法；武汉居民、大学生医疗保险政策指南","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/城乡居民","ReimbursementTreatmentThree":"职工（在职报销60%，退休报销65%）；居民报销50%","OutpatientStartPayLineThree":"无起付线","OutpatientEndPayLineThree":"职工5000；城乡居民4000","PolicyLinkThree":"武人社发【2017】46号调整门诊重症政策的通知20170826","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"湖北","City":"宜昌","ReimbursementRatio":"职工乙类报销70%，居民在一级、二级、三级医疗机构分别报销80%、65%、50%","InsuranceType":"(职工)","ReimbursementTreatment":"职工住院基本医疗费用政策范围内的乙类费用，统筹基金支付70%，个人自付30%。","OutpatientStartPayLine":"统筹基金不支付","OutpatientEndPayLine":"统筹基金不支付","HospitalizationStartPayLine":"统筹基金起付标准为一级医疗机构300元，二级医疗机构600元，三级医疗机构1000元","HospitalizationEndPayLine":"12万","PolicyLink":"宜昌市职工基本医疗保险实施办法","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"\"参保居民在约定机构发生的符合医疗保险规定支付范围的门诊医疗费用，累计金额在50元以上至400元以下的费用普通门诊统筹基金报销40%。超过400元以上的费用由个人支付。住院待遇：（一）在当地惠民医院（含惠民窗口，下同）、一级医疗机构、乡镇卫生院及社区卫生服务机构就医，同一保险年度内每次住院起付标准均为100元，起付标准以上的甲类药品、一般诊疗项目、一般服务项目、一般设施费用由医疗保险基金支付70%，起付标准以上的乙类药品、特殊诊疗项目、特殊服务项目、特殊设施费用由医疗保险基金支付60%。其中，无生活来源、无劳动能力、无法定赡养抚养人的参保居民在上述医疗机构住院，不设起付标准；低保对象在惠民医院发生的住院医疗费用，先享受惠民医院减免优惠后，医疗保险基金再按上述规定的比例支付，减免和报销之和不得低于80%。\n　　（二）在当地二级及相应医疗机构就医，同一保险年度内第一次住院起付标准为300元，第二次及以上住院起付标准为150元，起付标准以上的甲类药品、一般诊疗项目、一般服务项目、一般设施费用由医疗保险基金支付60%，起付标准以上的乙类药品、特殊诊疗项目、特殊服务项目、特殊设施费用由医疗保险基金支付45%。\n　　（三）在当地三级及相应医疗机构就医，同一保险年度内第一次住院起付标准为500元，第二次及以上住院起付标准为250元，起付标准以上的甲类药品、一般诊疗项目、一般服务项目、一般设施费用由医疗保险基金支付50%，起付标准以上的乙类药品、特殊诊疗项目、特殊服务项目、特殊设施费用由医疗保险基金支付40%。\"","OutpatientStartPayLineTwo":"50","OutpatientEndPayLineTwo":"400","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"3万","PolicyLinkTwo":"宜昌市城镇居民基本医疗保险实施办法；宜昌市城镇居民基本医疗保险普通门诊统筹管理试行办法","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"270元/月","OutpatientStartPayLineThree":"无","OutpatientEndPayLineThree":"无","PolicyLinkThree":"宜昌市基本医疗保险门诊慢性病管理暂行办法","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"湖北","City":"十堰","ReimbursementRatio":"乙类药品报销90%","InsuranceType":"(职工)","ReimbursementTreatment":"\"在职：90%/88%/85% (一级/二级/三级医院)\n退休：92%/90%/87% (一级/二级/三级医院)\n\"","OutpatientStartPayLine":"","OutpatientEndPayLine":"","HospitalizationStartPayLine":"","HospitalizationEndPayLine":"","PolicyLink":"","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"\"85%/75%/65% (一级/二级/三级医院)\n\"","OutpatientStartPayLineTwo":"门诊统筹不设起付标准。参保居民在门诊统筹定点机构就诊发生的普通门诊（含急诊），一个保险年度内发生的政策范围内门诊医疗费用累计金额在400元（建档立卡贫困人口为800元）以下的，医保门诊统筹基金报销50%，限额为200元（建档立卡贫困人口限额为400元），超过报销限额部分的费用由个人自理。","OutpatientEndPayLineTwo":"","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"10万","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"职工：260元/月，报销85%；居民：200元/月，报销70%","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"湖南","City":"长沙","ReimbursementRatio":"0.8","InsuranceType":"(职工)","ReimbursementTreatment":"单行支付；住院、门诊和药店“双通道”药品医保报销待遇统一；未申请双通道的跟乙类政策报销，自付比例20%","OutpatientStartPayLine":"无","OutpatientEndPayLine":"\"先由基本医疗保险统筹基金支付，\n超统筹基金年度支付限额后，参加了城镇职工大病互助的，由城镇职工大病互助按规定支付。20+25=45万\"","HospitalizationStartPayLine":"无","HospitalizationEndPayLine":"\"先由基本医疗保险统筹基金支付，\n超统筹基金年度支付限额后，参加了城镇职工大病互助，由城镇职工大病互助按规定支付。20+25=45万\"","PolicyLink":"湘医保发〔2021〕6号","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"单行支付；住院、门诊和药店“双通道”药品医保报销待遇统一；未申请双通道的跟乙类政策报销，自付比例20%","OutpatientStartPayLineTwo":"无","OutpatientEndPayLineTwo":"\"先由基本医疗保险统筹基金支付，\n超统筹基金年度支付限额后，参加了城\n乡居民大病保险的，由城乡居民大病保\n险按规定支付，15+30=45万\"","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"\"先由基本医疗保险统筹基金支付，\n超统筹基金年度支付限额后，参加了城\n乡居民大病保险的，由城乡居民大病保\n险按规定支付，15+30=45万\"","PolicyLinkTwo":"http://ybj.hunan.gov.cn/ybj/first113541/firstF/f2113606/202108/t20210826_20398569.html","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/城乡居民","ReimbursementTreatmentThree":"门特门慢基金支付：职工80%，城居70%","OutpatientStartPayLineThree":"不设起付标准","OutpatientEndPayLineThree":"限额200元/月","PolicyLinkThree":"长医保发（2019）67号","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"湖南","City":"湘潭","ReimbursementRatio":"0.8","InsuranceType":"(职工)","ReimbursementTreatment":"单行支付；住院、门诊和药店“双通道”药品医保报销待遇统一；未申请双通道的跟乙类政策报销，自付比例20%","OutpatientStartPayLine":"无","OutpatientEndPayLine":"\"先由基本医疗保险统筹基金支付，\n超统筹基金年度支付限额后，参加了城镇职工大病互助的，由城镇职工大病互助按规定支付。20+25=45万\"","HospitalizationStartPayLine":"无","HospitalizationEndPayLine":"\"先由基本医疗保险统筹基金支付，\n超统筹基金年度支付限额后，参加了城镇职工大病互助，由城镇职工大病互助按规定支付。20+25=45万\"","PolicyLink":"湘医保发〔2021〕6号","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"单行支付；住院、门诊和药店“双通道”药品医保报销待遇统一；未申请双通道的跟乙类政策报销，自付比例20%","OutpatientStartPayLineTwo":"无","OutpatientEndPayLineTwo":"\"先由基本医疗保险统筹基金支付，\n超统筹基金年度支付限额后，参加了城\n乡居民大病保险的，由城乡居民大病保\n险按规定支付，15+30=45万\"","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"\"先由基本医疗保险统筹基金支付，\n超统筹基金年度支付限额后，参加了城\n乡居民大病保险的，由城乡居民大病保\n险按规定支付，15+30=45万\"","PolicyLinkTwo":"http://ybj.hunan.gov.cn/ybj/first113541/firstF/f2113606/202108/t20210826_20398569.html","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/城乡居民","ReimbursementTreatmentThree":"\"城镇职工医保在职职工为 85%，退休职工为 90%；城乡居\n民医保为 65%\"","OutpatientStartPayLineThree":"不设起付标准","OutpatientEndPayLineThree":"限额150元/月","PolicyLinkThree":"潭人社发〔2018〕12 号","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"湖南","City":"衡阳","ReimbursementRatio":"0.8","InsuranceType":"(职工)","ReimbursementTreatment":"单行支付；住院、门诊和药店“双通道”药品医保报销待遇统一；未申请双通道的跟乙类政策报销，自付比例20%","OutpatientStartPayLine":"无","OutpatientEndPayLine":"\"先由基本医疗保险统筹基金支付，\n超统筹基金年度支付限额后，参加了城镇职工大病互助的，由城镇职工大病互助按规定支付。20+25=45万\"","HospitalizationStartPayLine":"无","HospitalizationEndPayLine":"\"先由基本医疗保险统筹基金支付，\n超统筹基金年度支付限额后，参加了城镇职工大病互助，由城镇职工大病互助按规定支付。20+25=45万\"","PolicyLink":"湘医保发〔2021〕6号","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"单行支付；住院、门诊和药店“双通道”药品医保报销待遇统一；未申请双通道的跟乙类政策报销，自付比例20%","OutpatientStartPayLineTwo":"无","OutpatientEndPayLineTwo":"\"先由基本医疗保险统筹基金支付，\n超统筹基金年度支付限额后，参加了城\n乡居民大病保险的，由城乡居民大病保\n险按规定支付，15+30=45万\"","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"\"先由基本医疗保险统筹基金支付，\n超统筹基金年度支付限额后，参加了城\n乡居民大病保险的，由城乡居民大病保\n险按规定支付，15+30=45万\"","PolicyLinkTwo":"http://ybj.hunan.gov.cn/ybj/first113541/firstF/f2113606/202108/t20210826_20398569.html","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/城乡居民","ReimbursementTreatmentThree":"\"城镇职工80%；城乡居\n民医保为 70%\"","OutpatientStartPayLineThree":"不设起付标准","OutpatientEndPayLineThree":"限额2400元/年","PolicyLinkThree":"衡医保发〔2020〕25号","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"湖南","City":"邵阳","ReimbursementRatio":"0.8","InsuranceType":"(职工)","ReimbursementTreatment":"单行支付；住院、门诊和药店“双通道”药品医保报销待遇统一；未申请双通道的跟乙类政策报销，自付比例20%","OutpatientStartPayLine":"无","OutpatientEndPayLine":"\"先由基本医疗保险统筹基金支付，\n超统筹基金年度支付限额后，参加了城镇职工大病互助的，由城镇职工大病互助按规定支付。20+25=45万\"","HospitalizationStartPayLine":"无","HospitalizationEndPayLine":"\"先由基本医疗保险统筹基金支付，\n超统筹基金年度支付限额后，参加了城镇职工大病互助，由城镇职工大病互助按规定支付。20+25=45万\"","PolicyLink":"湘医保发〔2021〕6号","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"单行支付；住院、门诊和药店“双通道”药品医保报销待遇统一；未申请双通道的跟乙类政策报销，自付比例20%","OutpatientStartPayLineTwo":"无","OutpatientEndPayLineTwo":"\"先由基本医疗保险统筹基金支付，\n超统筹基金年度支付限额后，参加了城\n乡居民大病保险的，由城乡居民大病保\n险按规定支付，15+30=45万\"","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"\"先由基本医疗保险统筹基金支付，\n超统筹基金年度支付限额后，参加了城\n乡居民大病保险的，由城乡居民大病保\n险按规定支付，15+30=45万\"","PolicyLinkTwo":"http://ybj.hunan.gov.cn/ybj/first113541/firstF/f2113606/202108/t20210826_20398569.html","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/城乡居民","ReimbursementTreatmentThree":"我司产品未在二级目录内不能享受待遇","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"福建","City":"福州","ReimbursementRatio":"0.8","InsuranceType":"(职工)","ReimbursementTreatment":"不设起付线，报销比例为80%，支付额度计入当地职工基本医保年度最高支付限额，共用封顶线。","OutpatientStartPayLine":"0","OutpatientEndPayLine":"12万","HospitalizationStartPayLine":"0","HospitalizationEndPayLine":"12万","PolicyLink":"福建省医疗保障局关于部分医保药品单列门诊统筹支付的通知","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"不设起付线，报销比例为60%，支付额度计入当地职工基本医保年度最高支付限额，共用封顶线。","OutpatientStartPayLineTwo":"0","OutpatientEndPayLineTwo":"12万","HospitalizationStartPayLineTwo":"0%","HospitalizationEndPayLineTwo":"12万","PolicyLinkTwo":"福建省医疗保障局关于部分医保药品单列门诊统筹支付的通知","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工门特；城乡居民门诊特殊病种","ReimbursementTreatmentThree":"\"1、统筹基金最高支付限额包括起付标准、医保目录内个人负担部分。2、参保人员有两个以上门诊特殊病种按一个起付标准计算。3、序号1—4门诊特殊病种超过最高支付限额部分的医疗费用，不享受大额医疗费用补充保险待遇。\n\"","OutpatientStartPayLineThree":"城镇职工：800元（其中社区卫生服务中心、乡镇卫生院取消起付线）；城乡居民：400（社区卫生服务中心及乡镇卫生院除外）","OutpatientEndPayLineThree":"都是12万","PolicyLinkThree":"福州市职工基本医疗保险指南(2015年9月)；福州市关于城乡居民基本医保政策一体化实施方案","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"福建","City":"厦门","ReimbursementRatio":"0.8","InsuranceType":"(职工)","ReimbursementTreatment":"参保人员门诊起付标准内的医疗费用，在执行国家基本药物制度及零差价的社区卫生服务中心、乡镇卫生院等一级及以下定点医疗机构门诊就医时发生的属于国家基本药物的药品费用、门诊费及常规医疗检查费，不超过500元部分由社会统筹医疗基金全部报销，在其它定点医疗机构就医的医药费用，由个人全部自付。","OutpatientStartPayLine":"在职1844.16元；退休922.08元","OutpatientEndPayLine":"10万元","HospitalizationStartPayLine":"\"在职：三级1000元，二级600元，一级200元\n退休：三级500元，二级300元，一级100元\"","HospitalizationEndPayLine":"10万元","PolicyLink":"厦门市城镇职工基本医疗保险规定（厦门市人民政府令第163号）","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"1、参保人员门诊起付标准内的医疗费用，在执行国家基本药物制度及零差价的社区卫生服务中心、乡镇卫生院等一级及以下定点医疗机构门诊就医时发生的属于国家基本药物的药品费用、诊疗费及常规医疗检查费用，不超过500元部分由社会统筹医疗基金全部报销，在其它定点医疗机构就医发生的费用，由个人全部自付； 2、对连续参保缴费者，其门诊报销比例在原基础上，每满一年提高一个百分点，最多可提高5个百分点。07年1月份参保者，1－6月可按一个年度计算；3、本年度基本医疗保险费统筹最高限额为10万元；本年度补充医疗保险赔付最高限额：21 万元（个人负担25％）；","OutpatientStartPayLineTwo":"1000元","OutpatientEndPayLineTwo":"10万元","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"本年度基本医疗保险费统筹最高限额为10万元","PolicyLinkTwo":"城乡居民医疗费自付比例简明表","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"无特殊病种","ReimbursementTreatmentThree":"","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"福建","City":"泉州","ReimbursementRatio":"0.8","InsuranceType":"(职工)","ReimbursementTreatment":"不设起付线，报销比例为80%，支付额度计入当地职工基本医保年度最高支付限额，共用封顶线。","OutpatientStartPayLine":"0","OutpatientEndPayLine":"12万","HospitalizationStartPayLine":"0","HospitalizationEndPayLine":"12万","PolicyLink":"福建省医疗保障局关于部分医保药品单列门诊统筹支付的通知","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"不设起付线，报销比例为80%，支付额度计入当地职工基本医保年度最高支付限额，共用封顶线。","OutpatientStartPayLineTwo":"0","OutpatientEndPayLineTwo":"15万","HospitalizationStartPayLineTwo":"0%","HospitalizationEndPayLineTwo":"15万元","PolicyLinkTwo":"福建省医疗保障局关于部分医保药品单列门诊统筹支付的通知","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"属于规定范围内门诊特殊病种和治疗项目的医疗费用，视同住院医疗费用","OutpatientStartPayLineThree":"同住院","OutpatientEndPayLineThree":"居民15万元；职工12万","PolicyLinkThree":"\"泉州市人民政府关于印发泉州市 城镇居民基本医疗保险规定的通知 ；泉州市城镇职工基本医疗保险规定的通知\n\"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"福建","City":"漳州","ReimbursementRatio":"0.8","InsuranceType":"(职工)","ReimbursementTreatment":"不设起付线，报销比例为80%，支付额度计入当地职工基本医保年度最高支付限额，共用封顶线。","OutpatientStartPayLine":"0","OutpatientEndPayLine":"12万","HospitalizationStartPayLine":"0","HospitalizationEndPayLine":"12万","PolicyLink":"福建省医疗保障局关于部分医保药品单列门诊统筹支付的通知","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"不设起付线，报销比例为80%，支付额度计入当地职工基本医保年度最高支付限额，共用封顶线。","OutpatientStartPayLineTwo":"0","OutpatientEndPayLineTwo":"15万","HospitalizationStartPayLineTwo":"0%","HospitalizationEndPayLineTwo":"15万元","PolicyLinkTwo":"福建省医疗保障局关于部分医保药品单列门诊统筹支付的通知","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"属于规定范围内门诊特殊病种和治疗项目的医疗费用，视同住院医疗费用","OutpatientStartPayLineThree":"同住院","OutpatientEndPayLineThree":"居民15万元；职工12万","PolicyLinkThree":"\"泉州市人民政府关于印发泉州市 城镇居民基本医疗保险规定的通知 ；泉州市城镇职工基本医疗保险规定的通知\n\"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"云南","City":"昆明","ReimbursementRatio":"","InsuranceType":"(职工)","ReimbursementTreatment":"","OutpatientStartPayLine":"","OutpatientEndPayLine":"","HospitalizationStartPayLine":"","HospitalizationEndPayLine":"","PolicyLink":"","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"","OutpatientStartPayLineTwo":"","OutpatientEndPayLineTwo":"","HospitalizationStartPayLineTwo":"0%","HospitalizationEndPayLineTwo":"","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"","ReimbursementTreatmentThree":"","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"四川省","City":"成都市","ReimbursementRatio":"无乙类的先行自付，直接职工报75%，居民报65%/60%","InsuranceType":"(职工)","ReimbursementTreatment":"报销75%，单行支付五定管理，双通道管理即可医院报销也可定点药店报销","OutpatientStartPayLine":"/","OutpatientEndPayLine":"/","HospitalizationStartPayLine":"无起付线","HospitalizationEndPayLine":"15万","PolicyLink":"","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"高档报销65%，低档60%","OutpatientStartPayLineTwo":"/","OutpatientEndPayLineTwo":"/","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"15万","PolicyLinkTwo":"成医保发〔2019〕20号、成医保发〔2019〕33 号","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"职工报销75%，居民65%/60%","OutpatientStartPayLineThree":"无起付线","OutpatientEndPayLineThree":"15万","PolicyLinkThree":"成医保发〔2019〕20号、成医保发〔2019〕33 号","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"四川省","City":"绵阳","ReimbursementRatio":"0.7","InsuranceType":"(职工)","ReimbursementTreatment":"单行支付，不设起付线，报销70%","OutpatientStartPayLine":"","OutpatientEndPayLine":"","HospitalizationStartPayLine":"","HospitalizationEndPayLine":"10万","PolicyLink":"","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"","OutpatientStartPayLineTwo":"","OutpatientEndPayLineTwo":"","HospitalizationStartPayLineTwo":"0%","HospitalizationEndPayLineTwo":"","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"","ReimbursementTreatmentThree":"","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"四川省","City":"南充市","ReimbursementRatio":"职工65%居民50%","InsuranceType":"(职工)","ReimbursementTreatment":"单行支付，不设起付线，报销待遇职工65%居民50%","OutpatientStartPayLine":"","OutpatientEndPayLine":"","HospitalizationStartPayLine":"","HospitalizationEndPayLine":"10万","PolicyLink":"","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"单行支付，不设起付线，报销待遇职工65%居民50%","OutpatientStartPayLineTwo":"","OutpatientEndPayLineTwo":"","HospitalizationStartPayLineTwo":"0%","HospitalizationEndPayLineTwo":"10万","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"","ReimbursementTreatmentThree":"","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"宁夏","City":"银川","ReimbursementRatio":"非三定医疗机构：乙类药品自付5%后按照医疗机构级别不同报销比例不同。三定医疗机构（定点药店）：门诊：起付线500元/年，职工报销75%，居民报销60%；住院按住院医保政策报销。职工年度限额40万，职工年度限额13万。","InsuranceType":"(职工)","ReimbursementTreatment":"\"住院：自付5%后，一级95%，二级90%，三乙85%，三甲80%；非三定医疗机构：开展门诊统筹：社区报销70%，一级报销60%，二级报销40%。\n三定医疗机构（药店）门诊：起付线500元/年，职工报销75%，居民报销60%；\"","OutpatientStartPayLine":"\"非三定：开展门诊统筹，无起付线；\n三定医疗机构（药店）门诊：起付线500元/年\"","OutpatientEndPayLine":"非三定医疗机构：门诊统筹1300元/年；三定医疗机构，年度限额40万","HospitalizationStartPayLine":"三甲1200元，三乙800元，二级500元，一级300元","HospitalizationEndPayLine":"5万，超过进入大额医疗补助，5万-40万报销90%，40万以上报销70%","PolicyLink":"宁夏银川职工医保政策；宁夏谈判药品“双通道”管理机制","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"\"住院：自付5%后，一级95%，二级90%，三乙85%，三甲80%；非三定医疗机构：开展门诊统筹：社区报销70%，一级报销60%，二级报销40%。\n三定医疗机构（药店）门诊：起付线500元/年，职工报销75%，居民报销60%；\"","OutpatientStartPayLineTwo":"\"非三定：开展门诊统筹，无起付线；\n三定医疗机构（药店）门诊：起付线500元/年\"","OutpatientEndPayLineTwo":"非三定医疗机构：门诊统筹330元/年；三定医疗机构，年度限额13万","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"13万。个人负担超过起付线之上，按照金额分段报销60%--73%，上不封顶","PolicyLinkTwo":"进一步完善城乡居民基本医疗保险自治区级统筹制度的意见；宁夏谈判药品“双通道”管理机制","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/城乡居民","ReimbursementTreatmentThree":"非定点医疗机构：涉及门诊大病病种类风关，起付线500元，职工报销75%，居民60%","OutpatientStartPayLineThree":"500","OutpatientEndPayLineThree":"职工5000，居民3500","PolicyLinkThree":"宁夏银川门诊大病","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"广西","City":"南宁","ReimbursementRatio":"乙类药品报销比例主要存在于职工医保住院待遇当中","InsuranceType":"(职工)","ReimbursementTreatment":"三级医院住院乙类药品报销比例为：80%（在职），85%（退休）","OutpatientStartPayLine":"使用个人账户，统筹基金不支付","OutpatientEndPayLine":"使用个人账户，统筹基金不支付","HospitalizationStartPayLine":"\"600（第一次）\n300（第二次及以上）\"","HospitalizationEndPayLine":"上年度全区城镇单位在岗职工平均工资的6倍(2014年为46846元，即封顶线为281076元)","PolicyLink":"","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"三级医院住院报销比例为50%","OutpatientStartPayLineTwo":"不设起付线（报销比例55%）","OutpatientEndPayLineTwo":"200/年","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"上年度广西城镇居民人均可支配收入的6倍（2014年为24669元，即封顶线为148014元）","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"城镇职工和城镇居民","ReimbursementTreatmentThree":"糖尿病，居民由统筹基金支付60％，个人负担40％；在职人员统筹基金支付70％，退休人员统筹基金支付75％。","OutpatientStartPayLineThree":"职工：100/月，居民：30/月","OutpatientEndPayLineThree":"职工：6000/年，居民：2500/年","PolicyLinkThree":"具体请分别参考职工和居民的政策原文","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"广西","City":"柳州","ReimbursementRatio":"个人先支付费用为药品总额的10%或20%，其中重病人群住院时的个人先支付费用为药品总额的5%或15%","InsuranceType":"(职工)","ReimbursementTreatment":"职工在三级医疗机构起付线800/600/400元(3级2级1级)，报销比例82%/87%/92%(3级2级1级)","OutpatientStartPayLine":"800/600/400元(3级2级1级)","OutpatientEndPayLine":"6000","HospitalizationStartPayLine":"","HospitalizationEndPayLine":"","PolicyLink":"","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"居民报销比例60%/75%/90%(3级2级1级)，住院起付线（600、400、200）门诊报销比例50%/70%/85%(3级2级1级)，","OutpatientStartPayLineTwo":"300\\200\\100","OutpatientEndPayLineTwo":"2500","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"","ReimbursementTreatmentThree":"","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"西藏","City":"拉萨","ReimbursementRatio":"93-98%","InsuranceType":"(职工)","ReimbursementTreatment":"西藏谈判药品按照乙类管理，住院或者门特先行自付10%，剩余的90%按照起付线至20万元（含）基金支付93%，20万元至40万元（含）基金支付96%，40万元至60万元（含）基金支付98%","OutpatientStartPayLine":"无门诊统筹","OutpatientEndPayLine":"无门诊统筹","HospitalizationStartPayLine":"三级医院400元；二级医院300；一级医院200元","HospitalizationEndPayLine":"60w","PolicyLink":"","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"选择250元档的按90%报销，选择120元档次的按70%报销，选择60元档的按照60%报销","OutpatientStartPayLineTwo":"不低于100元","OutpatientEndPayLineTwo":"300元","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"6W","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"","ReimbursementTreatmentThree":"职工门特报销比例为90%，不设起付线。合并住院后，起付线至20万元（含）基金支付93%，20万元至40万元（含）基金支付96%，40万元至60万元（含）基金支付98%","OutpatientStartPayLineThree":"职工门特报销比例为90%，不设起付线，年度最高支付限额和住院合并计算","OutpatientEndPayLineThree":"60万一年","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"新疆","City":"乌鲁木齐","ReimbursementRatio":"0.9","InsuranceType":"(职工)","ReimbursementTreatment":"\"住院保险待遇：在职为一级医院95%；二级医院90%；三级医院85%\n退休分别为一级医院95%；二级医院95%；三级医院90%\"","OutpatientStartPayLine":"普通门诊统筹基金不支付，使用个人帐户","OutpatientEndPayLine":"普通门诊统筹基金不支付，使用个人帐户","HospitalizationStartPayLine":"一级医院200元，二级医院400，三级医院900","HospitalizationEndPayLine":"基本医保8万，大额医疗补充22万","PolicyLink":"关于提高我市城镇职工基本医疗保险统筹和大额医疗补助金最高支付限额的通知；乌鲁木齐市关于调整我市城镇职工基本医疗保险统筹基金起付标准的通知; 乌医保【2019】46号关于调整乌鲁木齐市基本医疗保险有关政策的通知","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"住院保险待遇：乡镇卫生院90%；一级医院90%；二级医院80%；三级医院65%","OutpatientStartPayLineTwo":"取消慢性病10元起付标准","OutpatientEndPayLineTwo":"门诊统筹基金支付比例为70%","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"城乡居民年度内住院基本医疗保险上限9万元，年度内累计个人负担合规医疗费用超1.5万元（含1.5万元）后启动城乡居民大病保险。1.5至5万元以下（含5万元）的部分支付比例为50%，5至10万元（含10万元）部分支付比例为55%，10至20万元（含20万元）部分支付比例为60%，20万元以上部分支付比例为65%，不设最高支付限额，即住院报销金额不设上限。","PolicyLinkTwo":"《关于调整乌鲁木齐市基本医疗保险有关政策的通知 》乌医保[2019]46号","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/城乡居民","ReimbursementTreatmentThree":"\"职工：特殊慢性病治疗统筹基金支付比例80%；各种恶性肿瘤、肝硬化、精神病、慢性活动性肝炎、慢性肾功能衰竭、器官移植后排异治疗6种慢性病统筹基金支付比例90%。\n城乡居民：一类慢性病统筹基金支付比例为70%；恶性肿瘤、白血病、肾功能衰竭、苯丙酮尿症、血友病的统筹基金支付比例为80%，取消慢性病10元起付标准；一类慢性病年度统筹基金最高支付限额为4000元。\"","OutpatientStartPayLineThree":"居民：一类慢性病统筹基金支付比例为70%；恶性肿瘤、白血病、肾功能衰竭、苯丙酮尿症、血友病的统筹基金支付比例为80%，取消慢性病10元起付标准；","OutpatientEndPayLineThree":"居民：一类慢性病年度统筹基金最高支付限额为4000元；职工无限额","PolicyLinkThree":"《关于调整乌鲁木齐市基本医疗保险有关政策的通知 》乌医保[2019]46号","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"新疆","City":"兵团","ReimbursementRatio":"0.9","InsuranceType":"(职工)","ReimbursementTreatment":"住院报销 一级医院80%-96%；二级医院80%-93%；三级医院80%-90%；自负合规费用2.5万以上享受大病保险，实行分档累加按比例支付，职工大病保险最低报销比例55%，最高可达到95%。0 至5万元（含 5万元）的支付比例为 55%，5 至10万元（含10万元）的支付比例为 65%，10至20万元（含 20万元）的支付比例为 75%，20 至30万元（含30万元）的支付比例为85%，30万元以上的支付比例为95%的。","OutpatientStartPayLine":"普通门诊统筹基金不支付，使用个人帐户","OutpatientEndPayLine":"普通门诊统筹基金不支付，使用个人帐户","HospitalizationStartPayLine":"一级医院200元，二级医院400元，三级医院700元","HospitalizationEndPayLine":"基本医保3.5万，大额医疗补充14.5万","PolicyLink":"兵团职工基本医保政策；新疆生产建设兵团关于实施大病保险的公告","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"住院报销 一级医院80%；二级医院70%；三级医院60%；自负合规费用1.5万以上享受大病保险，兵团城镇居民大病保险起付标准以上的医疗费用，分档累加按比例支付，具体标准为：0 至5万元（含 5 万元）的支付比例为 50%，5 至10万元（含10万元）的支付比例为 60%，10 至20万元（含 20万元）的支付比例为 70%，20 至30万元（含30万元）的支付比例为80%，30 万元以上的支付比例为90%","OutpatientStartPayLineTwo":"普通门诊统筹基金不支付，使用个人帐户","OutpatientEndPayLineTwo":"普通门诊统筹基金不支付，使用个人帐户","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"8.7万","PolicyLinkTwo":"\"兵团城镇居民基本医疗保险待遇\n\"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/城镇居民","ReimbursementTreatmentThree":"0.8","OutpatientStartPayLineThree":"不设起付线","OutpatientEndPayLineThree":"同住院统筹封顶线","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"新疆","City":"伊宁","ReimbursementRatio":"0.9","InsuranceType":"(职工)","ReimbursementTreatment":"自付10%，其余按照乙类报销90%，无限额","OutpatientStartPayLine":"1800","OutpatientEndPayLine":"10万","HospitalizationStartPayLine":"第一次住院1300元；第二次650","HospitalizationEndPayLine":"","PolicyLink":"","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"一级85%；二级75%；三级65%","OutpatientStartPayLineTwo":"","OutpatientEndPayLineTwo":"","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"10万","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"","ReimbursementTreatmentThree":"7万以上部分报销70%","OutpatientStartPayLineThree":"7万","OutpatientEndPayLineThree":"10万","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"新疆","City":"克拉玛依","ReimbursementRatio":"0.9","InsuranceType":"(职工)","ReimbursementTreatment":"自付10%，其余按照乙类报销90%，无限额","OutpatientStartPayLine":"1800","OutpatientEndPayLine":"10万","HospitalizationStartPayLine":"第一次住院1300元；第二次650","HospitalizationEndPayLine":"","PolicyLink":"","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"一级85%；二级75%；三级65%","OutpatientStartPayLineTwo":"","OutpatientEndPayLineTwo":"","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"10万","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"","ReimbursementTreatmentThree":"7万以上部分报销70%","OutpatientStartPayLineThree":"7万","OutpatientEndPayLineThree":"10万","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"新疆","City":"石河子","ReimbursementRatio":"0.9","InsuranceType":"(职工)","ReimbursementTreatment":"住院报销 一级医院80%-96%；二级医院80%-93%；三级医院80%-90%；自负合规费用2.5万以上享受大病保险，实行分档累加按比例支付，职工大病保险最低报销比例55%，最高可达到95%。0 至5万元（含 5万元）的支付比例为 55%，5 至10万元（含10万元）的支付比例为 65%，10至20万元（含 20万元）的支付比例为 75%，20 至30万元（含30万元）的支付比例为85%，30万元以上的支付比例为95%的。","OutpatientStartPayLine":"普通门诊统筹基金不支付，使用个人帐户","OutpatientEndPayLine":"普通门诊统筹基金不支付，使用个人帐户","HospitalizationStartPayLine":"一级医院200元，二级医院400元，三级医院700元","HospitalizationEndPayLine":"基本医保3.5万，大额医疗补充14.5万","PolicyLink":"兵团职工基本医保政策；新疆生产建设兵团关于实施大病保险的公告","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"住院报销 一级医院80%；二级医院70%；三级医院60%；自负合规费用1.5万以上享受大病保险，兵团城镇居民大病保险起付标准以上的医疗费用，分档累加按比例支付，具体标准为：0 至5万元（含 5 万元）的支付比例为 50%，5 至10万元（含10万元）的支付比例为 60%，10 至20万元（含 20万元）的支付比例为 70%，20 至30万元（含30万元）的支付比例为80%，30 万元以上的支付比例为90%","OutpatientStartPayLineTwo":"普通门诊统筹基金不支付，使用个人帐户","OutpatientEndPayLineTwo":"普通门诊统筹基金不支付，使用个人帐户","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"8.7万","PolicyLinkTwo":"\"兵团城镇居民基本医疗保险待遇\n\"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/城镇居民","ReimbursementTreatmentThree":"0.8","OutpatientStartPayLineThree":"不设起付线","OutpatientEndPayLineThree":"同住院统筹封顶线","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"新疆","City":"昌吉","ReimbursementRatio":"0.9","InsuranceType":"(职工)","ReimbursementTreatment":"自付5%，其余按照乙类报销80%，无限额","OutpatientStartPayLine":"不设起付线","OutpatientEndPayLine":"2万","HospitalizationStartPayLine":"首次1300；二次650","HospitalizationEndPayLine":"7万","PolicyLink":"","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"一级75%；二级60%；三级45%","OutpatientStartPayLineTwo":"800元","OutpatientEndPayLineTwo":"","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"(城乡居民)","ReimbursementTreatmentThree":"","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"甘肃省","City":"兰州市","ReimbursementRatio":"\"住院：职工：先自付20%后纳入乙类，自付10%，再按照医保报销政策报销；居民：直接按乙类自付10%后报销70%；\n门诊（药店）：职工自付10%后，报销75%；居民自付10%报销70%\"","InsuranceType":"(职工)","ReimbursementTreatment":"\"住院：先自付20%后纳入乙类，自付10%，再按照医保报销政策报销，职工（退休）个人自付比例：三级医院：起付标准以上至1万元12%（9%），1万以上至2万元8%（6%），2万以上至6万4%（3%）\n门诊（药店）：职工自付10%后，报销75%；\"","OutpatientStartPayLine":"无","OutpatientEndPayLine":"无","HospitalizationStartPayLine":"三级甲等：1400，三级乙等：1000；二级：400元，一级和社区卫生机构200元","HospitalizationEndPayLine":"基本医疗保险封顶线6万，超过进入大额医疗保险，上不封顶","PolicyLink":"关于进一步完善《兰州市基本医疗保险谈判药品管理经办规程》的通知","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"\"住院：直接按乙类自付10%后报销70%；\n门诊（药店）：居民自付10%报销70%\"","OutpatientStartPayLineTwo":"无","OutpatientEndPayLineTwo":"无","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"基本医疗保险封顶4万，超出进入大病保险，上不封顶","PolicyLinkTwo":"关于进一步完善《兰州市基本医疗保险谈判药品管理经办规程》的通知","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"","ReimbursementTreatmentThree":"","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"贵州","City":"贵阳","ReimbursementRatio":"\"在职职工84-95%；\n退休职工92-97.5%；\n居民60-77%\"","InsuranceType":"(职工)","ReimbursementTreatment":"\"在职：\n省医、贵医、省肿瘤1500\n其它三级医院850/900/950\n二级医院700\n一级医院300/500\n省医、贵医、省肿瘤84%\n其它三级医院89%\n二级医院94%\n一级医院95%\n退休：\n省医、贵医、省肿瘤1200\n其它三级医院650/700/750\n二级医院500\n一级医院200/300\n省医、贵医、省肿瘤92%\n其它三级医院94.5%\n二级医院97%\n一级医院97.5%\n\"","OutpatientStartPayLine":"普通门诊统筹基金不支付，使用个人账户","OutpatientEndPayLine":"普通门诊统筹基金不支付，使用个人账户","HospitalizationStartPayLine":"无起付线","HospitalizationEndPayLine":"基本医保15万；大额封顶线 :  25万","PolicyLink":"贵州基本医保政策","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"\"起付标准：\n县三级800；县以上三级1000；贵医、省医、省肿瘤、贵医口腔1400\n二级400\n一级及以下100\n报销比例：\n三级60%\n二级75%\n一级及以下77%\n限额25万\n大病：\n起付标准7000\n报销比例7000-6万报60%\n6-9万报65%\n9万以上70%\n限额20万\n乙类先行自付比例15%\"","OutpatientStartPayLineTwo":"二级及以下起付线0元；报销比例一级二级50%，乡镇卫生院（社区）60%；村卫生室70%","OutpatientEndPayLineTwo":"最高支付限额400","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"25+20","PolicyLinkTwo":"贵阳市城镇居民基本医疗保险试点实施办法","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工、城镇居民","ReimbursementTreatmentThree":"\"职工门慢：起付线200-1500；报销比例在职88%，退休94%；最高支付限额1.2万\n职工大病：起付线视同住院；报销比例在职88%，退休94%，支付限额视同住院\n居民门慢：起付线视同住院；报销比例视同住院；最高支付限额6000\n居民大病：起付、比例、限额均视同住院\"","OutpatientStartPayLineThree":"\"职工门慢200-1500\n职工大病视同住院\n居民门慢大病均视同住院\"","OutpatientEndPayLineThree":"\"职工门慢1.2万，职工大病视同住院\n居民门慢6000，大病视同住院\"","PolicyLinkThree":"贵州省人民医院贵阳市市级医保医疗待遇","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"贵州","City":"遵义","ReimbursementRatio":"\"职工82-91%\n居民60-85%\"","InsuranceType":"(职工)","ReimbursementTreatment":"\"住院职工：\n起付标准：乡镇/社区医院50，县级医院100-300，市级医院400，省级医院450；支付比例：在职：社区医院88%，县级医院87%，市级医院83%，省级医院82%；退休：社区医院91%，县级医院90%，市级医院86%，省级医院85%；基本医疗保险支付限额4万；大额保险支付比例92%，限额25万。\n门诊双通道城镇职工92%\"","OutpatientStartPayLine":"普通门诊统筹基金不支付，使用个人账户","OutpatientEndPayLine":"普通门诊统筹基金不支付，使用个人账户","HospitalizationStartPayLine":"\"\n乡镇/社区医院50，县级医院100-300，市级医院400，省级医院450\"","HospitalizationEndPayLine":"基本医保4万；大额封顶线 :  25万","PolicyLink":"《遵义市城镇职工 基本医疗保险实施办法的通知》遵府发〔2010〕28号","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"\"住院居民：\n起付标准：一级医院100，二级400，市三级800，省三级1200；报销比例：一级85%，二级80%，市三级70%，省三级60%，基本医疗保险支付限额25万；大病起付线6000，报销比例：6000-6万报60%，6万-10万报70%，10万以上80%；最高支付限额50万，先行自付比例10%\n门诊双通道75%\"","OutpatientStartPayLineTwo":"0","OutpatientEndPayLineTwo":"60","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"最高统筹支付限额25万元+50万（大病）","PolicyLinkTwo":"关于调整城镇居民基本医疗保险待遇 有关问题的通知2015","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工、城镇居民","ReimbursementTreatmentThree":"\"职工门慢起付线0元，报销比例80%，支付限额按病种限定；门诊大病起付线0元，报销比例92%，支付限额视同住院\n居民门慢起付线0元，报销比例60%，支付限额按病种定；门诊大病起付线0元，报销比例及限额视同住院\"","OutpatientStartPayLineThree":"0","OutpatientEndPayLineThree":"2400","PolicyLinkThree":"《遵义市城镇职工 基本医疗保险实施办法的通知》遵府发〔2010〕28号;关于调整城镇居民基本医疗保险待遇 有关问题的通知2018","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"重庆","City":"重庆","ReimbursementRatio":"一，二，三级医院分别是90%，87%，85%","InsuranceType":"(职工)","ReimbursementTreatment":"\"退休：95%；在职，分医院级别一级90%;二级87%;三级85%。补充：统筹基金支付超过4.7万元以上的，符合大额医疗费互助基金报销规定的，最多50万元，报销比例100%。\n门槛费：一级二级社区医院160/400元；一二三级医院200/440/880元\"","OutpatientStartPayLine":"个人账户支付普通门诊，统筹基金不支付","OutpatientEndPayLine":"个人账户支付普通门诊，统筹基金不支付","HospitalizationStartPayLine":"一级二级社区医院160/400元；一二三级医院200/440/880元","HospitalizationEndPayLine":"4.7+50万","PolicyLink":"重庆市城镇职工医疗保险政策解读","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"\"参保人员住院发生的政策范围内医疗费用，按以下标准报销：一档：一级医疗机构80%，二级60%，三级40%。二档：在一档的基础上提高5个百分点。未成年人在同档参保成年人的基础上提高5个百分点。\n起付线：一级医疗机构100元/次，二级300元/次，三级800元/次\"","OutpatientStartPayLineTwo":"不设起付标准","OutpatientEndPayLineTwo":"年度居民医保的门诊定额包干标准为150元/人","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"28（一档）/32（二档）万","PolicyLinkTwo":"\"重庆市城乡居民合作医疗保险市级统筹实施办法的通知；渝北区2016年城乡居民医保市级统筹政策宣传资料\n\"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工、城乡居民","ReimbursementTreatmentThree":"职工：肿瘤统筹基金按90％支付；其他特殊病种统筹基金按80％支付。特病支付限额与住院合并计算。限额以上，由大额医疗费互助基金支付报销比例100% 支付限额 50万元 。城乡居民：特殊疾病中的慢性疾病门诊（糖尿病，精神病）医药费不设报销起付线，实行按比例、限额的办法。每次报销比例为一级医疗机构80%、二级60%、三级40%，年报销限额为1000元/年、人。重大疾病门诊（肿瘤）实行与住院相同的报销比例和起付线，其起付线一年计算1次（一年内到不同等级医疗机构就医的以最高等级计算），封顶线与住院合并计算，直至当年的成年人报销封顶线；儿童重大疾病住院和门诊的累加封顶线一档10万元，二档15万元。大病医疗保险：参加我区城乡居民合作医疗保险的居民住院和特殊疾病中的重大疾病门诊发生属于居民医保基金报销范围的医疗费用，由居民医保基金按规定比例支付后的自付费用首次或累计超过起付标准（2019年9月1日起，起付标准调整为13193元）以上的，报销比例提高至60%，最高报销金额20万元。对于建档贫困人员9月3日起全面取消大病保险封顶线。","OutpatientStartPayLineThree":"职工：一级医院200元，二级440元，三级882元。居民：不设报销起付线","OutpatientEndPayLineThree":"职工：54.7万；居民：28（一档）/32（二档）万","PolicyLinkThree":"\"关于做好重庆市2019年城乡居民基本医疗保障工作的通知 渝医保发【2019】65号；\n重庆市城镇职工医疗保险政策解读；重庆市城乡居民合作医疗保险特殊疾病管理暂行办法\"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"陕西","City":"西安","ReimbursementRatio":"：先自付4%。职工报76%，居民报60%","InsuranceType":"(职工)","ReimbursementTreatment":"：先自付4%。报销76%，","OutpatientStartPayLine":"无","OutpatientEndPayLine":"无","HospitalizationStartPayLine":"无","HospitalizationEndPayLine":"封顶40万；40万以上进入大额补助医疗保险，自付5%，无封顶","PolicyLink":"关于做好国家基本医疗保险，工伤保险和生育保险药品目录（2019年版）执行落实工作的通知","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"先自付5%。报销60%，","OutpatientStartPayLineTwo":"无","OutpatientEndPayLineTwo":"无","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"20万，20万以上进入大病二次报销，无封顶线","PolicyLinkTwo":"关于做好国家基本医疗保险，工伤保险和生育保险药品目录（2019年版）执行落实工作的通知","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"","ReimbursementTreatmentThree":"","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"关于我市医疗保险特殊药品落地实施的通知","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"青海","City":"西宁","ReimbursementRatio":"三级定点医疗机构50%；二级及以下定点医疗机构70%。","InsuranceType":"(职工)","ReimbursementTreatment":"自付35%，其余按照乙类报销。一级85%；二级80%；三级75%","OutpatientStartPayLine":"200","OutpatientEndPayLine":"10000","HospitalizationStartPayLine":"一级医疗机构350元，二级医疗机构550元，三级医疗机构750元","HospitalizationEndPayLine":"25万/年","PolicyLink":"西宁本市职工基本医疗保险","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"卫生院60%，二级医院40%，三级医院30%","OutpatientStartPayLineTwo":"10万以下的三级医院659元、二级医院300元、一级医院不设起付线","OutpatientEndPayLineTwo":"2000","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"10万","PolicyLinkTwo":"西宁市城镇居民基本医疗保险","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"年度个人自付费用超过7000元以上的部分，纳入大病保险范围，按照85%比例报销","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"10000","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"江苏","City":"无锡","ReimbursementRatio":"0.7","InsuranceType":"(职工)","ReimbursementTreatment":"\"1.门诊，个人账户用完后，在约定社区卫生服务中心（站）或经批准转至其他定点医疗机构就医发生的符合规定的门诊医疗费由统筹基金分别按在职和退休（职）人员70%和85%的比例支付。\n2.住院，在职职工在三级医疗机构出院结算，医疗费用在1万元（含1万元）以下，统筹基金支付84%，个人自付比例为16%；医疗费用在1万元至4万元（含4万元），统筹基金支付88%，个人自付比例为12%；医疗费用在4万元至12万元（含12万元），统筹基金支付92%，个人自付比例8%。在职职工在二级及以下医疗机构出院结算，医疗费用在1万元（含1万元）以下，统筹基金支付88%，个人自付比例为12%；医疗费用在1万元至4万元（含4万元），统筹基金支付90%，个人自付比例为10%；医疗费用在4万元至12万元（含12万元），统筹基金支付92%，个人自付比例8%。在职职工在一级医疗机构出院结算，医疗费用在1万元（含1万元）以下，统筹基金支付96.4%，个人自付比例为3.6%；医疗费用在1万元至4万元（含4万元），统筹基金支付97%，个人自付比例3%；医疗费用在4万元至12万元（含12万元），统筹基金支付92%，个人自付比例8%。在职职工在社区服务机构出院结算，医疗费用在12万元（含12万元）以下，统筹基金支付92%，个人自付比例为8%。退休人员在上述个人自付比例基础上减半执行，建国前参加革命工作的老工人个人自付比例为在职职工的30%。\n医疗费用在4万元至30万元，不分医疗机构级别和人员类别个人均支付8%，基本医疗保险统筹基金支付92%。\"","OutpatientStartPayLine":"参保人员个人帐户用完","OutpatientEndPayLine":"在职5000；退休6000","HospitalizationStartPayLine":"社区300；一级400；二级在职750，退休600；三级在职950，退休750","HospitalizationEndPayLine":"30万","PolicyLink":"无锡医疗职工保险常见问题","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"\"1.门诊：800以内，社区报销50%，其他医院40%；\n2.住院：在社区卫生服务中心就医为90％；在市内和市外医院就医，办理转诊手续的分别为65％和55％，未办理转诊手续的分别按上述比例的50％执行。\"","OutpatientStartPayLineTwo":"不设起付标准","OutpatientEndPayLineTwo":"800元","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"20万，缴费满5年增加5万","PolicyLinkTwo":"无锡\\无锡居民医保政策解读（一二三四）.docx","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"\"1.职工门诊特殊病种（恶性肿瘤化疗、放疗（含核素治疗）、肾透析、器官移植排异、血友病、生物治疗（CIK/DC)）在不同等级医疗机构进行治疗时，其医疗费用合并计算，个人不再支付统筹基金起付费，且统筹段的个人自付比例统一按一级医疗机构的标准执行。1万元以内，在职88%，退休94%；1-4万元，在职90%，退休95%；4-30万元，在职92%，退休96%；30万元以上，在职和退休均为92%\n2.居民医保基金支付比例：1.8万-5万元，50%；5-10万元，60%；10万元以上，80%。未办理转诊手续的分别按上述比例的50％执行。\"","OutpatientStartPayLineThree":"不设起付标准","OutpatientEndPayLineThree":"与住院报销共享最高支付限额职工30万；居民20万。","PolicyLinkThree":"无锡居民医保政策，职工医保政策问答","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"江苏","City":"南通","ReimbursementRatio":"85%-60%","InsuranceType":"(职工)","ReimbursementTreatment":"职工门诊统筹待遇在职70%，退休80%","OutpatientStartPayLine":"600元","OutpatientEndPayLine":"在职和退休：3500元","HospitalizationStartPayLine":"社会医疗统筹基金，对参保人员住院医疗费用起付标准以上， 0 元至 2 万元（含）部分，在一级定点医疗机构在职人员和退休 人员（下同）分别支付 90%、94%，在二级定点医疗机构分别支 付 85%、89%，在三级定点医疗机构分别支付 83%、87%；2 万 元至 10 万元（含）部分，在一级定点医疗机构分别支付 94%、 98%，在二级定点医疗机构分别支付 90%、94%，在三级定点医 疗机构分别支付 88%、92%。 将 10 万元至 20 万元（含）部分，由大额医疗救助资金支付 部分比例调整为在一级定点医疗机构支付 90%、二级定点医疗机构支付 87%、在三级定点医疗机构支付85%。取消原“连续缴纳 大额医疗救助费 5 年以上的分别提高 5 个百分点”的规定。","HospitalizationEndPayLine":"20万元","PolicyLink":"通医保发【2019】23号","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"居民门诊统筹50%","OutpatientStartPayLineTwo":"","OutpatientEndPayLineTwo":"600元","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"20万元","PolicyLinkTwo":"通医保发【2019】23号","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"门慢患者每年补助2000元。","OutpatientStartPayLineThree":"\"职工和居民起付线10000元；\n大病保险起付标准以上 0 元5万元（含）的部分，职工医保和居民医保大病保险资金支付比例50%；5万至10 万元（含）的部分，职工医保和居民医保大病保险资金支付比例调整为 60%；10 万元至 20 万元（含）的部分，职工医保和居民医保大病保险资金支付比例调整为 80%；20 万元以上部分，职工医保和居民医保大病保险资金支付比例调整为 90%\"","OutpatientEndPayLineThree":"","PolicyLinkThree":"通医保发【2019】23号","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"巴瑞替尼片","ProductName":"艾乐明","DosageForm":"片剂","Specification":"是","ApprovaledText":"2mg","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"适用于对一种或多种改善病情抗风湿药(DMARS)疗效不佳或不耐受的中重度活动性类风湿关节炎成年患者。巴瑞替尼可以与甲氨蝶呤或其他非生物改善病情抗风湿药联合使用","Province":"江苏","City":"扬州","ReimbursementRatio":"0.7","InsuranceType":"(职工)","ReimbursementTreatment":"\"普通门诊：在职35岁到退休，按照本人缴费基数的2.6-3.5%划入个人账户，退休按退休金总额4.5%划入。\n住院：一级医院，报销92%；二级医院，报销88%，三级医院报销86%\"","OutpatientStartPayLine":"","OutpatientEndPayLine":"","HospitalizationStartPayLine":"一级：400元，二级：600元，三级800元","HospitalizationEndPayLine":"23万元","PolicyLink":"","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"定点医疗机构报销50%","OutpatientStartPayLineTwo":"100-600元","OutpatientEndPayLineTwo":"","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"全石城镇居民年人均可支配收入的6倍","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"\"职工：一类：恶性肿瘤、血透、血友病及肝、肾移植；起付线500，报销同住院。二类：糖尿病（合并感染或有心、脑、肾、眼、神经并发症之一者）；慢性肝炎和肝硬化(失代偿期)；精神分裂症、情感性精神障碍；慢性肾功能不全；再生障碍性贫血；系统性红斑狼疮；类风湿性关节炎；帕金森氏病及综合征；肺结核。慢性肝炎和肝硬化（失代偿期）；冠心病；阿尔茨海默症（病）；中风后遗症。起付线500，报销同住院，年度上限2500。\n居民：门特同职工报销，年度结算1500-2000元\"","OutpatientStartPayLineThree":"500元","OutpatientEndPayLineThree":"2500元","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"上海","City":"上海","ReimbursementRatio":"0.9","InsuranceType":"(职工)","ReimbursementTreatment":"\"在职职工门诊急诊医疗费用：在职职工一年内门诊急诊就医或者到定点零售药店配药所发生的费用，先由其个人医疗帐户当年计入资金支付。不足部分由个人支付至门急诊自负段标准计1500元，超过部分按照下列规定支付：\n　　（一）44岁以下人员，在一级医疗机构门诊急诊的，由附加基金支付65%；在二级医疗机构门诊急诊的，由附加基金支付60%；在三级医疗机构门诊急诊的，由附加基金支付50%。\n　　（二）45岁以上人员，在一级医疗机构门诊急诊的，由附加基金支付75%；在二级医疗机构门诊急诊的，由附加基金支付70%；在三级医疗机构门诊急诊的，由附加基金支付60%。其中，1955年12月31日前出生、2000年12月31日前参加工作的，超过门急诊自负段标准部分的医疗费用，在一级医疗机构门诊急诊的，由附加基金支付75%；在二、三级医疗机构门诊急诊的，由附加基金支付70%。\n\n退休人员门诊急诊医疗费用：退休人员一年内门诊急诊就医或者到定点零售药店配药所发生的除本办法第二十六条、第二十八条规定以外的费用，先由其个人医疗帐户当年计入资金支付。不足部分由个人支付至门急诊自负段标准计700元，超过部分按照下列规定支付(不含到定点零售药店配药所发生的费用)：\n　　（一）69岁以下人员，在一级医疗机构门诊急诊的，由附加基金支付80%；在二级医疗机构门诊急诊的，由附加基金支付75%；在三级医疗机构门诊急诊的，由附加基金支付70%。其中，1955年12月31日前出生、2000年12月31日前参加工作并于2001年1月1日后办理退休手续的人员，超过门急诊自负段标准部分的医疗费用，在一级医疗机构门诊急诊的，由附加基金支付85%；在二级医疗机构门诊急诊的，由附加基金支付80%；在三级医疗机构门诊急诊的，由附加基金支付75%。\n　　（二）70岁以上人员，在一级医疗机构门诊急诊的，由附加基金支付85%；在二级医疗机构门诊急诊的，由附加基金支付80%；在三级医疗机构门诊急诊的，由附加基金支付75%。\n　　\n住院：起付线：在职职工1500，退休人员1200，退休老人700；报销比例：在职职工85%，退休人员92%\n住院/急诊观察+门诊大病/家庭病床合计限额57万，最高限额以上的医疗费用由地方附加医疗保险附加基金支付80%，个人自负20%\"","OutpatientStartPayLine":"在职1500，退休700-300","OutpatientEndPayLine":"不设封顶线","HospitalizationStartPayLine":"在职1500元，退休700-1200元","HospitalizationEndPayLine":"住院/急诊观察+门诊大病/家庭病床合计57万","PolicyLink":"","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"\"门诊急诊（含家庭病床）居民医保基金支付比例为：在社区卫生服务中心（或者一级医疗机构）门诊急诊的，支付70％；在二级医疗机构门诊急诊的，支付60％；在三级医疗机构门诊急诊的，支付50％。\n住院医疗待遇：居民医保基金支付比例为：60周岁及以上人员、以及城镇重残人员，在社区卫生服务中心（或者一级医疗机构）住院的支付90％，在二级医疗机构住院的支付80％，在三级医疗机构住院的支付70％；60周岁以下人员，在社区卫生服务中心（或者一级医疗机构）住院的支付80％，在二级医疗机构住院的支付75％，在三级医疗机构住院的支付60％。\n在基本医疗保险报销后，个人自负部分大病二次报销60%，低保、低收入家庭成员报销65%\"","OutpatientStartPayLineTwo":"60周岁及以上人员、城镇重残人员以及中小学生和婴幼儿为300元；超过18周岁、不满60周岁人员为500元。","OutpatientEndPayLineTwo":"不设封顶线","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"不设封顶线","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"\"职工门诊大病\n居民大病二次报销\"","ReimbursementTreatmentThree":"\"一.职工在门诊进行重症尿毒症透析、恶性肿瘤治疗（化学治疗、内分泌特异治疗、放射治疗、同位素治疗、介入治疗、中医治疗）、部分精神病病种治疗（精神分裂症、中重度抑郁症、躁狂症、强迫症、精神发育迟缓伴发精神障碍、癫痫伴发精神障碍、偏执性精神病）（以下统称“门诊大病”）所发生的医疗费用，在职职工的，由统筹基金支付85%；退休人员的，由统筹基金支付92%。其余部分由其个人医疗帐户历年结余资金支付，仍不足支付的，由职工自负。\n二、参保居民罹患上述大病后，在本市基本医疗保险定点医疗机构发生、符合本市基本医疗保险报销范围的费用，在基本医疗保险报销后，参保居民在基本医疗保险政策范围内个人自负的费用，纳入城乡居民大病保险支付范围，由大病保险资金报销60%，本市低保、低收入家庭成员报销65%。城乡居民中已参加上海市中小学生、婴幼儿住院医疗互助基金的，应先扣除互助基金支付部分。\"","OutpatientStartPayLineThree":"不设起付标准","OutpatientEndPayLineThree":"不设封顶线","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"安徽","City":"合肥","ReimbursementRatio":"0.7","InsuranceType":"(职工)","ReimbursementTreatment":"一级医院，起付线200，小于6万，报销94%，6-30万内报销97%，大于30万，不报。二级医院起付线400，小于6万，报销92%，6-30万报销96%，30万封顶。三级起付线600，小于6万，报销90%，6-30万报销95%，30万封顶。","OutpatientStartPayLine":"200-600","OutpatientEndPayLine":"30万","HospitalizationStartPayLine":"一级200     二级400     三级600","HospitalizationEndPayLine":"30万","PolicyLink":"http://ybj.hefei.gov.cn/zcwj/zcwj/14817903.html","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"在社区卫生服务中心门诊发生医疗费，统筹基金支付80%，最高限额20或50元/年；居民一级医院住院：医保范围内费用超过200元(起付标准)以上部分报销90%;二级医院住院：医保范围内费用超过400元(起付标准)以上部分报销85%; 三级医院住院：医保范围内费用超过600元(起付标准)以上部分报销80%；省属三级住院：医保范围内费用超过1000元（起付标准）以上部分报销75%","OutpatientStartPayLineTwo":"不设起伏标准","OutpatientEndPayLineTwo":"普通160元/年；>60岁男/55岁女 240元/年","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"30万","PolicyLinkTwo":"http://ybj.hefei.gov.cn/zcwj/zcwj/14817903.html","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"职工报销比例同住院；居民50%报销","OutpatientStartPayLineThree":"1.5万","OutpatientEndPayLineThree":"30万","PolicyLinkThree":"http://ybj.hefei.gov.cn/zcwj/zcwj/14817903.html","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"安徽","City":"芜湖","ReimbursementRatio":"0.7","InsuranceType":"(职工)","ReimbursementTreatment":"住院报销<1万元部分 在职人员三级医院85%，二级医院88%，一级医院90%；退休人员再增加2%。1万-3万元部分，在职人员三级医院88%，二级医院90%，一级医院92%；退休人员再增加2%。3万元以上部分不区分医院级别均为90%。","OutpatientStartPayLine":"普通门诊医疗费用由个人账户支付，统筹基金不支付","OutpatientEndPayLine":"普通门诊医疗费用由个人账户支付，统筹基金不支付","HospitalizationStartPayLine":"社区300；一级700；二级800；三级900","HospitalizationEndPayLine":"基本医疗保险统筹基金3万元，基本医疗保险统筹基金和医疗救助基金累计实际支付限额为30万元","PolicyLink":"芜湖市城镇职工医疗保险政策","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"普通门诊自费。住院报销，220元缴费标准，一级二级三级医院报销比例分别为：（起付线至10000元以下）70% ，65%，55%；（10000元及以上） 72%，67%，65%；260元缴费标准，一级二级三级医院报销比例分别为：（起付线至10000元以下）80%， 75%， 65%；（10000元及以上） 82%，77%，75%；同时对不同额度的单次住院医药费用实行分段保底补偿。","OutpatientStartPayLineTwo":"50元","OutpatientEndPayLineTwo":"80元缴费标准200元；260元缴费标准400元","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"30万","PolicyLinkTwo":"芜湖市市区居民基本医疗保险有关政策规定","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工、居民","ReimbursementTreatmentThree":"\"职工门慢：同等条件下住院比例报销；\n居民门特：医保执行同级医院住院报销规定。\n同时，居民享受2016年城镇大病医疗补充保险的起付标准为2万元（个人负担合规医疗费用累计超过部分），起付标准以上(元) 分段支付比例\n（0-20000含) 50%，（20000-100000含) 60%，（100000-200000含) 70%，（200000以上） 80%。\n\"","OutpatientStartPayLineThree":"居民：一级100 元   二级300 元   三级500元；职工不设起付标准","OutpatientEndPayLineThree":"居民同住院最高支付限额；职工4万元","PolicyLinkThree":"芜湖职工、居民基本医疗保险政策；2016年芜湖市城镇大病医疗补充保险实施办法","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"安徽","City":"马鞍山","ReimbursementRatio":"0.7","InsuranceType":"(职工)","ReimbursementTreatment":"门诊全部由职工个户支付","OutpatientStartPayLine":"无","OutpatientEndPayLine":"无","HospitalizationStartPayLine":"一级医院200，二级400，三级600","HospitalizationEndPayLine":"30万","PolicyLink":"","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"乡镇、社区，20-50元内报销80%，100元封顶；二级以上医院，300以上600以内报销40%，封顶线是1500.","OutpatientStartPayLineTwo":"不设","OutpatientEndPayLineTwo":"100-1500","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"30万","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"起付线1万-5万，报销60%，5万-10万，报销65%，10-20万报销80%","OutpatientStartPayLineThree":"1万","OutpatientEndPayLineThree":"30万","PolicyLinkThree":"马鞍山基本医疗管理办法","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"江苏","City":"镇江","ReimbursementRatio":"0.7","InsuranceType":"(职工)","ReimbursementTreatment":"\"门诊统筹：职工报销定点医疗机构：90%；一级：75%；二级：70%；三级50%。\n住院：社区，1万以内职工报销85%，退休报销90%；社区，1万-5万职工报销90%，退休报销92.5。二级以上医疗机构，1万以内职工报销80%，退休报销90%；二级以上医疗机构，1万-5万，职工90%，退休95%\"","OutpatientStartPayLine":"在职为年缴费工资总额10%，退休为年度退休总额的5%","OutpatientEndPayLine":"无","HospitalizationStartPayLine":"","HospitalizationEndPayLine":"无","PolicyLink":"","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"首诊社区报销50%","OutpatientStartPayLineTwo":"","OutpatientEndPayLineTwo":"个人缴费标准的3倍","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"本市上年居民人均可支配收入的8倍","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"\"职工大病：5万-30万，报销95%；30万-50万：报销96%；50万以上，报销98%；\n居民门慢：高血压、糖尿病、前列腺增生、红斑狼疮、肾衰，社区报销50%；精神病、乙肝、癫痫、结核病、再障贫血，二级及以上报销50%；\n门特：终末期肾病透析重性精神病、耐多药结核、终末期肾病、恶性肿瘤、血友病、器官移植排异、先心、甲亢、儿童苯丙酮尿症：社区报销70%，二级及以上报销50%\"","OutpatientStartPayLineThree":"职工大病：5万元","OutpatientEndPayLineThree":"\"居民门慢：社区，个人缴费标准的8倍；二级及以上，个人缴费标准的15倍\n居民门特：二级及以上，个人缴费标准的15倍\"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"江苏","City":"淮安","ReimbursementRatio":"0.7","InsuranceType":"(职工)","ReimbursementTreatment":"\"门诊费用走个人账户，不统筹。\n住院：\n一级医院，400元-2万元，在职报销90%，退休报销95%；2万元-6万元，在职报销95%，退休报销97.5%；6万元以上，在职和退休均报销90%。\n二级医院，600元-2万元，在职报销90%，退休报销95%；2万元-6万元，在职报销95%，退休报销97.5%；6万元以上，在职和退休均报销90%。\n三级医院，1000元-2万元，在职报销90%，退休报销95%；2万元-6万元，在职报销95%，退休报销97.5%；6万元以上，在职和退休均报销90%。\"","OutpatientStartPayLine":"","OutpatientEndPayLine":"","HospitalizationStartPayLine":"一级400元，二级600元，三级1000元","HospitalizationEndPayLine":"无","PolicyLink":"","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"\"门诊：参保人员一个统筹年度内在首诊医疗卫生机构发生的医保甲类药品（含基本药物）、一般诊疗费和其他符合规定的普通门诊（急诊）医疗费用和产前检查医疗费用，按50%补偿（其中一般诊疗费补偿70%），年度内最高补偿限额为300元。未在首诊医疗机构所发生的门诊医药费用不予补偿(除急诊急救外)。纳入家庭医生签约，补偿最高400元。\n住院：一级医院报销85%，二级医院报销75%，三级医院报销65%\"","OutpatientStartPayLineTwo":"","OutpatientEndPayLineTwo":"年度内最高补偿限额为300元，未在首诊医疗机构所发生的的门诊医药费用不予补偿（除急诊急救外）。纳入家庭医生签约，补偿最高400元","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"24万元","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"\"职工：报销同住院；\n居民：大病保险：1.5-6万元，报销50%，6-10万元，报销70%，10万元以上，报销85%。22种大病，按病种付费报销70%\"","OutpatientStartPayLineThree":"\"职工：精神类疾病：300元，其他门特：750元\n居民大病保险住院：1.5万元\"","OutpatientEndPayLineThree":"职工：恶性肿瘤门诊放化疗、系统性红斑狼疮、肾衰竭透析、器官移植排异、慢性肝炎（含肝硬化）：最高支付限额；血友病（轻型）：2万元；血友病（中重型）：8万元；再生障碍性贫血：1.5万元；支架术后抗凝、冠状动脉大桥后抗凝一年：1万元；恶性肿瘤内分泌治疗：8000元；冠心病、高血压（极高危）、中度糖尿病、帕金森病、恶性肿瘤术后、精神类疾病：3000元；儿童脑瘫：1800元；结核病：2000元。","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"江苏","City":"盐城","ReimbursementRatio":"60%-70%","InsuranceType":"(职工)","ReimbursementTreatment":"\"职工门诊：零差率基层医疗机构报销70%，其他医疗机构报销50%；\n职工住院：1万元以下，二、三级医院报销80%；一级及以下医院报销85%，基本药物基层医疗机构报销90%。\n1万-5万元，二、三级医院报销85%；一级及以下医院报销90%，基本药物基层医疗机构报销95%。\n5万-7万元，二、三级医院报销90%；一级及以下医院和基本药物基层医疗机构报销95%。\n7万元以上，报销90%。\n退休人员个人负担比例减半。\"","OutpatientStartPayLine":"500元（低保、特困、重残0起付线）","OutpatientEndPayLine":"2500元","HospitalizationStartPayLine":"\"二级综合及以上医院：800元，递减100元，不低于500元；\n一级及其他二级医院：600元，递减100元，不低于400元；\n基本药物基层医院：300元；\n转市外住院：1000元\"","HospitalizationEndPayLine":"","PolicyLink":"","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"\"居民门诊：报销50%\n居民住院：一级医院，300元-1万元，报80%，一万元以上报75%；二级医院，500元-一万元，报70%，一万元以上报65%；三级医院，1000元-一万元，报60%，一万元以上报55%；转外，1000元-1万元，报55%，一万元以上报40%。\"","OutpatientStartPayLineTwo":"","OutpatientEndPayLineTwo":"1500元","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"\"职工：在医保范围内凭发票报销80%，无上限。门慢18种：社区报90%，二级及以上医院报销80%；门诊大病24中，二级及以上报80%，一级及以下报90%。\n居民：门慢13种，一级70%，二级60%，三级50%；门特14种，一级、二级70%，三级66%。大病，7000-5万元，报50%，5-10万元，报60%，10-20万元，报70%，20万元以上，报80%。\"","OutpatientStartPayLineThree":"300元","OutpatientEndPayLineThree":"\"职工：门慢18种，在职：1200元；退休：1500元\n居民：门慢13种，3000元；门特14种，6万元\"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"江苏","City":"南京","ReimbursementRatio":"0.7","InsuranceType":"(职工)","ReimbursementTreatment":"\"门诊统筹： 社区医疗机构报销比例，在职70%，退休75%，建国前老人100%；其他医疗机构报销比例，在职60%，退休65%，建国前老人95%.\n住院报销：在职 一级医院97%，二级医院95%，三级医院90%；退休 一级医院98%，二级医院97%，三级医院93%。\"","OutpatientStartPayLine":"职工1200；退休1000；建国前老工人200","OutpatientEndPayLine":"职工2000；退休3000；建国前老工人4000","HospitalizationStartPayLine":"一级300   二级500   三级1000","HospitalizationEndPayLine":"不封顶","PolicyLink":"南京城镇职工医保","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"\"1.“居民”看门诊200元以内的费用由个人承担.在社区医院就诊基金支付50%，在其他医院就诊基金支付30%;80周岁以上居民，在社区医院就诊基金支付55%，在其他医院就诊基金支付35%.\n2.住院待遇-老年居民和其他居民：一级报销90%，二级报销85%，三级报销65%。学生儿童一级报销95%，二级报销90%，三级报销80%.80周岁以上：一级报销95%，二级报销90%，三级报销70%。\"","OutpatientStartPayLineTwo":"200","OutpatientEndPayLineTwo":"普通居民年度基金支付限额300。80周岁以上330元。","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"统筹基金年度支付限额30万；逐年增加1万，最高增加到36万。","PolicyLinkTwo":"南京市城镇居民基本医疗保险政策","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"职工：70%居民60%","OutpatientStartPayLineThree":"无","OutpatientEndPayLineThree":"无","PolicyLinkThree":"单独支付","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"江苏","City":"常州","ReimbursementRatio":"0.7","InsuranceType":"(职工)","ReimbursementTreatment":"\"1.普通门诊医疗费用由医保基金补贴70%，按规定办理转诊手续在二、三级医疗机构支付比例：60%，50%。未办理转诊：二三级医疗机构支付比例：50%，40%。\n2.住院待遇，未退休（退职）人员支付90%、退休（退职）人员支付95%。\"","OutpatientStartPayLine":"1200元","OutpatientEndPayLine":"在职4000  退休5000     建国前工人6000","HospitalizationStartPayLine":"在职：一级400二级600，三级1000元。  退休建国前工人：：一级320二级480，三级800元。","HospitalizationEndPayLine":"15万","PolicyLink":"常州职工基本医疗保险政策解读","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"门诊：首诊50%，二三级：40%。 住院：一、二级、老年非从业居民：85%；未成年及大学生：95%。四院新北区二院阳湖园区及其他三级：老年非从业居民：75%；未成年及大学生：85%。","OutpatientStartPayLineTwo":"200元","OutpatientEndPayLineTwo":"1500元","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"25万，缴满5年增加5万","PolicyLinkTwo":"常州\\常州居民医保.docx","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"职工：70%居民60%","OutpatientStartPayLineThree":"无","OutpatientEndPayLineThree":"无","PolicyLinkThree":"2021年度常州市市本级城乡居民基本医疗保险宣传提纲 ；常州市市本级职工基本医疗保险宣传提纲","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"江苏","City":"徐州","ReimbursementRatio":"0.75","InsuranceType":"(职工)","ReimbursementTreatment":"参保人员在实行基本药物零差率销售的基层医疗卫生机构（含爱心医院）就医，超过起付标准所发生的政策范围内费用，门诊统筹基金按75%的比例予以补助；在其他基层医疗机构和A级定点零售药店，按70%补助；在二级医院（含县级医院，下同），按60%补助；在三级医院，按50%补助。低保、特困、重度残疾人员、70周岁以上（含70周岁）退休人员，在上述比例基础上提高10个百分点；69周岁以下（含69周岁）退休人员提高5个百分点。            住院报销：在职 1万一下一级医院94%，二级医院92%，三级医院85%；，1-5万： 一级医院96%，二级医院94%，三级医院90%；5万以上：一级医院98%，二级医院96%，三级医院92%。","OutpatientStartPayLine":"1500元","OutpatientEndPayLine":"1200元","HospitalizationStartPayLine":"市内住院治疗的起付标准为：三级医疗机构1000元，二级医疗机构500元，一级医疗机构及社区卫生服务机构200元。","HospitalizationEndPayLine":"10万元","PolicyLink":"关于统一全市城镇职工医疗保险待遇标准的通知","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"门诊统筹：甲类药物（含基本药物）。基层医疗机构：50%，社区卫生服务中心60%。村卫生室：80%。居民住院：一级90%，二级：80%，三级：70%。","OutpatientStartPayLineTwo":"起付：30","OutpatientEndPayLineTwo":"限额600，纳入家庭医生签约的900元。","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"20万","PolicyLinkTwo":"徐州城乡居民医保待遇","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"职工：70%居民60%","OutpatientStartPayLineThree":"无","OutpatientEndPayLineThree":"2万","PolicyLinkThree":"徐州关于贯彻落实国家医保谈判药品“双通道”管理机制有关事项的通知","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"江苏","City":"泰州","ReimbursementRatio":"0.7","InsuranceType":"(职工)","ReimbursementTreatment":"住院待遇，起付线-1.5万元，一级95%，二级91%，三级91%；1.5万元-9万元，一级96%，二级95%，三级95%；9万元以上：一级、二级、三级均为90%","OutpatientStartPayLine":"30元","OutpatientEndPayLine":"市区医院：500元乡镇卫生院150元。","HospitalizationStartPayLine":"一级400元，二级600元，三级800元","HospitalizationEndPayLine":"无","PolicyLink":"2020泰州市职工基本医疗保险政策宣传","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"住院待遇：起付线-6万元，一级80%，二级70%，三级63%；6-20万元，一级、二级、三级均为63%","OutpatientStartPayLineTwo":"30元","OutpatientEndPayLineTwo":"市区医院：500元乡镇卫生院150元。","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"20万","PolicyLinkTwo":"2021泰州市职工基本医疗保险政策宣传","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"职工：70%居民60%","OutpatientStartPayLineThree":"无","OutpatientEndPayLineThree":"无","PolicyLinkThree":"单独支付政策","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"江苏","City":"苏州","ReimbursementRatio":"0.7","InsuranceType":"(职工)","ReimbursementTreatment":"\"普通门诊：职工报销60%，基层80%；退休报销70%，基层90%。\n住院：4万元以下的部分，按在职职工90%、退休人员95%的比例结付；4万元以上的部分，统一按95%的比例结付\n\"","OutpatientStartPayLine":"个人账户用完后，职工600元、退休400元。","OutpatientEndPayLine":"职工4000元；退休4800元","HospitalizationStartPayLine":"市级及市级以上医院：在职职工（含灵活就业参保人员、“协保”人员、参加职工医疗保险的领取失业保险金人员，下同）800元，退休人员600元；区（县）级医院、专科医院：在职职工600元，退休人员400元；乡镇等基层医院：在职职工300元，退休人员200元。","HospitalizationEndPayLine":"基本医疗保险统筹基金20万元。住院和门特累计20万以上的部分，由大额医疗费用社会共济基金结付95%，自付5%。","PolicyLink":"苏州\\苏州职工医保待遇.docx","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"\"门诊报销比例：居民 签约社区医院及乡镇医院60%，非签约的社区医院及乡镇医院40%，区（县）级医院专科医院40%，市级及以上医院35%。学生少儿60%。\n居民住院报销：乡镇等基层医院，起付线至4万元，报销75%；4万元至10万元，报销80%；10万元至20万元，报销90%。区（县）级医院、专科医院，起付线至4万元，报销75%，4万-10万元，报销80%，10万-20万元，报销90%。市级及以上医院，起付线至4万元，报销75%，4万-10万元，报销80%，10万-20万元，报销90%\n\"","OutpatientStartPayLineTwo":"不设起付标准","OutpatientEndPayLineTwo":"2000元","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"20万","PolicyLinkTwo":"苏州居民医保待遇","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"先按个人负担进行自付，职工：90%，居民80%。","OutpatientStartPayLineThree":"不设起付标准","OutpatientEndPayLineThree":"单独支付总治疗费10万，超过后进入乙类报销","PolicyLinkThree":"单独支付","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"浙江","City":"杭州","ReimbursementRatio":"","InsuranceType":"(职工)","ReimbursementTreatment":"起付线在职1000元，退休300元；在职三级报销76%，其他80%，社区86%；退休分别是82%，86%和92%","OutpatientStartPayLine":"在职1000元，退休300元","OutpatientEndPayLine":"无封顶线","HospitalizationStartPayLine":"社区300元，其他医疗机构500元，三级800元","HospitalizationEndPayLine":"无封顶线","PolicyLink":"","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"居民起付线300元，分城乡一档和二档，一档三级报销40%，其他60%，社区70%；二档分别是30%，50%和60%","OutpatientStartPayLineTwo":"300","OutpatientEndPayLineTwo":"无封顶线","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"无封顶线","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"城乡+居民","ReimbursementTreatmentThree":"","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"浙江","City":"宁波","ReimbursementRatio":"","InsuranceType":"(职工)","ReimbursementTreatment":"职工门诊：三级70%，其他75%；社区80%  ；住院：80%-90%","OutpatientStartPayLine":"1500","OutpatientEndPayLine":"10000","HospitalizationStartPayLine":"一级800，二级1000；三级1200","HospitalizationEndPayLine":"无","PolicyLink":"","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"A档门诊社区60%；二级35%；三级30%. B档分别是50%，35%，20%                                   A档住院社区85%，小于4万70%，大于4万75%；B档统一65%","OutpatientStartPayLineTwo":"无","OutpatientEndPayLineTwo":"A档4000   B档3000","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"A档30万      B档20万","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工+居民","ReimbursementTreatmentThree":"","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"银屑病既不是门特也不是门慢，也不是大病","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"浙江","City":"嘉兴","ReimbursementRatio":"","InsuranceType":"(职工)","ReimbursementTreatment":"门诊：三级50%，其他60%，社区80%；住院：三级80%，二级85%，社区90%","OutpatientStartPayLine":"500","OutpatientEndPayLine":"6000","HospitalizationStartPayLine":"三级800       二级500       社区300","HospitalizationEndPayLine":"20万","PolicyLink":"","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"门诊：社区50%，二级机构20%，其他机构10%              住院：一级医院80%，二级75%，三级65%，","OutpatientStartPayLineTwo":"无","OutpatientEndPayLineTwo":"800元","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"20","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"","ReimbursementTreatmentThree":"大病：居民5万以下60%；5万以上70%","OutpatientStartPayLineThree":"1.5万","OutpatientEndPayLineThree":"无","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"浙江","City":"湖州","ReimbursementRatio":"","InsuranceType":"(职工)","ReimbursementTreatment":"门诊二三级机构50%，一级60%                                                 住院：80%-90%","OutpatientStartPayLine":"0","OutpatientEndPayLine":"在职960        退休1080","HospitalizationStartPayLine":"一级300，二级600，三级800元","HospitalizationEndPayLine":"无","PolicyLink":"","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"门诊：一级及以下55%，三级20%，二级30%                                               住院：一级85%，三级60%，二级75%","OutpatientStartPayLineTwo":"0","OutpatientEndPayLineTwo":"1200元","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"8倍人均收入","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工+居民","ReimbursementTreatmentThree":"","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"浙江","City":"温州","ReimbursementRatio":"","InsuranceType":"(职工)","ReimbursementTreatment":"门诊三级60%，二级70%，一级80%                                                        住院：在职95%，退休90%","OutpatientStartPayLine":"退休400，在职600","OutpatientEndPayLine":"10000","HospitalizationStartPayLine":"一级200，二级300，三级及以上600","HospitalizationEndPayLine":"上年度社平工资6倍","PolicyLink":"","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"门诊：三级35%，二级40%，三级50%； 住院三级70%，二级80%，一级90%","OutpatientStartPayLineTwo":"100","OutpatientEndPayLineTwo":"1500","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"20万","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"","ReimbursementTreatmentThree":"","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"浙江","City":"丽水","ReimbursementRatio":"","InsuranceType":"(职工)","ReimbursementTreatment":"门诊：社区50%，其他40%，住院：15万以下社区92%，二级87%，三级83%；15万以上90%","OutpatientStartPayLine":"0","OutpatientEndPayLine":"5000，慢病根据基本提高1000-5000不等","HospitalizationStartPayLine":"1000","HospitalizationEndPayLine":"30万","PolicyLink":"","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"门诊：市内社区70%，市内等级医院及慢病药店50%，市内其他机构40%                                                住院：支付额10万以下社区84%，二级79%，三级70%，10万以上70%","OutpatientStartPayLineTwo":"300","OutpatientEndPayLineTwo":"3000","HospitalizationStartPayLineTwo":"100000%","HospitalizationEndPayLineTwo":"18万","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工+居民","ReimbursementTreatmentThree":"","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"浙江","City":"衢州","ReimbursementRatio":"","InsuranceType":"(职工)","ReimbursementTreatment":"门诊：一级70%，二级60%，三级50%；住院：一级87%，二级84%，三级84%","OutpatientStartPayLine":"300","OutpatientEndPayLine":"3000","HospitalizationStartPayLine":"800元","HospitalizationEndPayLine":"35万","PolicyLink":"","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"门诊：一级50%，二级30%；三级20%                                                住院：一级85%，二级75%。三级哦65%","OutpatientStartPayLineTwo":"100","OutpatientEndPayLineTwo":"1800","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"15万","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"","ReimbursementTreatmentThree":"","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"浙江","City":"金华","ReimbursementRatio":"","InsuranceType":"(职工)","ReimbursementTreatment":"住院：三级医院85%，退休90%；二级及以下88%，退休92%；基层卫生95%                 门诊：普通门诊基层50%，其他机构20%","OutpatientStartPayLine":"0","OutpatientEndPayLine":"3000元","HospitalizationStartPayLine":"三家1200，三乙1000，二级及以下800，社区500","HospitalizationEndPayLine":"30万","PolicyLink":"","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"\"门诊：基层50%，其他医疗机构20%\n住院：三级医院75%，二级及以下80%，基层卫生90%\"","OutpatientStartPayLineTwo":"0","OutpatientEndPayLineTwo":"1500","HospitalizationStartPayLineTwo":"0%","HospitalizationEndPayLineTwo":"20万","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"","ReimbursementTreatmentThree":"","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"浙江","City":"绍兴","ReimbursementRatio":"0.97","InsuranceType":"(职工)","ReimbursementTreatment":"\"门诊（起付标准400元，最高支付限额5000元）：\n在职：基层报销75%，其他医疗机构报销65%，指定零售药店报销65%，基层首诊、7日转诊其他报销70%；\n退休：基层报销80%，其他医疗机构报销70%，指定零售药店报销70%，基层首诊、7日转诊其他报销75%。\n\n住院和门诊规定病种：（起付线：基层300元；二级以下800元；三级1200元，门诊规定病种400元）\n1. <5万：在职基层报销85%，其他医疗机构报销80%；退休基层报销90%，其他医疗机构报销85%；\n2. 5万-10万元：在职基层报销95%，其他医疗机构报销85%；退休基层报销95%，其他医疗机构报销90%；\n3. 10万-25万元：在职报销90%；退休报销90%；\n4. 25万元以上：在职和退休均报销90%\n5-10万 85%-95%\n10-25万 90%-95%\n>25万 90%\"","OutpatientStartPayLine":"400元","OutpatientEndPayLine":"5000元","HospitalizationStartPayLine":"基层300元；二级以下800元；三级1200元，门诊规定病种400元","HospitalizationEndPayLine":"无封顶线","PolicyLink":"","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"\"门诊：基层50%；其他医疗机构15%；基层首诊、7日转诊其他20%；\n住院：基层85% 其他75%\"","OutpatientStartPayLineTwo":"50元","OutpatientEndPayLineTwo":"800元；上年度签约1000元","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"28万","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"","ReimbursementTreatmentThree":"\"2021年3月10日起，\n1、一个医保年度内，参保人员住院和门诊规定病种经基本医疗保险政策规定报销后个人自付及转外就医承担的自理比例费用，\n2、慢性病病种门诊费用中，职工医保普通门诊最高支付限额内、居民医保普通门诊累计净报销限额内，符合医保支付范围内的个人自付部分\n3、符合规定的PET-CT费用\n以上累计超过2.5万元部分，大病保险基金报销70%，最高支付限额40万元。\n\n一个医保年度内，参保人员使用特殊药品发生的累计费用，8000元以上至40万元部分，大病保险基金报销70%。（困难人群特殊药品起付线4000，报销比例80%）\"","OutpatientStartPayLineThree":"2.5万元","OutpatientEndPayLineThree":"40万元","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"浙江","City":"台州","ReimbursementRatio":"0.97","InsuranceType":"(职工)","ReimbursementTreatment":"\"门诊：先纳入个人账户当年资金支付，超过个人账户当年资金额度部分走统筹。基层86%，市内一级80%，市内二级75%，市内三级70%，市内药店60%；市外一级及以下40%，市外二级及以上55%，市外一级80%，市外二级75%，市外三级70%。\n住院及门诊特殊病：\n基层和市内一级：在职，600元-5万元，报销86%；5万-市平6倍上浮35万，报销96%。退休，600元-5万元，报销91%，5万、市平6倍上浮35万，报销96%。\n市内二级：在职，800元-5万元，报销83%；5万-市平6倍上浮35万，报销93%。退休，800元-5万元，报销88%，5万、市平6倍上浮35万，报销93%.\n市内三级：在职，800元-5万元，报销80%；5万-市平6倍上浮35万，报销90%。退休，800元-5万元，报销85%，5万、市平6倍上浮35万，报销90%\n市外一级及以下：在职和退休，1000元-市平6倍上浮35万，均报销55%。\n市外二级及以上：在职，600元-5万元，报销70%；5万-市平6倍上浮35万，报销80%。退休，600元-5万元，报销75%；5万-市平6倍上浮35万，报销80%。\n市外二级：在职，800-5万元，报销83%；5万-市平6倍上浮35万，报销93%。退休，800-5万元，报销88%；5万-市平6倍上浮35万，报销93%。\n市外三级：在职，800-5万元，报销80%；5万-市平6倍上浮35万，报销90%。退休，800-5万元，报销85%；5万-市平6倍上浮35万，报销90%。\"","OutpatientStartPayLine":"无","OutpatientEndPayLine":"在职人员 10000 元、退休人员 12000 元","HospitalizationStartPayLine":"600-1000","HospitalizationEndPayLine":"上一年度全市在岗职工平均工资的 6 倍再上浮 35 万元","PolicyLink":"","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"\"门诊： 一级及以下，报销50%；二级报销20%；三级报销10%。\n住院： 一级及以下，报销80%；二级报销75%；三级报销70%。台州市外，一级及以下，报销40%；二级及以上，报销50%。\"","OutpatientStartPayLineTwo":"无","OutpatientEndPayLineTwo":"900元，签约1200元","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"上一年度市城乡居民人均可支配收入水平的 6 倍","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工和居民","ReimbursementTreatmentThree":"\"一个医保年度内，参保人员住院、特殊病种门诊合规医疗费用统筹基金支付后累计个人负担部分及大病保险特殊用药费用，\n2万元以上部分，\n由大病保险基金承担75%，不设封顶线。\n困难群众起付线降低一半，支付比例提高到85%。\"","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"浙江","City":"舟山","ReimbursementRatio":"0.97","InsuranceType":"(职工)","ReimbursementTreatment":"\"门诊：\n在职：其他医疗机构，840元以内，报销50%；840元-1.5万元，报销50%；1.5万元以上，报销70%。\n退休：其他医疗机构，840元以内，报销50%；840元-1.5万元，报销55-60%；1.5万元以上，报销70%。\n在职：基层，840元以内，报销55%（慢性病65%）；840元-1.5万元，报销60%（慢性病65%）；1.5万元以上，报销75%。\n退休：基层，840元以内，报销55%（慢性病65%）；840元-1.5万元，报销65-70%；1.5万元以上，报销75%。\n住院：\n起付线-4万元，二级、三级报销80%；二级以下报销85%。\n4万-6万元，报销85%。\n6万以上，报销90%。\"","OutpatientStartPayLine":"无","OutpatientEndPayLine":"无封顶线","HospitalizationStartPayLine":"\"市内：三级800元，二级500元，二级以下300元；\n市外：三级1000元，二级800元，二级以下600元\"","HospitalizationEndPayLine":"无封顶线","PolicyLink":"","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"\"门诊：市内基层报销50%（慢性病60%），市内其他报销25%，市外报销10%。\n住院：\n市内二级以下，300元以上，报销80%。\n市内二级，800元以上，报销70%。\n市内三级，1000元-6万元，报销55%；6万元以上，报销60%。\n市外，1000元-6万元，报销45%；6万元以上，报销50%\n\"","OutpatientStartPayLineTwo":"无","OutpatientEndPayLineTwo":"无封顶线","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"无封顶线","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工和居民","ReimbursementTreatmentThree":"\"一个医保年度内，参保人员个人发生的住院和规定(慢性病)病种门诊等费用中按规定需由个人支付的自理、自付费用，以及使用浙江省大病保险特殊药品的费用，超过大病保险年度起付标准部分，纳入大病保险支付范围。大病保险不设置年度最高支付限额。\n2021年1月起，一个医保年度内，参保人员发生的合规医疗费用，经基本医疗保险按规定报销后剩余费用（含浙江省大病保险特殊药品、诊疗项目费用），个人自负2.5万元大病保险起付线后部分，支付比例提高到70%；其中医疗救助对象大病保险起付线为1.25万元，支付比例提高到80%。\"","OutpatientStartPayLineThree":"2.5万","OutpatientEndPayLineThree":"无封顶线","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"内蒙","City":"呼和浩特","ReimbursementRatio":"","InsuranceType":"(职工)","ReimbursementTreatment":"\"’-门诊统筹：三级医院统筹基金支付比例为60%，二级及以下医院统筹基金支付比例为80%。\n-住院报销：在职人员，起付线~2万元 三甲医院报销88%、三乙医院报销90%，其他医疗机构92%；20001元-5万， 三甲医院报销90%、三乙医院报销92%，其他医疗机构95%； 5万以上，三甲医院报销95%、三乙医院报销96%，其他医疗机构98%。退休人员在职工基础上增加一个百分点。\n-参保人员大额补充医疗保险按以下比例赔付。\n（一）住院医疗费基本医疗保险统筹基金年度内累计支付4万元至8万元（含8万元）的个人按比例负担部分，大额补充医疗保险支付比例为50%。\n（二）住院医疗费基本医疗保险统筹基金年度内累计支付8万元至19万元（含19万元）的个人按比例负担部分和超过19万元以上符合基本医疗保险规定范围的医疗费，大额补充医疗保险支付比例为95%。\n（三）甲类特殊慢性病门诊治疗基本医疗保险统筹基金年度内累计支付2万元至8万元（含8万元）的个人按比例负担部分，大额补充医疗保险支付比例为50%；基本医疗保险统筹基金年度内累计支付8万元至19万元（含19万元）的个人按比例负担部分和超过19万元以上符合基本医疗保险规定范围的医疗费，大额补充医疗保险支付比例为95%。\n（四）住院治疗、本条第三项甲类特殊慢性病门诊治疗使用乙类药品、特检特治、特殊材料按规定个人负担部分，大额补充医疗保险支付比例为50%。\n（五）住院医疗费基本医疗保险统筹基金年度内累计支付4万元在本条一、二项使用基本医疗保险规定范围外且临床治疗必需的自费药品、特殊材料超限价费用年度累计1万元以上的，大额补充医疗保险支付比例为40%。\n（六）城镇职工大额补充医疗保险年度内累计支付限额为20万元。\"","OutpatientStartPayLine":"1000元","OutpatientEndPayLine":"4000元","HospitalizationStartPayLine":"\"三级甲等医院首次1000元，第二次700元，第三次及以上0元\n三级乙等医院首次800元，第二次560元，第三次及以上0元\n二级医院首次500元，第二次350元，第三次及以上0元\n二级以下医院首次300元，第二次210元，第三次及以上0元\"","HospitalizationEndPayLine":"基本19万，城镇职工大额补充医疗保险年度内累计支付限额为20万元","PolicyLink":"\"呼和浩特市城镇职工基本医疗保险政策须知\n呼和浩特市城镇职工大额补充医疗保险办法\"","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"\"居民门诊：1.所有参保人员在定点乡镇卫生院、社区卫生服务中心门、急诊就医的，每季度门、急诊费用累计超过100元以上的部分按65%支付，每季度支付限额为150元;在二级定点医疗机构门、急诊就医的，每季度门、急诊费用累计超过200元以上的部分按60%支付， 60周岁（含）以上的参保人员每季度支付限额为600元，60周岁以下的每季度支付限额为500元；在三级定点医疗机构门、急诊就医的，年度门、急诊费用累计超过1200元以上的部分按50%支付，60周岁（含）以上的参保人员年度支付限额为2400元，60周岁以下的年度支付限额为2000元。\n居民住院： 起付线-1万元， 三甲70%，三乙75%，二级80%，一级85%。 1万元-3万元， 三甲75%，三乙78%，二级85%，一级90%。 3万元以上， 三甲78%，三乙80%，二级90%，一级95%。\n城镇居民大病补充保险年度起付标准为年度累计个人负担费用14000元；合规医疗费用按60%支付。\"","OutpatientStartPayLineTwo":"一级100，二级200，三级1200","OutpatientEndPayLineTwo":"一级150元/季；二级60周岁以上600元/季，60岁以下500元/季；三级60周岁以上2400元/年，60岁以下2000元/年","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"基本13万，大病补充：儿童、学生等15万，具体居民10万","PolicyLinkTwo":"\"呼和浩特市城乡居民门诊统筹实施办法\n呼和浩特市城乡居民基本医疗保险 门诊特殊慢性病实施办法\n呼和浩特市城乡居民大病补充保险实施办法\"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"","ReimbursementTreatmentThree":"","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"否","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"北京","City":"北京","ReimbursementRatio":"","InsuranceType":"(职工)","ReimbursementTreatment":"","OutpatientStartPayLine":"","OutpatientEndPayLine":"","HospitalizationStartPayLine":"","HospitalizationEndPayLine":"","PolicyLink":"","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"","OutpatientStartPayLineTwo":"","OutpatientEndPayLineTwo":"","HospitalizationStartPayLineTwo":"0%","HospitalizationEndPayLineTwo":"","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"","ReimbursementTreatmentThree":"","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"吉林","City":"长春","ReimbursementRatio":"0.9","InsuranceType":"(职工)","ReimbursementTreatment":"特药职工先行自付20%，后进入统筹报销比例区级91%，市级88%，省级85%；住院退休区级93%，市级90%，省级87% 。","OutpatientStartPayLine":"","OutpatientEndPayLine":"","HospitalizationStartPayLine":"三级(省级)1200元 三级( 市级)700元 二级(县区)400元，一级200元","HospitalizationEndPayLine":"基本医疗保险20万/年；大病补充50万/年，公务员补助4万/年","PolicyLink":"关于切实做好国家基本医疗保险、工伤保险和生育保险药品目录执行工作的通知","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"\"住院成年居民：特药先行自付30%，后进入统筹支付。在一级及以下，起付线以上—3万，80%；3万元—6万元，85%；6万以上90%\n在二级医疗机构，起付线以上—3万，70%；3万元—6万元，75%；6万以上80%。（未成年分别为：80%、85%、90%）\n在三级（原市级）医疗机构，起付线以上—3万，60%；3万元—6万元，65%；6万以上70%。（未成年分别为：70%、75%、80%）\n在三级（原省级）医疗机构，起付线以上—3万，55%；3万元—6万元，60%；6万以上65%。（未成年分别为：65%、70%、75%）\n\"","OutpatientStartPayLineTwo":"","OutpatientEndPayLineTwo":"","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"20万元/年大额30万","PolicyLinkTwo":"长春市城乡居民基本医疗保险实施办法","InsuranceTypeThree":"http://xxgk.jl.gov.cn/zsjg/fgw/xxgkmlqy/202111/t20211123_8297201.html","CrowdType":"职工、居民","ReimbursementTreatmentThree":"居民先行自付30%、职工先行自付20%，进入统筹报销待遇","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"关于加强国家医保谈判药品配备使用完善“双通道药品”管理机制的通知 (jl.gov.cn)","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"吉林","City":"吉林市","ReimbursementRatio":"","InsuranceType":"(职工)","ReimbursementTreatment":"特药职工先行自付比例20%，后按乙类报销","OutpatientStartPayLine":"职工没有门诊统筹待遇，用个人账户支付","OutpatientEndPayLine":"职工没有门诊统筹待遇","HospitalizationStartPayLine":"一级（含以下）定点医疗机构为400元，二级定点医疗机构为800元，三级定点医疗机构为1100元。","HospitalizationEndPayLine":"9万+41万大额","PolicyLink":"关于加强国家医保谈判药品配备使用完善“双通道药品”管理机制的通知 (jl.gov.cn)","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"\"特药居民先行自付比例30%。住院成年居民：在一级及以下，起付线以上—3万，80%；3万元—6万元，85%；6万以上90%\n在二级医疗机构，起付线以上—3万，70%；3万元—6万元，75%；6万以上80%。（未成年分别为：80%、85%、90%）\n在三级（原市级）医疗机构，起付线以上—3万，60%；3万元—6万元，65%；6万以上70%。（未成年分别为：70%、75%、80%）\n在三级（原省级）医疗机构，起付线以上—3万，55%；3万元—6万元，60%；6万以上65%。（未成年分别为：65%、70%、75%）\n\"","OutpatientStartPayLineTwo":"按住院起付线","OutpatientEndPayLineTwo":"同住院","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"20万元/年","PolicyLinkTwo":"20万元/年","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工、居民","ReimbursementTreatmentThree":"居民先行自付30%、职工先行自付20%，进入统筹报销待遇","OutpatientStartPayLineThree":"门诊特殊疾病全年只缴纳一次性住院起付线，享受住院统筹基金支付待遇","OutpatientEndPayLineThree":"统筹基金限额","PolicyLinkThree":"关于加强国家医保谈判药品配备使用完善“双通道药品”管理机制的通知 (jl.gov.cn)","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"天津","City":"天津","ReimbursementRatio":"0.95","InsuranceType":"(职工)","ReimbursementTreatment":"门诊报销：一级医院报销75%，二级是65%，三级是55%。药店按照外配处方医院报销比例报销。住院报销， 5.5万元以下职工85%，退休90%；5.5万-15万，报销80%.15万-35万职工大额医疗救助报销80%。","OutpatientStartPayLine":"在职800；退休 650-800","OutpatientEndPayLine":"最高9000","HospitalizationStartPayLine":"一级医院800 二级医院1100 三级医院1700","HospitalizationEndPayLine":"35万","PolicyLink":"市医保局财政局关于做好城乡居民基本医疗保障有关工作的通知、2020年度居民基本医疗保险宣传提纲、天津医保最新医保待遇","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"门诊报销比例：一级二级55%，新增三级报销政策，报销比例为50%。住院待遇：学生儿童一级85%、二级80%、三级75%。成年居民一级医院（高档85%、中档80%、低档75%）二级（高档80%、中档75%、低档70%）三级（高档75%、中档70%、抵挡65%）","OutpatientStartPayLineTwo":"600","OutpatientEndPayLineTwo":"4000","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"180000","PolicyLinkTwo":"市医保局财政局关于做好城乡居民基本医疗保障有关工作的通知、2020年度居民基本医疗保险宣传提纲、天津医保最新医保待遇","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"按照三级医疗机构门诊统筹报销比例执行55%","OutpatientStartPayLineThree":"职工起付线按照上一年市职工平均工资1%；居民601","OutpatientEndPayLineThree":"门诊保障机制一药一标准21924元","PolicyLinkThree":"《天津市医保局市卫生健康委关于持续做好国家医保谈判药品供应保障和分类管理工作的通知》","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"山东","City":"青岛","ReimbursementRatio":"根据不同参保人群/医院级别划分","InsuranceType":"(职工)","ReimbursementTreatment":"\"门统：职工60%，使用基药提高10个百分点；\n\n住院：三级0-4万报86%；4万以上报95%；二级0-4万88%；4万以上报95%；一级0-4万报90%;4万以上95%；\"","OutpatientStartPayLine":"0","OutpatientEndPayLine":"1120元","HospitalizationStartPayLine":"一级200；二级500；三级800；","HospitalizationEndPayLine":"20万","PolicyLink":"","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"\"门统：居民一档50%；居民二档40%；少年50%；大学生80%；\n\n住院：0-18万-\n居民一档：三级报70%；二级报80%；一级报85%\n居民二档和少年：三级报55%；二级报75%；一级报85%；\n大学生级报80%；二级报85%；一级报90%\"","OutpatientStartPayLineTwo":"0","OutpatientEndPayLineTwo":"居民一档720元；居民二档和少年400元；大学生暂无封顶；","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"18万","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"\"职工：三级医院86%；二级88%；一级90%；超限额以上部分1-3级医院可报50%；社区可报70%;\n\n居民：三级医院一档65%；二档55%；少年和大学生80%；\n二级医院一档70%；二档65%；少年和大学生85%；\n一级医院一档80%；二档80%；少年和大学生90%；居民超限额以上不予支付\"","OutpatientStartPayLineThree":"\"职工：三级800元；二级500元；一级200元’；社区200元\n\n居民：与职工相同\n\"","OutpatientEndPayLineThree":"4000元","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"山东","City":"济南","ReimbursementRatio":"根据不同参保人群/医院级别划分","InsuranceType":"(职工)","ReimbursementTreatment":"\"普通门统:\n社区报80%；二级及一级报60%；三级报40%;\n\n住院：三级起付线-1万元报85%；1万-40万报88%；40万-60万报90%；二级及以下起付线-1万报90%；1万-40万报93%；40万-60万报90%\"","OutpatientStartPayLine":"社区400元；二级及一级700元；三级1200元","OutpatientEndPayLine":"3000元","HospitalizationStartPayLine":"三级医院：第一次住院1000元；第二次500元；第三次0元；二级及一级医院:第一次400；第二次200；第三次0元；","HospitalizationEndPayLine":"60万","PolicyLink":"2021年济南市职工医保待遇标准","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"\"普通门统：\n50%\n\"","OutpatientStartPayLineTwo":"0","OutpatientEndPayLineTwo":"400元","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"25万元（含个人按一定比例负担部分）","PolicyLinkTwo":"2021年济南市居民医保待遇标准","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"","ReimbursementTreatmentThree":"无银屑病种","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"山东","City":"烟台","ReimbursementRatio":"","InsuranceType":"(职工)","ReimbursementTreatment":"住院：一级起付200以上-25万报90%；二级起付500以上报90%；三级起付800以上报85%，800-1w报90%","OutpatientStartPayLine":"普通门诊由个人账户支付，统筹基金不支付","OutpatientEndPayLine":"普通门诊由个人账户支付，统筹基金不支付","HospitalizationStartPayLine":"一级200；二级500；三级800；","HospitalizationEndPayLine":"25万","PolicyLink":"根据不同参保人群/医院级别划分","InsuranceTypeTwo":"(城镇居民)","ReimbursementTreatmentTwo":"\"普通门诊：50%\n门统50%；\n住院：一级基层90%；非基层70%；二级一档58%；二档72%；三级一档45%；二档60%；\"","OutpatientStartPayLineTwo":"0","OutpatientEndPayLineTwo":"居民一档18万；二档22万","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"居民一档18万；二档22万","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"\"职工：恶性肿瘤、糖尿病并发症甲、精神障碍，甲类病种报85%；\n乙类：起付300以上报80%;\n\n居民：甲类一档40%；二档60%；乙类一档35%；二档50%；\n\n\n\n\n\"","OutpatientStartPayLineThree":"\"职工：300元\n\n居民：甲类300；乙类300\"","OutpatientEndPayLineThree":"\"职工单病种2000元；\n\n居民一档800；二档1200\n\"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"山东","City":"潍坊","ReimbursementRatio":"根据不同参保人群/医院级别划分","InsuranceType":"(职工)","ReimbursementTreatment":"仅在签约基层医疗机构有普通门诊统筹，50%报销比例。在职住院报销：社区96%，一级医院92%，二级医院90%，三级医院88%；退休住院报销：社区98%，一级医院96%，二级医院95%，三级医院94%。","OutpatientStartPayLine":"仅在签约基层医疗机构有普通门诊统筹，起付20元","OutpatientEndPayLine":"500元","HospitalizationStartPayLine":"社区400元，一级医院500元，二级医院700元，三级医院900元","HospitalizationEndPayLine":"基本医保6万，大额24万，重特大疾病50万","PolicyLink":"潍坊市城镇职工医疗保险实施办法","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"基层医疗机构有普通门诊统筹，无起付标准，报销比例50%；城镇居民基本医疗保险统筹基金年度最高支付限额为18万元。其中，年度内统筹基金支付额度超出6万元时，超出部分统一按80%的比例支付，最高支付12万元。住院报销比例 一档缴费二档缴费分别为：一级医院85%，90%；二级医院70%，80%；三级医院55%，65%。","OutpatientStartPayLineTwo":"基层医疗机构有普通门诊统筹，无起付标准","OutpatientEndPayLineTwo":"450元","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"18万","PolicyLinkTwo":"潍坊市城镇居民基本医疗保险有关政策","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/城乡居民","ReimbursementTreatmentThree":"报销比例居民： 一档缴费60%，二档缴费70%；职工医保报销 70%。","OutpatientStartPayLineThree":"居民：一级医院200，二级医院600，三级医院900元；职工起付线同一次住院标准","OutpatientEndPayLineThree":"职工7200；居民5000","PolicyLinkThree":"潍坊市城镇居民基本医疗保险有关政策；潍坊市城镇职工医疗保险实施办法","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"山东","City":"淄博","ReimbursementRatio":"根据不同参保人群/医院级别划分","InsuranceType":"(职工)","ReimbursementTreatment":"城镇职工门诊统筹需要签约，从社区医院转诊，报销比例50%。住院报销比例：根据医疗费金额不同，三级医院，在职74%-90%，退休87%-95%；二级医院在职78%-90%，退休89%-95%；一级医院在职82%-90%，90%-95%。","OutpatientStartPayLine":"无起付标准","OutpatientEndPayLine":"1200元","HospitalizationStartPayLine":"一级医院300元，二级医院500元，三级医院700元","HospitalizationEndPayLine":"基本医保90万；大额医疗救助42万","PolicyLink":"淄博城镇职工基本医疗保险政策","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"城乡居民门诊统筹需要签约，社区转诊报销比例30%。住院报销待遇，一类缴费标准的参保人，一级医院75%-85%，二级医院70%，三级医院55%。二类缴费标准的参保人报销比例降低5个点。","OutpatientStartPayLineTwo":"50元","OutpatientEndPayLineTwo":"900元","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"20万","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"无病种","ReimbursementTreatmentThree":"","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"山东","City":"临沂","ReimbursementRatio":"根据不同参保人群/医院级别划分","InsuranceType":"(职工)","ReimbursementTreatment":"社区、乡镇报50%","OutpatientStartPayLine":"个人账户","OutpatientEndPayLine":"300元","HospitalizationStartPayLine":"一级200；二级500；三级1000；其中市内二、三级中医定点分别400；900","HospitalizationEndPayLine":"15万","PolicyLink":"","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"0.55","OutpatientStartPayLineTwo":"1000","OutpatientEndPayLineTwo":"15万","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"15万","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"甲类70%；乙类60%","OutpatientStartPayLineThree":"0","OutpatientEndPayLineThree":"8000","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"山西","City":"太原市","ReimbursementRatio":"0.95","InsuranceType":"(职工)","ReimbursementTreatment":"\"报销比例：起付~0.5万：一级85％，二级83％，三级81％；     0.5~1万：一级87％，二级85％，三级83％；1万以上：  一级89％，二级87％，三级85％\n特药等待发文\"","OutpatientStartPayLine":"普通门诊由个人账户支付，统筹基金不支付","OutpatientEndPayLine":"普通门诊由个人账户支付，统筹基金不支付","HospitalizationStartPayLine":"一级400元；二级600元；三级800元","HospitalizationEndPayLine":"省直职工50万，职工40万，离休职工40万（基本医疗封顶线为8万元，大病封顶线为32万，一年最多可报销40万元）","PolicyLink":"《关于统一执行《国家基本医疗保险、工伤保险和生育保险药品目录（2021年）》的通知》晋医保发［2021］25号《太原市基本医疗保险大额门诊特殊药品就医管理实施细则》（并医险中心字【2020】16号）","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"门诊按80%的比例支付。住院：基本医疗保险统筹基金起付标准以上、最高支付限额以下，符合政策规定的医疗费用，统筹基金支付比例分别为85%、75%、65%；特药等待发文","OutpatientStartPayLineTwo":"30","OutpatientEndPayLineTwo":"120元/月","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"14万","PolicyLinkTwo":"《关于统一执行《国家基本医疗保险、工伤保险和生育保险药品目录（2021年）》的通知》晋医保发［2021］25号《太原市基本医疗保险大额门诊特殊药品就医管理实施细则》（并医险中心字【2020】16号）","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工、居民","ReimbursementTreatmentThree":"等待发文","OutpatientStartPayLineThree":"等待发文","OutpatientEndPayLineThree":"等待发文","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"河北省","City":"石家庄市","ReimbursementRatio":"根据不同参保人群/医院级别划分","InsuranceType":"(职工)","ReimbursementTreatment":"\"门诊：\n乙类药品先行自付5%。一级及以下医疗机构80%，二级70%，三级60%。\n住院：\n1、在职\n【县区住院】一级及以下医疗机构支付比例为92%，二级90%。\n【市区住院】一级医疗机构支付比例90%，二级85%，市属三级医疗机构83%，省属三级医疗机构80%。\n2、退休\n支付比例比在职职工提高3%。\"","OutpatientStartPayLine":"一级及以下医疗机构700元，二级1000元；三级1500元。","OutpatientEndPayLine":"在职1500元/年，退休2500元/年。","HospitalizationStartPayLine":"\"1、在职：\n【县区住院】一级及以下医疗机构每次起付线200元，二级医每次起付线300元。\n【市区住院】一级医疗机构每次起付线200元，二级700元，市属三级医疗机构900元，省属三级医疗机构1200元。\n2、退休：\n起付标准在在职职工基础上降低100元。\"","HospitalizationEndPayLine":"25万元/年","PolicyLink":"关于印发石家庄市城镇职工基本医疗保险实施办法的通知（石政规〔2019〕7号）","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"\"门诊：\n乙类先行自付10%，40元/人/年包干使用。\n住院：\n乙类先行自付10%。\n【县区住院】\n一级及以下医院90，二级80%。\n【市区住院】\n一级医院支付比例为85%，二级医院基70%，市属三级医院65%，省属三级医院60%。\"","OutpatientStartPayLineTwo":"40元/人/年包干使用。","OutpatientEndPayLineTwo":"40元/人/年包干使用。","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"20万元/年","PolicyLinkTwo":"关于印发石家庄市城乡居民基本医疗保险实施办法的通知（石政发〔2016〕59号）","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"","ReimbursementTreatmentThree":"","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"河北省","City":"保定","ReimbursementRatio":"根据不同参保人群/医院级别划分","InsuranceType":"(职工)","ReimbursementTreatment":"\"乙类药品先行自付比例5%。\n在职：第一次住院85%，第二次87%，第三次及以上89%。\n退休：第一次住院88%，第二次90%，第三次92%。\"","OutpatientStartPayLine":"普通门诊由个人账户支付费用","OutpatientEndPayLine":"普通门诊由个人账户支付费用","HospitalizationStartPayLine":"一个医疗保险业务年度内，一级医院第一次住院起付标准金为500 元，第二次400 元，第三次及以上300 元；二级医院分别为900 元、800元、700 元；三级医院分别为1200 元、1100 元、1000 元。中医院的住院起付标准金执行一级医院标。","HospitalizationEndPayLine":"9万元","PolicyLink":"关于印发《保定市城镇基本医疗保险生育保险市级统筹实施细则》的通知 （保人社字〔2015〕19号）","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"\"门诊：\n每人每年40元，由参保家庭户共享使用，可结转，不能冲抵参保缴费。\n\n住院：\n【参保县域内】\n乡镇卫生院（社区卫生服务中心）90%，一级及二级医疗机构75%，三级60%。\n【参保县域外统筹市域内】\n二级及以下医疗机构70%，三级55%。\n【统筹市域外】医疗机构50%。\n用中医药治疗的医药和诊疗费用支付比例提高5个百分。对学生儿童（含大学生）一级及以上医疗机构支付比例提高10个百分点。\"","OutpatientStartPayLineTwo":"无","OutpatientEndPayLineTwo":"40元/人/年","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"20万元/年","PolicyLinkTwo":"关于印发《保定市城乡居民基本医疗保险实施办法》的通知（保政发〔2018〕25号）","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"\"职工：80%\n居民：60%\"","OutpatientStartPayLineThree":"\"职工：500元/年\n居民：成人800元/年，学生儿童500元/年\"","OutpatientEndPayLineThree":"\"职工：2000元/年\n居民：1500元/年\"","PolicyLinkThree":"\"关于印发《保定市城乡居民基本医疗保险门诊特殊疾病管理办法》的通知（保医保发〔2019〕48 号）\n关于印发《保定市城镇职工基本医疗保险门诊特殊疾病管理办法》的通知（保医保发〔2019〕47 号）\"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"河北省","City":"邯郸市","ReimbursementRatio":"根据不同参保人群/医院级别划分","InsuranceType":"(职工)","ReimbursementTreatment":"\"门诊：普通门诊由个人账户支付费用\n住院：\n乙类药品先行自付比例5%。\n在职职工在一级及其以下医疗机构92%、二级医疗机构90%、三级医疗机构88%。退休人员相应提高三个百分点。\"","OutpatientStartPayLine":"普通门诊由个人账户支付费用","OutpatientEndPayLine":"普通门诊由个人账户支付费用","HospitalizationStartPayLine":"\"首次住院的起付标准为：三级定点医疗机构900元、二级定点医疗机构600元、一级定点医疗机构300元。\n参保人员在一个年度内多次住院的，第二次住院的起付标准减半计算；第三次及以上住院的起付标准为三级定点医疗\n机构300元，二级定点医疗机构200元，一级定点医疗机构100元。\"","HospitalizationEndPayLine":"8万元/年","PolicyLink":"关于印发邯郸市城镇职工基本医疗保险市级统筹实施细则的通知（市政府〔2014〕91号）","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"\"门诊：50%\n住院：\n乙类药品先行自付比例5%。\n乡镇卫生院、社区卫生服务中心90%;一级医疗机构85%;县统筹区内二级医疗机构77%，县统筹区外二级医疗机构72%;三级医疗机构65%;转外医疗机构50%。住院使用中药(汤剂，目录内中药饮片)支付比例100%。\"","OutpatientStartPayLineTwo":"不设起付线","OutpatientEndPayLineTwo":"75元/年","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"15万元/年","PolicyLinkTwo":"关于印发《邯郸市城乡居民基本医疗保险实施办法》（试行）的通知","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"河北省","City":"唐山","ReimbursementRatio":"根据不同参保人群/医院级别划分","InsuranceType":"(职工)","ReimbursementTreatment":"\"门诊：普通门诊由个人账户支付费用\n住院：\n乙类药品先行自付比例5%。\n在职职工在一级及其以下医疗机构92%、二级医疗机构90%、三级医疗机构88%。退休人员相应提高三个百分点。\"","OutpatientStartPayLine":"普通门诊由个人账户支付费用","OutpatientEndPayLine":"普通门诊由个人账户支付费用","HospitalizationStartPayLine":"\"首次住院的起付标准为：三级定点医疗机构900元、二级定点医疗机构600元、一级定点医疗机构300元。\n参保人员在一个年度内多次住院的，第二次住院的起付标准减半计算；第三次及以上住院的起付标准为三级定点医疗\n机构300元，二级定点医疗机构200元，一级定点医疗机构100元。\"","HospitalizationEndPayLine":"8万元/年","PolicyLink":"关于印发邯郸市城镇职工基本医疗保险市级统筹实施细则的通知（市政府〔2014〕91号）","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"\"门诊：50%\n住院：\n乙类药品先行自付比例5%。\n乡镇卫生院、社区卫生服务中心90%;一级医疗机构85%;县统筹区内二级医疗机构77%，县统筹区外二级医疗机构72%;三级医疗机构65%;转外医疗机构50%。住院使用中药(汤剂，目录内中药饮片)支付比例100%。\"","OutpatientStartPayLineTwo":"不设起付线","OutpatientEndPayLineTwo":"75元/年","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"15万元/年","PolicyLinkTwo":"关于印发《邯郸市城乡居民基本医疗保险实施办法》（试行）的通知","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"河北省","City":"秦皇岛","ReimbursementRatio":"1","InsuranceType":"(职工)","ReimbursementTreatment":"普通门诊统筹基金的起付标准为100元。起付标准以上合规医疗费用在职职工支付比例为50%，退休职工支付比例为60%，省外异地就医降低5%，最高支付限额为每人每年2000元。乙类按95%计入基本医疗保险支付范围，住院待遇：在职一级95%，二级92%，三级87%；退休一级96%，二级95%，三级92%。","OutpatientStartPayLine":"100元","OutpatientEndPayLine":"2000元","HospitalizationStartPayLine":"\"一级医疗机构 400元；\n二级医疗机构 600元；\n三级医疗机构 800元；\n\"","HospitalizationEndPayLine":"职工基本医疗保险统筹基金最高支付限额为每人每年15万元（职工大病保险基金年度最高支付限额为50万元）","PolicyLink":"秦皇岛市市本级职工大病保险实施细则","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"\"一、门诊报销比例50%；\n二、参保居民在省内及京津直接定点医疗机构就医政策范围内基金支付比例：一级定点医疗机构（含乡镇卫生院、社区卫生服务中心）90%；二级定点医疗机构75%；三级定点医疗机构60%。在省外医保定点医疗机构异地就医基金支付比例：一级定点医疗机构（含乡镇卫生院、社区卫生服务中心）70%；二级定点医疗机构60%；三级定点医疗机构50%。\"","OutpatientStartPayLineTwo":"50元","OutpatientEndPayLineTwo":"65","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"基金最高支付限额为每人每年15万元。（大病保险为每人每年40万元）","PolicyLinkTwo":"秦皇岛市城镇居民基本医疗保险市级统筹实施细则、秦皇岛市城乡居民大病保险市级统筹实施细则","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"药品乙类自付比例10%","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"秦皇岛市医疗保障局秦皇岛市人力资源和社会保障局关于非肿瘤类谈判药品自付比例调整的通知（秦医保〔2021〕34号）","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"河南","City":"郑州","ReimbursementRatio":"根据不同参保人群/医院级别划分","InsuranceType":"(职工)","ReimbursementTreatment":"\"门诊：普通门诊由个人账户支付费用。\n住院：\n在职，社区卫生服务机构95%，一类医疗机构95%，二类医疗机构90%，三类医疗机构88%；\n退休，社区卫生服务机构97%，一类医疗机构97%，二类医疗机构95%，三类医疗机构93%。\"","OutpatientStartPayLine":"普通门诊由个人账户支付费用","OutpatientEndPayLine":"普通门诊由个人账户支付费用","HospitalizationStartPayLine":"\"社区卫生服务机构（包括乡镇卫生院，下同）200元，一类医疗机构300元，二类医疗机构600元，三类医疗机构900元。\n同一自然年度内出院后再次住院，起付标准降低50%。\"","HospitalizationEndPayLine":"15万元/年","PolicyLink":"郑州市人民政府办公厅关于印发郑州市职工基本医疗保险办法的通知（郑政办〔2018〕3号）","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"\"门诊：\n市级(或二类)45%、县级(或一类)55%、乡镇卫生院、社区卫生服务中心(站、所)、村卫生室65%。\n住院：\n社区卫生服务中心（含乡镇卫生院）住院，报销比例：150元-1000元80%，1000元以上90%；\n县区级医疗机构住院，报销比例：600元-3000元65%，3000元以上75%；\n市级医疗机构住院，报销比例：1200-5000元60%，5000元以上70%；\n省级医疗机构住院，报销比例：2000-8000元55%6；8000元以上65%。\"","OutpatientStartPayLineTwo":"不设起付线","OutpatientEndPayLineTwo":"150元/年","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"15万元/年","PolicyLinkTwo":"\"郑州市人民政府办公厅关于印发郑州市城乡居民基本医疗保险办法(试行)的通知（郑政办〔2016 〕78 号）\n《关于做好2019年城乡居民基本医疗保障工作的通知》（郑医保〔2019〕8号）\"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"\"职工85%，居民80%\n\"","OutpatientStartPayLineThree":"\"职工：不设起付线\n居民：不设起付线\"","OutpatientEndPayLineThree":"","PolicyLinkThree":"2021.12.30 - 关于执行《国家基本医疗保险、工伤保险和生育保险药品目录(2021年)》的通知（豫医保办〔2021〕72号）","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"河南","City":"南阳","ReimbursementRatio":"根据不同参保人群/医院级别划分","InsuranceType":"(职工)","ReimbursementTreatment":"市域内，一级、二级、三级医疗机构合规费用支付比例分别为88%、83%、78%，对退休人员的支付比例在上述标准的基础上提高5%；市域外，支付比例较市域内相应级别医院降低10%。参加大额补充医疗保险的人员，在一个自然年度内发生的合规医疗费用，超过基本医保最高支付限额以上部分，职工大额补充医疗保险报销为90%。","OutpatientStartPayLine":"职工暂未开展门诊统筹","OutpatientEndPayLine":"职工暂未开展门诊统筹","HospitalizationStartPayLine":"市域内每次住院起付标准600元；市域外省内每次住院1500元，省外每次住院2000元。","HospitalizationEndPayLine":"职工医保基本医疗保险统筹基金最高支付6万元(不含生育津贴)，大额医疗保险基金最高支付54万元","PolicyLink":"南阳市基本医疗保险和生育保险市级统筹实施细则（暂行）》","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"乡级(乡镇卫生院或社区医疗机构)合规费用支付比例200-1000元(含下限不含上限，下同)的为75%;1000-2000元为80%，2000元以上为90%;县级(二级或相当规模以下医院)合规费用支付比例500-1500元为63%，1500-5000元为73%，5000元以上为85%;市级(二级或相当规模以下医院)合规费用支付比例600-3000元为55%，3000-6000元为65%，6000元以上为75%，市级(三级医院)合规费用支付比例1200-4000元为53%，4000-9000元为65%，9000元以上为75%。省级(二级或相当规模以下医院)合规费用支付比例1200-5000元为50%，5000元以上为70%，省级(三级医院)及省外合规费用支付比例2000-9000元为50%，9000元以上为60%。对80岁以上参保的城乡居民住院医疗费政策范围内支付比例在原有基础上提高5%","OutpatientStartPayLineTwo":"无","OutpatientEndPayLineTwo":"300元/年","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"城乡居民医保基本医疗保险统筹基金最高支付15万元，城乡居民大病保险最高支付40万元","PolicyLinkTwo":"南阳市人民政府办公室关于印发南阳市城乡居民基本医疗保险实施办法(试行)的通知（正宛政办[2016]91）","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"\"职工85%，居民80%\n\"","OutpatientStartPayLineThree":"\"职工：不设起付线\n居民：不设起付线\"","OutpatientEndPayLineThree":"","PolicyLinkThree":"2021.12.30 - 关于执行《国家基本医疗保险、工伤保险和生育保险药品目录(2021年)》的通知（豫医保办〔2021〕72号）","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"河南","City":"焦作","ReimbursementRatio":"","InsuranceType":"(职工)","ReimbursementTreatment":"住院报销比例三级综合医疗机构80%，二级医疗机构85%，一级医疗机构90%；","OutpatientStartPayLine":"住院报销比例三级综合医疗机构80%，二级医疗机构85%，一级医疗机构90%；","OutpatientEndPayLine":"住院报销比例三级综合医疗机构80%，二级医疗机构85%，一级医疗机构90%；","HospitalizationStartPayLine":"住院报销比例三级综合医疗机构80%，二级医疗机构85%，一级医疗机构90%；","HospitalizationEndPayLine":"住院报销比例三级综合医疗机构80%，二级医疗机构85%，一级医疗机构90%；","PolicyLink":"住院报销比例三级综合医疗机构80%，二级医疗机构85%，一级医疗机构90%；","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"参保居民发生的住院医疗费用且由城镇居民基本医疗保险统筹基金支付的，其起付标准、统筹基金支付比例为：一级医疗机构200元、85%；二级医疗机构600元、75%；三级医疗机构800元、70%；经批准转统筹区外定点医疗机构800元、60%。门诊报销不设起付线，按55%比例报销，一年内累计报销额度为300元","OutpatientStartPayLineTwo":"不设起付线","OutpatientEndPayLineTwo":"300元","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"6万元","PolicyLinkTwo":"焦作市城镇医疗保险筹资标准及报销政策","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"\"职工85%，居民80%\n\"","OutpatientStartPayLineThree":"\"职工：不设起付线\n居民：不设起付线\"","OutpatientEndPayLineThree":"","PolicyLinkThree":"2021.12.30 - 关于执行《国家基本医疗保险、工伤保险和生育保险药品目录(2021年)》的通知（豫医保办〔2021〕72号）","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"否","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"辽宁","City":"沈阳","ReimbursementRatio":"","InsuranceType":"(职工)","ReimbursementTreatment":"\"门诊报销统筹基金支付比例在职职工为60%，退休人员为65%。\n住院在职人员一级94%，区属二级93%，市属二级93%，三级88%，特大型三级86%；住院退休人员再增加3%..\"","OutpatientStartPayLine":"20元","OutpatientEndPayLine":"150/月","HospitalizationStartPayLine":"一级300，区属二级400，市属二级500，三级800，特大型三级1200","HospitalizationEndPayLine":"基本医疗保险15万元；大额医疗费用补助45万元；","PolicyLink":"沈阳市城镇职工门诊统筹就医指南；沈阳市城镇职工基本医疗保险参保就医指南","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"\"统筹基金支付比例为55%，起付标准和最高支付限额标准累计计算。\n居民医保住院支付比例：基层卫生医疗机构90%、一级85%、二级80%、三级75%、特三级70%。其中，成年居民在特三级定点医疗机构一个自然年度内单次住院发生的起付标准以上部分实行分段支付，1.5万元及以下部分支付比例为60%，1.5万元以上部分支付比例为70%。\"","OutpatientStartPayLineTwo":"40元/季度","OutpatientEndPayLineTwo":"150元/季度","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"15万元","PolicyLinkTwo":"沈阳市城乡居民基本医疗保险实施细则（沈医保发【2019】139号）","InsuranceTypeThree":"高值药品","CrowdType":"职工/城乡居民","ReimbursementTreatmentThree":"首自付20%，其余部分职工报销80%，居民报销70%","OutpatientStartPayLineThree":"不设起付标准","OutpatientEndPayLineThree":"参照住院","PolicyLinkThree":"转发关于做好国家医保谈判药品落地工作的通知","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"否","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"辽宁","City":"大连","ReimbursementRatio":"","InsuranceType":"(职工)","ReimbursementTreatment":"\"（一）支付比例。参保人员在定点社区卫生服务机构和一级定点医疗机构就诊的，门诊统筹基金支付45%；在统筹地区外，异地安置人员在安置地所选定点医疗机构就诊的支付30%。\n（二）最高支付限额。门诊统筹基金支付参保人员普通门诊医疗费用年度内按季度设定最高支付限额，每季度最高支付限额为180元。限额不滚存、不累计。\"","OutpatientStartPayLine":"不设起付标准","OutpatientEndPayLine":"180元/季度","HospitalizationStartPayLine":"三级医院为1200元或850元，二级医院及专科医院为500元，一级医院为300元。转诊异地住院治疗，起付标准为1500元。","HospitalizationEndPayLine":"25万+35万元","PolicyLink":"\"大连市职工基本医疗保险门诊医疗费用统筹办法（大人社发[2013]222号）；\n大连市职工基本医疗保险规定\"","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"\"门诊：统筹基金支付比例为50%。\n住院：1.未成年居民、大学生按照三级医院、二级及专科医院、一级医院、基层医疗机构及护理院分别为70%、80%、85%和90%;\n　　2.成年居民在三级甲等医院住院发生的起付标准以上保内医疗费用实行分段支付：2万元及以下的部分支付比例为50%、2万元以上的部分支付比例为65%;在其他三级医院、二级及专科医院、一级医院、基层医疗机构及护理院支付比例分别为65%、75%、80%和85%.\"","OutpatientStartPayLineTwo":"30元/季度","OutpatientEndPayLineTwo":"未成年人和大学生为100元/季度，成年人为50元/季度","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"未成年居民、大学生为20万元；成年居民为15万元。","PolicyLinkTwo":"大连市城镇居民基本医疗保险实施办法","InsuranceTypeThree":"高值药品","CrowdType":"职工/居民","ReimbursementTreatmentThree":"首自付20%，其余部分职工80%，居民70%","OutpatientStartPayLineThree":"职工300元；居民不设起付标准","OutpatientEndPayLineThree":"参照住院","PolicyLinkThree":"转发关于做好国家医保谈判药品落地工作的通知","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"否","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"辽宁","City":"鞍山","ReimbursementRatio":"","InsuranceType":"(职工)","ReimbursementTreatment":"在职职工住院基金支付三级医院80%，二级医院82%，一级医院85%，退休职工再增加5%。","OutpatientStartPayLine":"个人帐户主要用于支付门诊医疗费用；统筹基金不支付普通门诊费用","OutpatientEndPayLine":"个人帐户主要用于支付门诊医疗费用；统筹基金不支付普通门诊费用","HospitalizationStartPayLine":"三级700元，二级500元，一级300元","HospitalizationEndPayLine":"基本医疗保险6万；超限额补充医疗保险每年最高报销50万元","PolicyLink":"鞍山市城镇职工基本医疗保险制度改革试行方案","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"\"居民门诊医疗费首次起付标准为40元，年度内第二次以后（含第二次）起付标准减半均为20元，年度门诊医疗费起付标准累计不超过200元。门诊年度统筹基金累计最高支付限额为400元，每次统筹基金最高支付限额为100元。低于起付标准和超过最高支付限额的医疗费由个人支付。起付标准以上、最高限额以下的医疗费，由门诊统筹金按50%比例支付，其余部分由个人支付。\n居民住院报销起付标准以上至10000元，特三级60%，三级65%，二级75%，一级80%；超出10000元以上部分，特三级65%，三级70%，二级80%，一级80%\"","OutpatientStartPayLineTwo":"40元","OutpatientEndPayLineTwo":"400元/年","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"基本医疗保险6万元；超出部分大病保险支付，大病保险不设限额。","PolicyLinkTwo":"鞍山市城乡居民医疗保险实施细则","InsuranceTypeThree":"高值药品","CrowdType":"职工/居民","ReimbursementTreatmentThree":"首自付20%，其余部分职工80%，居民70%","OutpatientStartPayLineThree":"不设起付标准","OutpatientEndPayLineThree":"参照住院","PolicyLinkThree":"转发关于做好国家医保谈判药品落地工作的通知","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"否","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"辽宁","City":"本溪","ReimbursementRatio":"","InsuranceType":"(职工)","ReimbursementTreatment":"\"在三级定点医院就医的，在职职工统筹基金支付比例为85%，退休人员为90%；\n（二）在二级及以下定点医院就医的，在职职工统筹基金支付比例为87%，退休人员为92%；\"","OutpatientStartPayLine":"个人帐户主要用于支付门诊医疗费用；统筹基金不支付普通门诊费用","OutpatientEndPayLine":"个人帐户主要用于支付门诊医疗费用；统筹基金不支付普通门诊费用","HospitalizationStartPayLine":"\"三级甲等医院800元/人次；三级乙等医院600元/人次；二级甲等医院500元/人次（本钢南芬医院、北钢医院400元/人次）；二级乙等医院400元/人次；一级及以下医院300元/人次。\n2．在一个年度内多次住院的，起付标准依次降低100元，但最低不低于300元/人次。\"","HospitalizationEndPayLine":"基本医疗保险6万元 ；大额医疗补充保险统筹基金24万元","PolicyLink":"\"本溪市城镇职工基本医疗保险制度实施方案\n本人社发【2018】17号\"","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"\"门诊：在村卫生室、乡镇卫生院、社区卫生服务中心和大中专院校门诊就医的，基金按50%比例支付，在县域内二级医疗机构门诊就医的，基金按20%比例支付。\n住院：参保居民在本市定点医院住院的社区卫生服务中心及乡镇卫生院85%。二级及二级以下医院75%；三级医院55%。其中，大中小学生在三级医院住院基金按照65%比例支付。\"","OutpatientStartPayLineTwo":"普通门诊合规医疗费用基金支付起付标准为每人每年100元","OutpatientEndPayLineTwo":"300元/年","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"基本医疗保险6万元；大额医疗补充保险12万","PolicyLinkTwo":"\"本溪市城镇居民基本医疗保险\n实施细则\n\"","InsuranceTypeThree":"高值药品","CrowdType":"职工/居民","ReimbursementTreatmentThree":"首自付20%，其余部分职工80%，居民70%","OutpatientStartPayLineThree":"不设起付标准","OutpatientEndPayLineThree":"参照住院","PolicyLinkThree":"转发关于做好国家医保谈判药品落地工作的通知","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"黑龙江","City":"哈尔滨","ReimbursementRatio":"0.6","InsuranceType":"(职工)","ReimbursementTreatment":"个人自付 40% 后，统筹基金按照规定比例支付","OutpatientStartPayLine":"","OutpatientEndPayLine":"","HospitalizationStartPayLine":"社区200元、一级240元、二级480元、三级720元。","HospitalizationEndPayLine":"15万/年+大病35万/年","PolicyLink":"\"关于调整哈尔滨市城镇基本医疗保险生育保险待遇标准的通知，《黑龙江省基本医疗保险、工伤保险\n和生育保险药品目录》\"","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"个人自付 40% 后，统筹基金按照规定比例支付","OutpatientStartPayLineTwo":"","OutpatientEndPayLineTwo":"","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"18万/年","PolicyLinkTwo":"\"《关于做好2019年城乡居民基本医疗保障工作的通知》 《黑龙江省基本医疗保险、工伤保险\n和生育保险药品目录》\n\"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工、居民","ReimbursementTreatmentThree":"个人自付 40% 后，统筹基金按照规定比例支付","OutpatientStartPayLineThree":"特药门诊治疗不设起付线","OutpatientEndPayLineThree":"同住院","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"黑龙江","City":"大庆","ReimbursementRatio":"55-70%","InsuranceType":"(职工)","ReimbursementTreatment":"一、谈判药品先行自付30%后住院按85%报销，门诊按85%报销","OutpatientStartPayLine":"","OutpatientEndPayLine":"","HospitalizationStartPayLine":"1.市内三级甲等医院800元，其他三级医院600元；2. 市内区级医院、厂矿医院和民营医院400元；3.市内乡镇卫生院和 社区卫生服务中心200元；4.当年多次住院的，起付标准依次递减 100元，递减到200元为止","HospitalizationEndPayLine":"基本医保10万元/年，大额医疗保险基金年度最高支付限额17万元","PolicyLink":"_","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"特药先行自付45%，住院按55%、60%，门诊按80%","OutpatientStartPayLineTwo":"不设起付标准","OutpatientEndPayLineTwo":"同住院","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"15万元","PolicyLinkTwo":"大庆市城镇居民基本医疗保险管理办法的通知","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工、居民","ReimbursementTreatmentThree":"职工：银屑病慢病待遇，起付线600元/年，70%，封顶2000元，也可选择特药待遇","OutpatientStartPayLineThree":"职工600元；","OutpatientEndPayLineThree":"职工：2000元","PolicyLinkThree":"\"大庆市城镇职工医疗保险门诊指定慢性疾病及门诊大病管理办法；大庆市城镇居民基本医疗保险管理办法的通知 \n\"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"黑龙江","City":"齐齐哈尔","ReimbursementRatio":"","InsuranceType":"(职工)","ReimbursementTreatment":"住院55%，门诊55%","OutpatientStartPayLine":"统筹基金不支付普通门诊费用","OutpatientEndPayLine":"统筹基金不支付普通门诊费用","HospitalizationStartPayLine":"1.市内三级甲等医院800元，其他三级医院600元；2. 市内区级医院、厂矿医院和民营医院400元；3.市内乡镇卫生院和 社区卫生服务中心200元；4.当年多次住院的，起付标准依次递减 100元，递减到200元为止","HospitalizationEndPayLine":"基本医保10万元/年，大额医疗保险基金年度最高支付限额17万元","PolicyLink":"","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"住院50%，门诊50%","OutpatientStartPayLineTwo":"不设起付标准","OutpatientEndPayLineTwo":"门诊统筹报销比例为70%，年度最高支付限额为100元","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"15万元","PolicyLinkTwo":"大庆市城镇居民基本医疗保险管理办法的通知","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工、居民","ReimbursementTreatmentThree":"可以按特药报销","OutpatientStartPayLineThree":"特药待遇不设起付线","OutpatientEndPayLineThree":"住院额度","PolicyLinkThree":"齐齐哈尔市医疗保障局关于规范基本医疗保险门诊慢性病和门诊特殊疾病（治疗）的通知","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"黑龙江","City":"牡丹江","ReimbursementRatio":"0.6","InsuranceType":"(职工)","ReimbursementTreatment":"\"住院60%*90%，\n门诊60%*85%\"","OutpatientStartPayLine":"统筹基金不支付普通门诊费用","OutpatientEndPayLine":"统筹基金不支付普通门诊费用","HospitalizationStartPayLine":"1.市内三级甲等医院800元，其他三级医院600元；2. 市内区级医院、厂矿医院和民营医院400元；3.市内乡镇卫生院和 社区卫生服务中心200元；4.当年多次住院的，起付标准依次递减 100元，递减到200元为止","HospitalizationEndPayLine":"基本医保10万元/年，大额医疗保险基金年度最高支付限额17万元","PolicyLink":"关于加强牡丹江市基本医疗保险特殊药品管理工作的通知","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"\"住院60%*50%，\n门诊60%*65%\"","OutpatientStartPayLineTwo":"不设起付标准","OutpatientEndPayLineTwo":"同住院","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"15万元","PolicyLinkTwo":"大庆市城镇居民基本医疗保险管理办法的通知","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工、居民","ReimbursementTreatmentThree":"按特药待遇报销","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"否","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"","Province":"广东","City":"深圳","ReimbursementRatio":"一档（职工）：100%","InsuranceType":"(职工)","ReimbursementTreatment":"1 门诊：基本医疗保险一档参保人个人账户用于支付参保人门诊基本医疗费用、地方补充医疗费用、在定点零售药店凭本市市内定点医疗机构医生开具的处方购买医疗保险目录范围内药品的费用，个人账户不足支付部分由个人自付。基本医疗保险一档参保人连续参保满一年，在同一医疗保险年度内个人自付的门诊基本医疗费用和地方补充医疗费用超过本市上年度在岗职工平均工资5%的，超过部分由基本医疗保险大病统筹基金或地方补充医疗保险基金按规定支付70%，参保人年满70周岁以上的支付80%。   基本医疗保险一档参保人在本市定点社康中心发生的基本医疗费用和地方补充医疗费用，70%由其个人账户支付，30%由基本医疗保险大病统筹基金、地方补充医疗保险基金按规定支付                               2 住院：基本医疗保险一档参保人按8%缴交基本医疗保险费的支付比例为90%；","OutpatientStartPayLine":"基本医疗保险一档参保人连续参保满一年，在同一医疗保险年度内个人自付的门诊基本医疗费用和地方补充医疗费用超过本市上年度在岗职工平均工资5%的，","OutpatientEndPayLine":"\"基本医疗保险统筹基金支付限额：1. 连续参保时间不满6个月的，为本市上年度在岗职工平均工资的1倍；2 连续参保时间满6个月不满12个月的，为本市上年度在岗职工平均工资的2倍；\n　3 连续参保时间满12个月不满24个月的，为本市上年度在岗职工平均工资的3倍；4 连续参保时间满24个月不满36个月的，为本市上年度在岗职工平均工资的4倍；5 连续参保时间满36个月不满72个月的，为本市上年度在岗职工平均工资的5倍；6 连续参保时间满72个月以上的，为本市上年度在岗职工平均工资的6倍。   地补限额：1 连续参保时间不满6个月的，为1万元；\n2 连续参保时间满6个月不满12个月的，为5万元；3 连续参保时间满12个月不满24个月的，为10万元；\n4 连续参保时间满24个月不满36个月的，为15万元； 5 连续参保时间满36个月不满72个月的，为20万元； 6 连续参保时间满72个月以上的，为100万元。\n\n\"","HospitalizationStartPayLine":"起付线按照医院级别设定，市内一级以下医院为100元，二级医院为200元，三级医院为300元；市外医疗机构已按规定办理转诊或备案的为400元，未按规定办理转诊或备案的为1000元。","HospitalizationEndPayLine":"\"基本医疗保险统筹基金支付限额：1. 连续参保时间不满6个月的，为本市上年度在岗职工平均工资的1倍；2 连续参保时间满6个月不满12个月的，为本市上年度在岗职工平均工资的2倍；\n　3 连续参保时间满12个月不满24个月的，为本市上年度在岗职工平均工资的3倍；4 连续参保时间满24个月不满36个月的，为本市上年度在岗职工平均工资的4倍；5 连续参保时间满36个月不满72个月的，为本市上年度在岗职工平均工资的5倍；6 连续参保时间满72个月以上的，为本市上年度在岗职工平均工资的6倍。   地补限额：1 连续参保时间不满6个月的，为1万元；\n2 连续参保时间满6个月不满12个月的，为5万元；3 连续参保时间满12个月不满24个月的，为10万元；\n4 连续参保时间满24个月不满36个月的，为15万元； 5 连续参保时间满36个月不满72个月的，为20万元； 6 连续参保时间满72个月以上的，为100万元。\n\n\"","PolicyLink":"深圳市社会医疗保险办法","InsuranceTypeTwo":"(二档、三档)","ReimbursementTreatmentTwo":"\"属于基本医疗保险药品目录中甲类药品和乙类药品的，分别由社区门诊统筹基金按80%和60%的比例支付；\n参保人因病情需要经结算医院同意转诊到其他医疗机构发生的门诊医疗费用，或因工外出、出差在非结算医院发生的急诊抢救门诊医疗费用，由社区门诊统筹基金按前款规定支付标准的90%报销；其他情形在非结算医院发生的门诊医疗费用社区门诊统筹基金不予报销。\n社区门诊统筹基金在一个医疗保险年度内支付给每位基本医疗保险二档、三档参保人的门诊医疗费用，总额最高不得超过1000元。\n\"","OutpatientStartPayLineTwo":"不设起付线","OutpatientEndPayLineTwo":"1000元/年","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"\"基本医疗保险统筹基金支付限额：1. 连续参保时间不满6个月的，为本市上年度在岗职工平均工资的1倍；2 连续参保时间满6个月不满12个月的，为本市上年度在岗职工平均工资的2倍；\n　3 连续参保时间满12个月不满24个月的，为本市上年度在岗职工平均工资的3倍；4 连续参保时间满24个月不满36个月的，为本市上年度在岗职工平均工资的4倍；5 连续参保时间满36个月不满72个月的，为本市上年度在岗职工平均工资的5倍；6 连续参保时间满72个月以上的，为本市上年度在岗职工平均工资的6倍。   地补限额：1 连续参保时间不满6个月的，为1万元；\n2 连续参保时间满6个月不满12个月的，为5万元；3 连续参保时间满12个月不满24个月的，为10万元；\n4 连续参保时间满24个月不满36个月的，为15万元； 5 连续参保时间满36个月不满72个月的，为20万元； 6 连续参保时间满72个月以上的，为100万元。\n\n\"","PolicyLinkTwo":"深圳市社会医疗保险办法","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"","ReimbursementTreatmentThree":"0.9","OutpatientStartPayLineThree":"不设起付线","OutpatientEndPayLineThree":"1万元/年","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"广东","City":"深圳","ReimbursementRatio":"一档（职工）：100%","InsuranceType":"(职工)","ReimbursementTreatment":"1 门诊：基本医疗保险一档参保人个人账户用于支付参保人门诊基本医疗费用、地方补充医疗费用、在定点零售药店凭本市市内定点医疗机构医生开具的处方购买医疗保险目录范围内药品的费用，个人账户不足支付部分由个人自付。基本医疗保险一档参保人连续参保满一年，在同一医疗保险年度内个人自付的门诊基本医疗费用和地方补充医疗费用超过本市上年度在岗职工平均工资5%的，超过部分由基本医疗保险大病统筹基金或地方补充医疗保险基金按规定支付70%，参保人年满70周岁以上的支付80%。   基本医疗保险一档参保人在本市定点社康中心发生的基本医疗费用和地方补充医疗费用，70%由其个人账户支付，30%由基本医疗保险大病统筹基金、地方补充医疗保险基金按规定支付                               2 住院：基本医疗保险一档参保人按8%缴交基本医疗保险费的支付比例为90%；","OutpatientStartPayLine":"基本医疗保险一档参保人连续参保满一年，在同一医疗保险年度内个人自付的门诊基本医疗费用和地方补充医疗费用超过本市上年度在岗职工平均工资5%的，","OutpatientEndPayLine":"\"基本医疗保险统筹基金支付限额：1. 连续参保时间不满6个月的，为本市上年度在岗职工平均工资的1倍；2 连续参保时间满6个月不满12个月的，为本市上年度在岗职工平均工资的2倍；\n　3 连续参保时间满12个月不满24个月的，为本市上年度在岗职工平均工资的3倍；4 连续参保时间满24个月不满36个月的，为本市上年度在岗职工平均工资的4倍；5 连续参保时间满36个月不满72个月的，为本市上年度在岗职工平均工资的5倍；6 连续参保时间满72个月以上的，为本市上年度在岗职工平均工资的6倍。   地补限额：1 连续参保时间不满6个月的，为1万元；\n2 连续参保时间满6个月不满12个月的，为5万元；3 连续参保时间满12个月不满24个月的，为10万元；\n4 连续参保时间满24个月不满36个月的，为15万元； 5 连续参保时间满36个月不满72个月的，为20万元； 6 连续参保时间满72个月以上的，为100万元。\n\n\"","HospitalizationStartPayLine":"起付线按照医院级别设定，市内一级以下医院为100元，二级医院为200元，三级医院为300元；市外医疗机构已按规定办理转诊或备案的为400元，未按规定办理转诊或备案的为1000元。","HospitalizationEndPayLine":"\"基本医疗保险统筹基金支付限额：1. 连续参保时间不满6个月的，为本市上年度在岗职工平均工资的1倍；2 连续参保时间满6个月不满12个月的，为本市上年度在岗职工平均工资的2倍；\n　3 连续参保时间满12个月不满24个月的，为本市上年度在岗职工平均工资的3倍；4 连续参保时间满24个月不满36个月的，为本市上年度在岗职工平均工资的4倍；5 连续参保时间满36个月不满72个月的，为本市上年度在岗职工平均工资的5倍；6 连续参保时间满72个月以上的，为本市上年度在岗职工平均工资的6倍。   地补限额：1 连续参保时间不满6个月的，为1万元；\n2 连续参保时间满6个月不满12个月的，为5万元；3 连续参保时间满12个月不满24个月的，为10万元；\n4 连续参保时间满24个月不满36个月的，为15万元； 5 连续参保时间满36个月不满72个月的，为20万元； 6 连续参保时间满72个月以上的，为100万元。\n\n\"","PolicyLink":"深圳市社会医疗保险办法","InsuranceTypeTwo":"(二档、三档)","ReimbursementTreatmentTwo":"\"属于基本医疗保险药品目录中甲类药品和乙类药品的，分别由社区门诊统筹基金按80%和60%的比例支付；\n参保人因病情需要经结算医院同意转诊到其他医疗机构发生的门诊医疗费用，或因工外出、出差在非结算医院发生的急诊抢救门诊医疗费用，由社区门诊统筹基金按前款规定支付标准的90%报销；其他情形在非结算医院发生的门诊医疗费用社区门诊统筹基金不予报销。\n社区门诊统筹基金在一个医疗保险年度内支付给每位基本医疗保险二档、三档参保人的门诊医疗费用，总额最高不得超过1000元。\n\"","OutpatientStartPayLineTwo":"不设起付线","OutpatientEndPayLineTwo":"1000元/年","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"\"基本医疗保险统筹基金支付限额：1. 连续参保时间不满6个月的，为本市上年度在岗职工平均工资的1倍；2 连续参保时间满6个月不满12个月的，为本市上年度在岗职工平均工资的2倍；\n　3 连续参保时间满12个月不满24个月的，为本市上年度在岗职工平均工资的3倍；4 连续参保时间满24个月不满36个月的，为本市上年度在岗职工平均工资的4倍；5 连续参保时间满36个月不满72个月的，为本市上年度在岗职工平均工资的5倍；6 连续参保时间满72个月以上的，为本市上年度在岗职工平均工资的6倍。   地补限额：1 连续参保时间不满6个月的，为1万元；\n2 连续参保时间满6个月不满12个月的，为5万元；3 连续参保时间满12个月不满24个月的，为10万元；\n4 连续参保时间满24个月不满36个月的，为15万元； 5 连续参保时间满36个月不满72个月的，为20万元； 6 连续参保时间满72个月以上的，为100万元。\n\n\"","PolicyLinkTwo":"深圳市社会医疗保险办法","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"","ReimbursementTreatmentThree":"0.9","OutpatientStartPayLineThree":"不设起付线","OutpatientEndPayLineThree":"计入年度支付限额约53万+100万（补充医疗保险）","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"广东","City":"佛山","ReimbursementRatio":"0.9","InsuranceType":"一档、二档（有个帐）","ReimbursementTreatment":"\"门诊：属于《广东省基本医疗保险、工伤保险和生育保险药品目录（2010年版）》中规定的药品费用和纳入报销范围的常规基本医疗服务项目）所发生的费用，由统筹基金按以下规定支付：\n一类医疗机构90％。\n二类医疗机构70％。\n三类医疗机构40％。甲类药品100％核报；乙类药品及医院制剂60％核报\n住院：参保人在市内定点医疗机构发生的起付标准以上纳入统筹基金支付范围的医疗费用，由统筹基金根据医院类别支付至最高支付限额：一类医疗机构95％，二类医疗机构90％，三类医疗机构85％（恶性肿瘤手术治疗、心脑疾病手术治疗以及肝、肾和骨髓移植手术治疗住院的基金支付90％）。\n2.参保人在市内定点医疗机构住院，实行按病种付费结算的，在总费用标准（详见附件1）内，个人实际负担费用分别为：一类医疗机构10％，二类医疗机构20％，三类医疗机构35％。个人实际自付部分进入大病支付范围。\n\"","OutpatientStartPayLine":"不设起付线","OutpatientEndPayLine":"不设封顶线线","HospitalizationStartPayLine":"三类医疗机构1200元/次，二类医疗机构600元/次，一类医疗机构300元/次。","HospitalizationEndPayLine":"30万元","PolicyLink":"佛府办〔2016〕60号","InsuranceTypeTwo":"","ReimbursementTreatmentTwo":"","OutpatientStartPayLineTwo":"","OutpatientEndPayLineTwo":"","HospitalizationStartPayLineTwo":"0%","HospitalizationEndPayLineTwo":"","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"城乡一体化","ReimbursementTreatmentThree":"一级医疗机构95%，二级医疗机构90%，三级医疗机构85%","OutpatientStartPayLineThree":"不设起付标准","OutpatientEndPayLineThree":"1万元/年","PolicyLinkThree":"佛府办〔2016〕60号","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"广东","City":"东莞","ReimbursementRatio":"0.8","InsuranceType":"城乡统筹","ReimbursementTreatment":"社区门诊基金按70%支付，转诊诊定点医院60%支付，三级定点医疗机构50%支付。住院：一级定点医疗机构不足或等于5万，支付95%，5万以上不足10万，75%，10万以上少于15万，55%，15万以上，45%，二级各段减少5%，三级减少10%，市外三级减少15%","OutpatientStartPayLine":"不设起付线","OutpatientEndPayLine":"无封顶线","HospitalizationStartPayLine":"市内：三级医院1300，二级医院800，一级及以下医院500，市外三级医院2000，二级医院1500，一级及以下1000。","HospitalizationEndPayLine":"参保时间<6个月1万，6个月<1年2万，1年<2年5万，2年<3年10万，3年以上30万","PolicyLink":"东莞市社会基本医疗保险规定","InsuranceTypeTwo":"","ReimbursementTreatmentTwo":"","OutpatientStartPayLineTwo":"","OutpatientEndPayLineTwo":"","HospitalizationStartPayLineTwo":"0%","HospitalizationEndPayLineTwo":"","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工居民","ReimbursementTreatmentThree":"0.75","OutpatientStartPayLineThree":"不设起付线","OutpatientEndPayLineThree":"4000元/年","PolicyLinkThree":"东莞市社会基本医疗保险规定；东莞市补充医疗保险实施细则","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"广东","City":"惠州","ReimbursementRatio":"0.95","InsuranceType":"(职工)","ReimbursementTreatment":"门诊：一级医院报销比例80%，二级医院60%，三级医院55%，经定点门诊转诊支付比例分别减少10%，每次限额140元以下。住院：连续缴费6个月后，在定点医疗机构或经批准转院，支付比例95%，自行到市外就医，支付70%，缴费不到6个月，支付50%","OutpatientStartPayLine":"不设起付线","OutpatientEndPayLine":"1000","HospitalizationStartPayLine":"一级医院200，二级400，三级800，本市行政区域外医院1200","HospitalizationEndPayLine":"60万","PolicyLink":"惠州社会医疗保险 办法","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"门诊：A档单次支付比例55%，B档单次75%。住院：A档：一级医院：95%，二级医院：75%，三级医院：65%；B档：一级医院：95%，二级医院：85%，三级医院：75%","OutpatientStartPayLineTwo":"不设起付线","OutpatientEndPayLineTwo":"A档：500/年，50/次，B档：800，70/次","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"A档：40万，B档：50万","PolicyLinkTwo":"惠州社会医疗保险 办法","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工居民","ReimbursementTreatmentThree":"职工95%，居民55%","OutpatientStartPayLineThree":"不设起付线","OutpatientEndPayLineThree":"不设封顶线","PolicyLinkThree":"惠州社会医疗保险 办法","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"广东","City":"汕头","ReimbursementRatio":"0.9","InsuranceType":"(职工)","ReimbursementTreatment":"门诊：普通门诊基本医疗费按70％的比例支付；其他门诊基本医疗费用按50％的比例支付。。住院：参保人个人支付的比例：三级医疗机构为20%，二级医疗机构为15%，一级及以下医疗机构为10%；参保人属退休人员的，个人支付的比例为前述规定比例的80%。","OutpatientStartPayLine":"不设起付钱","OutpatientEndPayLine":"20元/月","HospitalizationStartPayLine":"一级300元二级500元三级1千元","HospitalizationEndPayLine":"连续参保12个月以下的，年度累计支付限额10万；参保12月以上的，年度40万元","PolicyLink":"汕头市人民政府关于进一步完善我市职工基本医疗保险制度有关问题的通知（汕府办〔2018〕21号）","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"\"门诊：普通门诊基本医疗费用按70％的比例支付；其他门诊基本医疗费用按50％的比例支付。住院：一档：一级定点医疗机构为85%，二级定点医疗机构为70%，三级定点医疗机构为50%，非定点医疗机构40%。\n　　（二）二档：一级定点医疗机构为85%，二级定点医疗机构为75%，三级定点医疗机构为60%，非定点医疗机构50%。\n\"","OutpatientStartPayLineTwo":"不设起付钱","OutpatientEndPayLineTwo":"120元/年，180元/年（特困）","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"\"居民：（一）连续参保缴费时间在12个月以下的，年度累计最高支付限额为10万元；（二）连续参保缴费时间在12个月以上的，年度累计最高支付限额为20万元。参保人门诊特定病种、门（急）诊抢救无效死亡、设立家庭病床、住院等发生的基本医疗费用。\n\"","PolicyLinkTwo":"汕头市城镇居民基本医疗保险暂行规定","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工居民","ReimbursementTreatmentThree":"0.7","OutpatientStartPayLineThree":"不设起付线","OutpatientEndPayLineThree":"职工350元/月，居民300元/月","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"广东","City":"湛江","ReimbursementRatio":"0.9","InsuranceType":"(职工)","ReimbursementTreatment":"\"门诊：60%\n住院：一级医疗机构88%，二级医疗机构85%，三级医疗机构82%比例支付\"","OutpatientStartPayLine":"暂无","OutpatientEndPayLine":"1600","HospitalizationStartPayLine":"一级医疗机构500元，二级医疗机构700元，三级医疗机构900元。","HospitalizationEndPayLine":"\"1）统筹基金10万，\n2）大病补助40万\"","PolicyLink":"湛人社【2013】81号","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"\"门诊：60%\n住院：一级医疗机构80%，二级医疗机构70%，三级医疗机构50%比例支付\"","OutpatientStartPayLineTwo":"20","OutpatientEndPayLineTwo":"300","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"基本医疗保险加大病保险年支付限额60万","PolicyLinkTwo":"\"湛人社【2015】464号\n湛人社【2016】514号\"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工+城乡居民","ReimbursementTreatmentThree":"银屑病。统筹基金支付比例：职工：一级88%，二级85%，三级82%；居民：一级医疗机构80%，二级医疗机构70%，三级医疗机构50%","OutpatientStartPayLineThree":"职工：不设起付线；居民：不设起付线","OutpatientEndPayLineThree":"最高支付限额为：职工：4000元/年；居民：3200元/年","PolicyLinkThree":"职工门慢：湛人社【2015】107号；居民：湛人社【2016】525号","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"广东","City":"广州","ReimbursementRatio":"","InsuranceType":"(职工)","ReimbursementTreatment":"\"职工门诊报销比例： 在基层选定医疗机构就医统筹基金的支付比例为80%；经基层选定医疗机构转诊后30日内在其他选定医疗机构和指定专科医疗机构就医统筹基金的支付比例为55%；未经基层选定医疗机构转诊到其他选定医疗机构和指定专科医疗机构就医统筹基金的支付比例为45%。    职工住院报销比例：  职工：一级定点医疗机构为90%，二级定点医疗机构为85%，三级定点医疗机构为80%；\n　　\"","OutpatientStartPayLine":"不设起付线","OutpatientEndPayLine":"统筹基金每月最高支付限额为300元。每月最高支付限额当月有效，不滚存、不累计。","HospitalizationStartPayLine":"\"职工：一级定点医疗机构为400元，二级定点医疗机构为800元，三级定点医疗机构为1600元；\n\"","HospitalizationEndPayLine":"在一个职工医保年度内，职工社会医疗保险统筹基金对参保人员住院、指定单病种、门诊特定项目、门诊指定慢性病及普通门诊就医发生的符合规定范围内的医疗费用，累计最高支付限额为上年度本市在岗职工年平均工资的6倍。","PolicyLink":"穗医保规字〔2019〕12号","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"门诊：居民在基层选定医疗机构门诊就医按60%比例支付                              住院：一级医疗机构85%，二级医疗机构70%，三级医疗机构55%比例支付","OutpatientStartPayLineTwo":"不设起付线","OutpatientEndPayLineTwo":"不超过600元","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"统筹基金年度累计最高支付限额为缴费基数的6倍","PolicyLinkTwo":"穗府办（2014）47号","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工+居民","ReimbursementTreatmentThree":"基层85%，其他医疗机构65%","OutpatientStartPayLineThree":"0","OutpatientEndPayLineThree":"按参保患者相应的住院基本医疗费用的支付比例执行，不纳入普通门诊统筹、相应门特医保统筹基金最高支付限额，直接计入医保基金年度累计最高支付限额计算","PolicyLinkThree":"广州市印发广州市建立国家医保谈判药品“双通道”管理机制实施细则的通知2022.1.10","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"广东","City":"珠海","ReimbursementRatio":"(基本医疗保险)","InsuranceType":"门诊 ： 参保人在选定的门诊统筹定点医疗机构就医所发生的下列门诊费用由门诊统筹基金支付70%，个人自付30%：住院:职工基本医疗保险一档、二档参保人，在职人员支付92%，退休人员支付94%；","ReimbursementTreatment":"不设起付线","OutpatientStartPayLine":"社保年度内转诊及急诊待遇支付限额合计为1500元（含自付部分）","OutpatientEndPayLine":"\"1.一级医院300元 2.二级医院500元3.三级医院1000元。\n\"","HospitalizationStartPayLine":"连续参保缴费时间1年以上的，40万/年；补充高额医疗费用：40-60万/年，最高补充20万/年；","HospitalizationEndPayLine":"珠海市医疗保险住院费用年度最高支付限额有关问题的通知珠人社[2017]155号","PolicyLink":"","InsuranceTypeTwo":"","ReimbursementTreatmentTwo":"","OutpatientStartPayLineTwo":"","OutpatientEndPayLineTwo":"","HospitalizationStartPayLineTwo":"0%","HospitalizationEndPayLineTwo":"","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"基本医疗保险","ReimbursementTreatmentThree":"中额门特：银屑病，支付比例70%","OutpatientStartPayLineThree":"不设起付线","OutpatientEndPayLineThree":"1中6000，2种8000，3种10000","PolicyLinkThree":"2020珠海市基本医疗保险门诊特定病种目录","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"广东","City":"中山","ReimbursementRatio":"0.7","InsuranceType":"(职工)","ReimbursementTreatment":"一级以下定点医疗机构支付95%，二级定点医疗机构支付92%，三级定点医疗机构支付90%，其余部分由个人自付。","OutpatientStartPayLine":"不设","OutpatientEndPayLine":"统账结合职工基本医疗保险、单建统筹职工基本医疗保险年度最高支付限额分别为本市上上年度职工年平均工资的0.04倍、0.03倍；年度最高支付限额取整至个位数。","HospitalizationStartPayLine":"一级以下定点医疗机构400元/次，二级定点医疗机构600元/次，三级定点医疗机构800元/次。","HospitalizationEndPayLine":"\"　（一）参保人连续缴纳统账结合职工基本医疗保险不满1年、1年以上的，年度最高支付限额分别为本市上上年度职工年平均工资的4倍、12倍。退休人员统账结合职工基本医疗保险年度最高支付限额为本市上上年度职工年平均工资的12倍。\n\n　　（二）参保人连续缴纳单建统筹职工基本医疗保险不满1年、1年以上的，年度最高支付限额分别为本市上上年度职工年平均工资的2倍、8倍。退休人员单建统筹职工基本医疗保险年度最高支付限额为本市上上年度职工年平均工资的8倍。\"","PolicyLink":"中山市人民政府关于印发中山市职工医疗保险办法的通知2021.10.15","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"一级以下定点医疗机构支付92%，二级定点医疗机构支付90%，三级定点医疗机构支付80%，其余部分由个人自付。","OutpatientStartPayLineTwo":"一级以下定点医疗机构600元/次，二级定点医疗机构800元/次，三级定点医疗机构1000元/次","OutpatientEndPayLineTwo":"城乡居民基本医疗保险年度最高支付限额为本市上上年度城乡居民人均可支配收入的8倍。","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"城乡居民基本医疗保险年度最高支付限额为本市上上年度城乡居民人均可支配收入的8倍。","PolicyLinkTwo":"中山市人民政府关于印发中山市城乡居民医疗保险办法的通知2021.10.15","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工居民","ReimbursementTreatmentThree":"二类门特：银屑病，报销70%","OutpatientStartPayLineThree":"不设","OutpatientEndPayLineThree":"12000","PolicyLinkThree":"2020年中山市门特病种名称、种类及待遇表","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"广东","City":"江门","ReimbursementRatio":"职工门特四类：1.本市一级及以下定点医疗机构基金支付比例为60%。居民四类门特：1.本市一级及以下定点医疗机构基金支付比例为60%。50%。","InsuranceType":"(职工)","ReimbursementTreatment":"职工住院：1级支付93%，二级90%，单机83%，非定点64%","OutpatientStartPayLine":"0","OutpatientEndPayLine":"基层50元/月，非基层40元/月","HospitalizationStartPayLine":"1档：1级：500元；2级：600元；3级900元；","HospitalizationEndPayLine":"60万","PolicyLink":"2021年度江门市基本医疗保险待遇标准","InsuranceTypeTwo":"居民","ReimbursementTreatmentTwo":"住院：一级85%，二级80%，三级65%，非定点40%","OutpatientStartPayLineTwo":"0","OutpatientEndPayLineTwo":"基层360元/年","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"30万","PolicyLinkTwo":"2021年度江门市基本医疗保险待遇标准","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工居民","ReimbursementTreatmentThree":"四类门特：银屑病","OutpatientStartPayLineThree":"无","OutpatientEndPayLineThree":"职工：180元/月；居民：180元/月","PolicyLinkThree":"2021年度江门市基本医疗保险待遇标准","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"江西","City":"南昌","ReimbursementRatio":"0.7","InsuranceType":"(职工)","ReimbursementTreatment":"70%报销比例双通道药品不设起付线和个人先行自付比例，年度累计药品费用，与基本医保、大病保险基金最高支付限额合并计算（门诊保障待遇同该要求一致）。","OutpatientStartPayLine":"无","OutpatientEndPayLine":"双通道药品不设起付线和个人先行自付比例，年度累计药品费用，与基本医保、大病保险基金最高支付限额合并计算","HospitalizationStartPayLine":"双通道药品不设起付线和个人先行自付比例，年度累计药品费用，与基本医保、大病保险基金最高支付限额合并计算（门诊保障待遇同该要求一致）。","HospitalizationEndPayLine":"10万","PolicyLink":"《江西省双通道谈判药品管理暂行办法》","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"60%报销比例，双通道药品不设起付线和个人先行自付比例，年度累计药品费用，与基本医保、大病保险基金最高支付限额合并计算（门诊保障待遇同该要求一致）。","OutpatientStartPayLineTwo":"双通道药品不设起付线和个人先行自付比例，年度累计药品费用，与基本医保、大病保险基金最高支付限额合并计算（门诊保障待遇同该要求一致）","OutpatientEndPayLineTwo":"双通道药品不设起付线和个人先行自付比例，年度累计药品费用，与基本医保、大病保险基金最高支付限额合并计算（门诊保障待遇同该要求一致）","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"10万","PolicyLinkTwo":"《江西省双通道谈判药品管理暂行办法》","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"\"城镇职工和城镇居民所有门诊特殊病种待遇纳入住院统筹基金最高支付限额及大病保险最高支付限额范围内；居民门诊特殊慢性病实行定点医疗机构管理，支付比例参照住院支付比例执行。\n参保居民年度最高支付限额按照住院统筹基金（含大病医疗保险）年度最高支付限额执行。\n\"","OutpatientStartPayLineThree":"职工：不设起付标准；居民执行住院医疗起付标准","OutpatientEndPayLineThree":"职工：10万；居民10万","PolicyLinkThree":"南昌市城镇职工基本医疗保险市级统筹实施意见；南昌市城乡居民基本医疗保险暂行办法","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"海南","City":"海口","ReimbursementRatio":"按住院","InsuranceType":"(职工)","ReimbursementTreatment":"住院：在一级医疗机构就医的报销90% ;在二级医疗机构就医的报销88%；在三级医疗机构就医的报销85%。退休all90%","OutpatientStartPayLine":"一级及以下定点医疗机构年度起付标准为10元；二级定点医疗机构年度起付标准为50元；三级定点医疗机构年度起付标准为100元.与门慢、门特、住院合并计算。","OutpatientEndPayLine":"统筹基金不支付普通门诊","HospitalizationStartPayLine":"在职800；退休600","HospitalizationEndPayLine":"最高支付限额为26万元/年 。但因患重大疾病最高支付额50万","PolicyLink":"海口市城镇从业人员基本医疗保险、《海南省城镇从业人员基本医疗保险普通门诊共济保障管理办法（试行）》的通知","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"参保居民发生起付标准以上、最高支付标准以下的门诊医疗费用，由 统筹基金和参保居民分别按比例分担：一级及以下定点医疗机构，统筹基金支 付比例为60%，个人支付比例为40%;二级定点医疗机构，统筹基金支付比例为 50%，个人支付比例为50%。每日最高支付限额为40元。","OutpatientStartPayLineTwo":"50元/年，门慢、门特、住院合并计算。","OutpatientEndPayLineTwo":"300元（超过限额，统筹基金不予支付；未达到，可结转下年度用于支付住院医疗费用）","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"15万/年","PolicyLinkTwo":"海南省城乡居民基本医疗保险普通门诊统筹管理办法（试行）","InsuranceTypeThree":"门慢门特","CrowdType":"从业/居民","ReimbursementTreatmentThree":"国谈（门特品种）不占所申请疾病的定额标准。按住院比例结算，计入个人年度医保统筹基金最高支付限额。","OutpatientStartPayLineThree":"不设","OutpatientEndPayLineThree":"按住院","PolicyLinkThree":"海南省医疗保障局关于调整基本医疗保险门诊慢性特殊疾病有关规定的通知琼医保规[2021]7号2021.09.01","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"湖北","City":"武汉","ReimbursementRatio":"乙类药品报销90%","InsuranceType":"(职工)","ReimbursementTreatment":"住院：（一）年度累计基本医疗保险内费用在10万以内，医保基金比例分别为： 　　1、社区、一级医院基金支付92%（在职）936%（退休）； 　　2、二级医院基金支付89%（在职）912%（退休）； 　　3、三级医院基金支付86%（在职）888%（退休）； 　　4、享受低保待遇的残疾人，统筹基金支付比例提高2%。 　　（二）年度累计基本医疗保险内费用10—20万，医保基金支付96%， 　　（三）年度累计基本医疗保险内费用在20—24万，医保基金支付98%。","OutpatientStartPayLine":"普通门诊统筹基金不支付","OutpatientEndPayLine":"普通门诊统筹基金不支付","HospitalizationStartPayLine":"社区卫生服务中心200元；一级医院400元；二级医院600元；三级医院800元。在一个保险年度内，参保人员两次及以上住院的，住院起付标准减半（社区卫生服务中心除外）。享受低保待遇的残疾人，免收住院起付标准费用。","HospitalizationEndPayLine":"24万","PolicyLink":"武汉市城镇职工基本医疗保险办法；城镇职工基本医疗保险政策指南","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"\"门诊报销50%；\n住院：在社区卫生服务中心、一级医院住院，医保基金支付80%，个人承担20%；\n　　在二级医院住院，医保基金支付70%，个人承担30%；\n　　在三级医院住院，医保基金支付60%，个人承担40%。\n　　享受低保待遇的残疾人，统筹基金支付比例在现行基础上提高2%。\"","OutpatientStartPayLineTwo":"200","OutpatientEndPayLineTwo":"1000","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"13万","PolicyLinkTwo":"武汉市城镇居民基本医疗保险办法；武汉居民、大学生医疗保险政策指南","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"","ReimbursementTreatmentThree":"","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"湖北","City":"宜昌","ReimbursementRatio":"职工乙类报销70%，居民在一级、二级、三级医疗机构分别报销80%、65%、50%","InsuranceType":"(职工)","ReimbursementTreatment":"职工住院基本医疗费用政策范围内的乙类费用，统筹基金支付70%，个人自付30%。","OutpatientStartPayLine":"统筹基金不支付","OutpatientEndPayLine":"统筹基金不支付","HospitalizationStartPayLine":"统筹基金起付标准为一级医疗机构300元，二级医疗机构600元，三级医疗机构1000元","HospitalizationEndPayLine":"12万","PolicyLink":"宜昌市职工基本医疗保险实施办法","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"\"参保居民在约定机构发生的符合医疗保险规定支付范围的门诊医疗费用，累计金额在50元以上至400元以下的费用普通门诊统筹基金报销40%。超过400元以上的费用由个人支付。住院待遇：（一）在当地惠民医院（含惠民窗口，下同）、一级医疗机构、乡镇卫生院及社区卫生服务机构就医，同一保险年度内每次住院起付标准均为100元，起付标准以上的甲类药品、一般诊疗项目、一般服务项目、一般设施费用由医疗保险基金支付70%，起付标准以上的乙类药品、特殊诊疗项目、特殊服务项目、特殊设施费用由医疗保险基金支付60%。其中，无生活来源、无劳动能力、无法定赡养抚养人的参保居民在上述医疗机构住院，不设起付标准；低保对象在惠民医院发生的住院医疗费用，先享受惠民医院减免优惠后，医疗保险基金再按上述规定的比例支付，减免和报销之和不得低于80%。\n　　（二）在当地二级及相应医疗机构就医，同一保险年度内第一次住院起付标准为300元，第二次及以上住院起付标准为150元，起付标准以上的甲类药品、一般诊疗项目、一般服务项目、一般设施费用由医疗保险基金支付60%，起付标准以上的乙类药品、特殊诊疗项目、特殊服务项目、特殊设施费用由医疗保险基金支付45%。\n　　（三）在当地三级及相应医疗机构就医，同一保险年度内第一次住院起付标准为500元，第二次及以上住院起付标准为250元，起付标准以上的甲类药品、一般诊疗项目、一般服务项目、一般设施费用由医疗保险基金支付50%，起付标准以上的乙类药品、特殊诊疗项目、特殊服务项目、特殊设施费用由医疗保险基金支付40%。\"","OutpatientStartPayLineTwo":"50","OutpatientEndPayLineTwo":"400","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"3万","PolicyLinkTwo":"宜昌市城镇居民基本医疗保险实施办法；宜昌市城镇居民基本医疗保险普通门诊统筹管理试行办法","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"","ReimbursementTreatmentThree":"","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"湖北","City":"十堰","ReimbursementRatio":"乙类药品报销90%","InsuranceType":"(职工)","ReimbursementTreatment":"\"在职：90%/88%/85% (一级/二级/三级医院)\n退休：92%/90%/87% (一级/二级/三级医院)\n\"","OutpatientStartPayLine":"","OutpatientEndPayLine":"","HospitalizationStartPayLine":"","HospitalizationEndPayLine":"","PolicyLink":"","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"\"85%/75%/65% (一级/二级/三级医院)\n\"","OutpatientStartPayLineTwo":"门诊统筹不设起付标准。参保居民在门诊统筹定点机构就诊发生的普通门诊（含急诊），一个保险年度内发生的政策范围内门诊医疗费用累计金额在400元（建档立卡贫困人口为800元）以下的，医保门诊统筹基金报销50%，限额为200元（建档立卡贫困人口限额为400元），超过报销限额部分的费用由个人自理。","OutpatientEndPayLineTwo":"","HospitalizationStartPayLineTwo":"0%","HospitalizationEndPayLineTwo":"","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"","ReimbursementTreatmentThree":"","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"湖南","City":"长沙","ReimbursementRatio":"0.7","InsuranceType":"(职工)","ReimbursementTreatment":"单行支付；住院、门诊和药店“双通道”药品医保报销待遇统一；未申请双通道的跟乙类政策报销，自付比例30%","OutpatientStartPayLine":"无","OutpatientEndPayLine":"\"先由基本医疗保险统筹基金支付，\n超统筹基金年度支付限额后，参加了城镇职工大病互助的，由城镇职工大病互助按规定支付。20+25=45万\"","HospitalizationStartPayLine":"无","HospitalizationEndPayLine":"\"先由基本医疗保险统筹基金支付，\n超统筹基金年度支付限额后，参加了城镇职工大病互助，由城镇职工大病互助按规定支付。20+25=45万\"","PolicyLink":"http://ybj.hunan.gov.cn/ybj/first113541/firstF/f2113606/202112/t20211224_21323472.html","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"单行支付；住院、门诊和药店“双通道”药品医保报销待遇统一；未申请双通道的跟乙类政策报销，自付比例30%","OutpatientStartPayLineTwo":"无","OutpatientEndPayLineTwo":"\"先由基本医疗保险统筹基金支付，\n超统筹基金年度支付限额后，参加了城\n乡居民大病保险的，由城乡居民大病保\n险按规定支付，15+30=45万\"","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"\"先由基本医疗保险统筹基金支付，\n超统筹基金年度支付限额后，参加了城\n乡居民大病保险的，由城乡居民大病保\n险按规定支付，15+30=45万\"","PolicyLinkTwo":"http://ybj.hunan.gov.cn/ybj/first113541/firstF/f2113606/202108/t20210826_20398569.html","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/城乡居民","ReimbursementTreatmentThree":"门特门慢基金支付：职工80%，城居70%","OutpatientStartPayLineThree":"不设起付标准","OutpatientEndPayLineThree":"限额200元/月","PolicyLinkThree":"长医保发（2019）67号","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"湖南","City":"湘潭","ReimbursementRatio":"0.7","InsuranceType":"(职工)","ReimbursementTreatment":"单行支付；住院、门诊和药店“双通道”药品医保报销待遇统一；未申请双通道的跟乙类政策报销，自付比例30%","OutpatientStartPayLine":"无","OutpatientEndPayLine":"\"先由基本医疗保险统筹基金支付，\n超统筹基金年度支付限额后，参加了城镇职工大病互助的，由城镇职工大病互助按规定支付。20+25=45万\"","HospitalizationStartPayLine":"无","HospitalizationEndPayLine":"\"先由基本医疗保险统筹基金支付，\n超统筹基金年度支付限额后，参加了城镇职工大病互助，由城镇职工大病互助按规定支付。20+25=45万\"","PolicyLink":"http://ybj.hunan.gov.cn/ybj/first113541/firstF/f2113606/202112/t20211224_21323472.html","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"单行支付；住院、门诊和药店“双通道”药品医保报销待遇统一；未申请双通道的跟乙类政策报销，自付比例30%","OutpatientStartPayLineTwo":"无","OutpatientEndPayLineTwo":"\"先由基本医疗保险统筹基金支付，\n超统筹基金年度支付限额后，参加了城\n乡居民大病保险的，由城乡居民大病保\n险按规定支付，15+30=45万\"","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"\"先由基本医疗保险统筹基金支付，\n超统筹基金年度支付限额后，参加了城\n乡居民大病保险的，由城乡居民大病保\n险按规定支付，15+30=45万\"","PolicyLinkTwo":"http://ybj.hunan.gov.cn/ybj/first113541/firstF/f2113606/202108/t20210826_20398569.html","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/城乡居民","ReimbursementTreatmentThree":"\"城镇职工医保在职职工为 85%，退休职工为 90%；城乡居\n民医保为 65%\"","OutpatientStartPayLineThree":"不设起付标准","OutpatientEndPayLineThree":"限额200元/月","PolicyLinkThree":"潭人社发〔2018〕12 号","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"湖南","City":"衡阳","ReimbursementRatio":"0.7","InsuranceType":"(职工)","ReimbursementTreatment":"单行支付；住院、门诊和药店“双通道”药品医保报销待遇统一；未申请双通道的跟乙类政策报销，自付比例30%","OutpatientStartPayLine":"无","OutpatientEndPayLine":"\"先由基本医疗保险统筹基金支付，\n超统筹基金年度支付限额后，参加了城镇职工大病互助的，由城镇职工大病互助按规定支付。20+25=45万\"","HospitalizationStartPayLine":"无","HospitalizationEndPayLine":"\"先由基本医疗保险统筹基金支付，\n超统筹基金年度支付限额后，参加了城镇职工大病互助，由城镇职工大病互助按规定支付。20+25=45万\"","PolicyLink":"http://ybj.hunan.gov.cn/ybj/first113541/firstF/f2113606/202112/t20211224_21323472.html","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"单行支付；住院、门诊和药店“双通道”药品医保报销待遇统一；未申请双通道的跟乙类政策报销，自付比例30%","OutpatientStartPayLineTwo":"无","OutpatientEndPayLineTwo":"\"先由基本医疗保险统筹基金支付，\n超统筹基金年度支付限额后，参加了城\n乡居民大病保险的，由城乡居民大病保\n险按规定支付，15+30=45万\"","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"\"先由基本医疗保险统筹基金支付，\n超统筹基金年度支付限额后，参加了城\n乡居民大病保险的，由城乡居民大病保\n险按规定支付，15+30=45万\"","PolicyLinkTwo":"http://ybj.hunan.gov.cn/ybj/first113541/firstF/f2113606/202108/t20210826_20398569.html","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/城乡居民","ReimbursementTreatmentThree":"\"城镇职工80%；城乡居\n民医保为 70%\"","OutpatientStartPayLineThree":"不设起付标准","OutpatientEndPayLineThree":"限额2000元/月","PolicyLinkThree":"衡医保发〔2020〕25号","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"湖南","City":"邵阳","ReimbursementRatio":"0.7","InsuranceType":"(职工)","ReimbursementTreatment":"单行支付；住院、门诊和药店“双通道”药品医保报销待遇统一；未申请双通道的跟乙类政策报销，自付比例30%","OutpatientStartPayLine":"无","OutpatientEndPayLine":"\"先由基本医疗保险统筹基金支付，\n超统筹基金年度支付限额后，参加了城镇职工大病互助的，由城镇职工大病互助按规定支付。20+25=45万\"","HospitalizationStartPayLine":"无","HospitalizationEndPayLine":"\"先由基本医疗保险统筹基金支付，\n超统筹基金年度支付限额后，参加了城镇职工大病互助，由城镇职工大病互助按规定支付。20+25=45万\"","PolicyLink":"http://ybj.hunan.gov.cn/ybj/first113541/firstF/f2113606/202112/t20211224_21323472.html","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"单行支付；住院、门诊和药店“双通道”药品医保报销待遇统一；未申请双通道的跟乙类政策报销，自付比例30%","OutpatientStartPayLineTwo":"无","OutpatientEndPayLineTwo":"\"先由基本医疗保险统筹基金支付，\n超统筹基金年度支付限额后，参加了城\n乡居民大病保险的，由城乡居民大病保\n险按规定支付，15+30=45万\"","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"\"先由基本医疗保险统筹基金支付，\n超统筹基金年度支付限额后，参加了城\n乡居民大病保险的，由城乡居民大病保\n险按规定支付，15+30=45万\"","PolicyLinkTwo":"http://ybj.hunan.gov.cn/ybj/first113541/firstF/f2113606/202108/t20210826_20398569.html","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/城乡居民","ReimbursementTreatmentThree":"我司产品未在二级目录内不能享受待遇","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"福建","City":"福州","ReimbursementRatio":"0.8","InsuranceType":"(职工)","ReimbursementTreatment":"不设起付线，报销比例为80%，支付额度计入当地职工基本医保年度最高支付限额，共用封顶线。","OutpatientStartPayLine":"0","OutpatientEndPayLine":"12万","HospitalizationStartPayLine":"0","HospitalizationEndPayLine":"12万","PolicyLink":"福建省医疗保障局关于部分医保药品单列门诊统筹支付的通知","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"不设起付线，报销比例为60%，支付额度计入当地职工基本医保年度最高支付限额，共用封顶线。","OutpatientStartPayLineTwo":"0","OutpatientEndPayLineTwo":"12万","HospitalizationStartPayLineTwo":"0%","HospitalizationEndPayLineTwo":"12万","PolicyLinkTwo":"福建省医疗保障局关于部分医保药品单列门诊统筹支付的通知","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工门特；城乡居民门诊特殊病种","ReimbursementTreatmentThree":"\"1、统筹基金最高支付限额包括起付标准、医保目录内个人负担部分。2、参保人员有两个以上门诊特殊病种按一个起付标准计算。3、序号1—4门诊特殊病种超过最高支付限额部分的医疗费用，不享受大额医疗费用补充保险待遇。\n\"","OutpatientStartPayLineThree":"城镇职工：800元（其中社区卫生服务中心、乡镇卫生院取消起付线）；城乡居民：400（社区卫生服务中心及乡镇卫生院除外）","OutpatientEndPayLineThree":"都是12万","PolicyLinkThree":"福州市职工基本医疗保险指南(2015年9月)；福州市关于城乡居民基本医保政策一体化实施方案","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"福建","City":"厦门","ReimbursementRatio":"0.8","InsuranceType":"(职工)","ReimbursementTreatment":"参保人员门诊起付标准内的医疗费用，在执行国家基本药物制度及零差价的社区卫生服务中心、乡镇卫生院等一级及以下定点医疗机构门诊就医时发生的属于国家基本药物的药品费用、门诊费及常规医疗检查费，不超过500元部分由社会统筹医疗基金全部报销，在其它定点医疗机构就医的医药费用，由个人全部自付。","OutpatientStartPayLine":"在职1844.16元；退休922.08元","OutpatientEndPayLine":"10万元","HospitalizationStartPayLine":"\"在职：三级1000元，二级600元，一级200元\n退休：三级500元，二级300元，一级100元\"","HospitalizationEndPayLine":"10万元","PolicyLink":"厦门市城镇职工基本医疗保险规定（厦门市人民政府令第163号）","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"1、参保人员门诊起付标准内的医疗费用，在执行国家基本药物制度及零差价的社区卫生服务中心、乡镇卫生院等一级及以下定点医疗机构门诊就医时发生的属于国家基本药物的药品费用、诊疗费及常规医疗检查费用，不超过500元部分由社会统筹医疗基金全部报销，在其它定点医疗机构就医发生的费用，由个人全部自付； 2、对连续参保缴费者，其门诊报销比例在原基础上，每满一年提高一个百分点，最多可提高5个百分点。07年1月份参保者，1－6月可按一个年度计算；3、本年度基本医疗保险费统筹最高限额为10万元；本年度补充医疗保险赔付最高限额：21 万元（个人负担25％）；","OutpatientStartPayLineTwo":"1000元","OutpatientEndPayLineTwo":"10万元","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"本年度基本医疗保险费统筹最高限额为10万元","PolicyLinkTwo":"城乡居民医疗费自付比例简明表","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"无特殊病种","ReimbursementTreatmentThree":"","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"福建","City":"泉州","ReimbursementRatio":"0.8","InsuranceType":"(职工)","ReimbursementTreatment":"不设起付线，报销比例为80%，支付额度计入当地职工基本医保年度最高支付限额，共用封顶线。","OutpatientStartPayLine":"0","OutpatientEndPayLine":"12万","HospitalizationStartPayLine":"0","HospitalizationEndPayLine":"12万","PolicyLink":"福建省医疗保障局关于部分医保药品单列门诊统筹支付的通知","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"不设起付线，报销比例为80%，支付额度计入当地职工基本医保年度最高支付限额，共用封顶线。","OutpatientStartPayLineTwo":"0","OutpatientEndPayLineTwo":"15万","HospitalizationStartPayLineTwo":"0%","HospitalizationEndPayLineTwo":"15万元","PolicyLinkTwo":"福建省医疗保障局关于部分医保药品单列门诊统筹支付的通知","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"属于规定范围内门诊特殊病种和治疗项目的医疗费用，视同住院医疗费用","OutpatientStartPayLineThree":"同住院","OutpatientEndPayLineThree":"居民15万元；职工12万","PolicyLinkThree":"\"泉州市人民政府关于印发泉州市 城镇居民基本医疗保险规定的通知 ；泉州市城镇职工基本医疗保险规定的通知\n\"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"福建","City":"漳州","ReimbursementRatio":"0.8","InsuranceType":"(职工)","ReimbursementTreatment":"不设起付线，报销比例为80%，支付额度计入当地职工基本医保年度最高支付限额，共用封顶线。","OutpatientStartPayLine":"0","OutpatientEndPayLine":"12万","HospitalizationStartPayLine":"0","HospitalizationEndPayLine":"12万","PolicyLink":"福建省医疗保障局关于部分医保药品单列门诊统筹支付的通知","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"不设起付线，报销比例为80%，支付额度计入当地职工基本医保年度最高支付限额，共用封顶线。","OutpatientStartPayLineTwo":"0","OutpatientEndPayLineTwo":"15万","HospitalizationStartPayLineTwo":"0%","HospitalizationEndPayLineTwo":"15万元","PolicyLinkTwo":"福建省医疗保障局关于部分医保药品单列门诊统筹支付的通知","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"属于规定范围内门诊特殊病种和治疗项目的医疗费用，视同住院医疗费用","OutpatientStartPayLineThree":"同住院","OutpatientEndPayLineThree":"居民15万元；职工12万","PolicyLinkThree":"\"泉州市人民政府关于印发泉州市 城镇居民基本医疗保险规定的通知 ；泉州市城镇职工基本医疗保险规定的通知\n\"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"云南","City":"昆明","ReimbursementRatio":"","InsuranceType":"(职工)","ReimbursementTreatment":"","OutpatientStartPayLine":"","OutpatientEndPayLine":"","HospitalizationStartPayLine":"","HospitalizationEndPayLine":"","PolicyLink":"","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"","OutpatientStartPayLineTwo":"","OutpatientEndPayLineTwo":"","HospitalizationStartPayLineTwo":"0%","HospitalizationEndPayLineTwo":"","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"","ReimbursementTreatmentThree":"","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"四川省","City":"成都市","ReimbursementRatio":"无乙类的先行自付，直接职工报75%，居民报65%/60%","InsuranceType":"(职工)","ReimbursementTreatment":"报销75%，单行支付五定管理，双通道管理即可医院报销也可定点药店报销","OutpatientStartPayLine":"/","OutpatientEndPayLine":"/","HospitalizationStartPayLine":"无起付线","HospitalizationEndPayLine":"15万","PolicyLink":"","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"高档报销65%，低档60%","OutpatientStartPayLineTwo":"/","OutpatientEndPayLineTwo":"/","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"15万","PolicyLinkTwo":"成医保发〔2019〕20号、成医保发〔2019〕33 号","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"职工报销75%，居民65%/60%","OutpatientStartPayLineThree":"无起付线","OutpatientEndPayLineThree":"15万","PolicyLinkThree":"成医保发〔2019〕20号、成医保发〔2019〕33 号","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"四川省","City":"绵阳","ReimbursementRatio":"0.7","InsuranceType":"(职工)","ReimbursementTreatment":"单行支付，不设起付线，报销70%","OutpatientStartPayLine":"","OutpatientEndPayLine":"","HospitalizationStartPayLine":"","HospitalizationEndPayLine":"10万","PolicyLink":"","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"","OutpatientStartPayLineTwo":"","OutpatientEndPayLineTwo":"","HospitalizationStartPayLineTwo":"0%","HospitalizationEndPayLineTwo":"","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"","ReimbursementTreatmentThree":"","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"四川省","City":"南充市","ReimbursementRatio":"职工65%居民50%","InsuranceType":"(职工)","ReimbursementTreatment":"单行支付药品职工医保支付比例为60%， 12个月内最高支付限额职工医保不超过10万元","OutpatientStartPayLine":"不设起付线","OutpatientEndPayLine":"10w","HospitalizationStartPayLine":"不设起付线","HospitalizationEndPayLine":"10万/年","PolicyLink":"","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"单行支付药品居民医保支付比例为45%，12个月内最高支付限额居民医保不超过7万元","OutpatientStartPayLineTwo":"不设起付线","OutpatientEndPayLineTwo":"7万","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"7万","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"报销费用的60%","OutpatientStartPayLineThree":"无","OutpatientEndPayLineThree":"600/年","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"宁夏","City":"银川","ReimbursementRatio":"非三定医疗机构：乙类药品自付5%后按照医疗机构级别不同报销比例不同。三定医疗机构（定点药店）：门诊：起付线500元/年，职工报销75%，居民报销60%；住院按住院医保政策报销。职工年度限额40万，职工年度限额13万。","InsuranceType":"(职工)","ReimbursementTreatment":"\"住院：自付5%后，一级95%，二级90%，三乙85%，三甲80%；非三定医疗机构：开展门诊统筹：社区报销70%，一级报销60%，二级报销40%。\n三定医疗机构（药店）门诊：起付线500元/年，职工报销75%，居民报销60%；\"","OutpatientStartPayLine":"\"非三定：开展门诊统筹，无起付线；\n三定医疗机构（药店）门诊：起付线500元/年\"","OutpatientEndPayLine":"非三定医疗机构：门诊统筹1300元/年；三定医疗机构，年度限额40万","HospitalizationStartPayLine":"三甲1200元，三乙800元，二级500元，一级300元","HospitalizationEndPayLine":"5万，超过进入大额医疗补助，5万-40万报销90%，40万以上报销70%","PolicyLink":"宁夏银川职工医保政策；宁夏谈判药品“双通道”管理机制","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"\"住院：自付5%后，一级95%，二级90%，三乙85%，三甲80%；非三定医疗机构：开展门诊统筹：社区报销70%，一级报销60%，二级报销40%。\n三定医疗机构（药店）门诊：起付线500元/年，职工报销75%，居民报销60%；\"","OutpatientStartPayLineTwo":"\"非三定：开展门诊统筹，无起付线；\n三定医疗机构（药店）门诊：起付线500元/年\"","OutpatientEndPayLineTwo":"非三定医疗机构：门诊统筹330元/年；三定医疗机构，年度限额13万","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"13万。个人负担超过起付线之上，按照金额分段报销60%--73%，上不封顶","PolicyLinkTwo":"进一步完善城乡居民基本医疗保险自治区级统筹制度的意见；宁夏谈判药品“双通道”管理机制","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"","ReimbursementTreatmentThree":"","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"广西","City":"南宁","ReimbursementRatio":"乙类药品报销比例主要存在于职工医保住院待遇当中","InsuranceType":"(职工)","ReimbursementTreatment":"三级医院住院乙类药品报销比例为：80%（在职），85%（退休）","OutpatientStartPayLine":"使用个人账户，统筹基金不支付","OutpatientEndPayLine":"使用个人账户，统筹基金不支付","HospitalizationStartPayLine":"\"600（第一次）\n300（第二次及以上）\"","HospitalizationEndPayLine":"上年度全区城镇单位在岗职工平均工资的6倍(2014年为46846元，即封顶线为281076元)","PolicyLink":"","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"三级医院住院报销比例为50%","OutpatientStartPayLineTwo":"不设起付线（报销比例55%）","OutpatientEndPayLineTwo":"200/年","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"上年度广西城镇居民人均可支配收入的6倍（2014年为24669元，即封顶线为148014元）","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"城镇职工和城镇居民","ReimbursementTreatmentThree":"糖尿病，居民由统筹基金支付60％，个人负担40％；在职人员统筹基金支付70％，退休人员统筹基金支付75％。","OutpatientStartPayLineThree":"职工：100/月，居民：30/月","OutpatientEndPayLineThree":"职工：5500/年，居民：2000/年","PolicyLinkThree":"具体请分别参考职工和居民的政策原文","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"广西","City":"柳州","ReimbursementRatio":"个人先支付费用为药品总额的10%或20%，其中重病人群住院时的个人先支付费用为药品总额的5%或15%","InsuranceType":"(职工)","ReimbursementTreatment":"职工在三级医疗机构起付线800/600/400元(3级2级1级)，报销比例82%/87%/92%(3级2级1级)","OutpatientStartPayLine":"800/600/400元(3级2级1级)","OutpatientEndPayLine":"4000","HospitalizationStartPayLine":"","HospitalizationEndPayLine":"","PolicyLink":"","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"居民报销比例60%/75%/90%(3级2级1级)，住院起付线（600、400、200）门诊报销比例50%/70%/85%(3级2级1级)，","OutpatientStartPayLineTwo":"300\\200\\100","OutpatientEndPayLineTwo":"2000","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"","ReimbursementTreatmentThree":"","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"西藏","City":"拉萨","ReimbursementRatio":"93-98%","InsuranceType":"(职工)","ReimbursementTreatment":"西藏谈判药品按照乙类管理，住院或者门特先行自付10%，剩余的90%按照起付线至20万元（含）基金支付93%，20万元至40万元（含）基金支付96%，40万元至60万元（含）基金支付98%","OutpatientStartPayLine":"无门诊统筹","OutpatientEndPayLine":"无门诊统筹","HospitalizationStartPayLine":"三级医院400元；二级医院300；一级医院200元","HospitalizationEndPayLine":"60w","PolicyLink":"","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"选择250元档的按90%报销，选择120元档次的按70%报销，选择60元档的按照60%报销","OutpatientStartPayLineTwo":"不低于100元","OutpatientEndPayLineTwo":"300元","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"6W","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"","ReimbursementTreatmentThree":"职工门特报销比例为90%，不设起付线。合并住院后，起付线至20万元（含）基金支付93%，20万元至40万元（含）基金支付96%，40万元至60万元（含）基金支付98%","OutpatientStartPayLineThree":"职工门特报销比例为90%，不设起付线，年度最高支付限额和住院合并计算","OutpatientEndPayLineThree":"60万一年","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"新疆","City":"乌鲁木齐","ReimbursementRatio":"0.9","InsuranceType":"(职工)","ReimbursementTreatment":"\"住院保险待遇：在职为一级医院95%；二级医院90%；三级医院85%\n退休分别为一级医院95%；二级医院95%；三级医院90%\"","OutpatientStartPayLine":"普通门诊统筹基金不支付，使用个人帐户","OutpatientEndPayLine":"普通门诊统筹基金不支付，使用个人帐户","HospitalizationStartPayLine":"一级医院200元，二级医院400，三级医院900","HospitalizationEndPayLine":"基本医保8万，大额医疗补充22万","PolicyLink":"关于提高我市城镇职工基本医疗保险统筹和大额医疗补助金最高支付限额的通知；乌鲁木齐市关于调整我市城镇职工基本医疗保险统筹基金起付标准的通知; 乌医保【2019】46号关于调整乌鲁木齐市基本医疗保险有关政策的通知","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"住院保险待遇：乡镇卫生院90%；一级医院90%；二级医院80%；三级医院65%","OutpatientStartPayLineTwo":"取消慢性病10元起付标准","OutpatientEndPayLineTwo":"门诊统筹基金支付比例为70%","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"城乡居民年度内住院基本医疗保险上限9万元，年度内累计个人负担合规医疗费用超1.5万元（含1.5万元）后启动城乡居民大病保险。1.5至5万元以下（含5万元）的部分支付比例为50%，5至10万元（含10万元）部分支付比例为55%，10至20万元（含20万元）部分支付比例为60%，20万元以上部分支付比例为65%，不设最高支付限额，即住院报销金额不设上限。","PolicyLinkTwo":"《关于调整乌鲁木齐市基本医疗保险有关政策的通知 》乌医保[2019]46号","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/城乡居民","ReimbursementTreatmentThree":"\"职工：特殊慢性病治疗统筹基金支付比例80%；各种恶性肿瘤、肝硬化、精神病、慢性活动性肝炎、慢性肾功能衰竭、器官移植后排异治疗6种慢性病统筹基金支付比例90%。\n城乡居民：一类慢性病统筹基金支付比例为70%；恶性肿瘤、白血病、肾功能衰竭、苯丙酮尿症、血友病的统筹基金支付比例为80%，取消慢性病10元起付标准；一类慢性病年度统筹基金最高支付限额为4000元。\"","OutpatientStartPayLineThree":"居民：一类慢性病统筹基金支付比例为70%；恶性肿瘤、白血病、肾功能衰竭、苯丙酮尿症、血友病的统筹基金支付比例为80%，取消慢性病10元起付标准；","OutpatientEndPayLineThree":"居民：一类慢性病年度统筹基金最高支付限额为4000元；职工无限额","PolicyLinkThree":"《关于调整乌鲁木齐市基本医疗保险有关政策的通知 》乌医保[2019]46号","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"新疆","City":"兵团","ReimbursementRatio":"0.9","InsuranceType":"(职工)","ReimbursementTreatment":"住院报销 一级医院80%-96%；二级医院80%-93%；三级医院80%-90%；自负合规费用2.5万以上享受大病保险，实行分档累加按比例支付，职工大病保险最低报销比例55%，最高可达到95%。0 至5万元（含 5万元）的支付比例为 55%，5 至10万元（含10万元）的支付比例为 65%，10至20万元（含 20万元）的支付比例为 75%，20 至30万元（含30万元）的支付比例为85%，30万元以上的支付比例为95%的。","OutpatientStartPayLine":"普通门诊统筹基金不支付，使用个人帐户","OutpatientEndPayLine":"普通门诊统筹基金不支付，使用个人帐户","HospitalizationStartPayLine":"一级医院200元，二级医院400元，三级医院700元","HospitalizationEndPayLine":"基本医保3.5万，大额医疗补充14.5万","PolicyLink":"兵团职工基本医保政策；新疆生产建设兵团关于实施大病保险的公告","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"住院报销 一级医院80%；二级医院70%；三级医院60%；自负合规费用1.5万以上享受大病保险，兵团城镇居民大病保险起付标准以上的医疗费用，分档累加按比例支付，具体标准为：0 至5万元（含 5 万元）的支付比例为 50%，5 至10万元（含10万元）的支付比例为 60%，10 至20万元（含 20万元）的支付比例为 70%，20 至30万元（含30万元）的支付比例为80%，30 万元以上的支付比例为90%","OutpatientStartPayLineTwo":"普通门诊统筹基金不支付，使用个人帐户","OutpatientEndPayLineTwo":"普通门诊统筹基金不支付，使用个人帐户","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"8.7万","PolicyLinkTwo":"\"兵团城镇居民基本医疗保险待遇\n\"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/城镇居民","ReimbursementTreatmentThree":"0.8","OutpatientStartPayLineThree":"不设起付线","OutpatientEndPayLineThree":"同住院统筹封顶线","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"新疆","City":"伊宁","ReimbursementRatio":"0.9","InsuranceType":"(职工)","ReimbursementTreatment":"自付10%，其余按照乙类报销90%，无限额","OutpatientStartPayLine":"1800","OutpatientEndPayLine":"10万","HospitalizationStartPayLine":"第一次住院1300元；第二次650","HospitalizationEndPayLine":"","PolicyLink":"","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"一级85%；二级75%；三级65%","OutpatientStartPayLineTwo":"","OutpatientEndPayLineTwo":"","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"10万","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"","ReimbursementTreatmentThree":"7万以上部分报销70%","OutpatientStartPayLineThree":"7万","OutpatientEndPayLineThree":"10万","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"新疆","City":"克拉玛依","ReimbursementRatio":"0.9","InsuranceType":"(职工)","ReimbursementTreatment":"一级个人自付5%，报销95%；二级个人自付8%，报销92%；三级个人自付10%，报销90%","OutpatientStartPayLine":"起付线为总费用额的4%","OutpatientEndPayLine":"不封顶","HospitalizationStartPayLine":"一级400元，二级600元，三级800元。第二次住院减半，第三次及以上不涉。","HospitalizationEndPayLine":"","PolicyLink":"关于印发克拉玛依市城镇职工医疗保险实施办法的通知【新克政发202181号】","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"一级85%；二级75%；三级65%","OutpatientStartPayLineTwo":"","OutpatientEndPayLineTwo":"","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"10万","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工","ReimbursementTreatmentThree":"在一个统筹年度内，门诊，急诊，住院发生的政策范围内的费用，报销后，在职人员个人自付超过2000元，退休人员个人自付超过1000元的部分，再由职工大病保险基金按照50%比例支付。","OutpatientStartPayLineThree":"起付线为总费用额的4%","OutpatientEndPayLineThree":"不设","PolicyLinkThree":"关于印发克拉玛依市城镇职工医疗保险实施办法的通知【新克政发202181号】","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"新疆","City":"石河子","ReimbursementRatio":"0.9","InsuranceType":"(职工)","ReimbursementTreatment":"住院报销 一级医院80%-96%；二级医院80%-93%；三级医院80%-90%；自负合规费用2.5万以上享受大病保险，实行分档累加按比例支付，职工大病保险最低报销比例55%，最高可达到95%。0 至5万元（含 5万元）的支付比例为 55%，5 至10万元（含10万元）的支付比例为 65%，10至20万元（含 20万元）的支付比例为 75%，20 至30万元（含30万元）的支付比例为85%，30万元以上的支付比例为95%的。","OutpatientStartPayLine":"普通门诊统筹基金不支付，使用个人帐户","OutpatientEndPayLine":"普通门诊统筹基金不支付，使用个人帐户","HospitalizationStartPayLine":"一级医院200元，二级医院400元，三级医院700元","HospitalizationEndPayLine":"基本医保3.5万，大额医疗补充14.5万","PolicyLink":"兵团职工基本医保政策；新疆生产建设兵团关于实施大病保险的公告","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"住院报销 一级医院80%；二级医院70%；三级医院60%；自负合规费用1.5万以上享受大病保险，兵团城镇居民大病保险起付标准以上的医疗费用，分档累加按比例支付，具体标准为：0 至5万元（含 5 万元）的支付比例为 50%，5 至10万元（含10万元）的支付比例为 60%，10 至20万元（含 20万元）的支付比例为 70%，20 至30万元（含30万元）的支付比例为80%，30 万元以上的支付比例为90%","OutpatientStartPayLineTwo":"普通门诊统筹基金不支付，使用个人帐户","OutpatientEndPayLineTwo":"普通门诊统筹基金不支付，使用个人帐户","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"8.7万","PolicyLinkTwo":"\"兵团城镇居民基本医疗保险待遇\n\"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/城镇居民","ReimbursementTreatmentThree":"0.8","OutpatientStartPayLineThree":"不设起付线","OutpatientEndPayLineThree":"同住院统筹封顶线","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"新疆","City":"昌吉","ReimbursementRatio":"0.9","InsuranceType":"(职工)","ReimbursementTreatment":"自付5%，其余按照乙类报销80%，无限额","OutpatientStartPayLine":"不设起付线","OutpatientEndPayLine":"2万","HospitalizationStartPayLine":"首次1300；二次650","HospitalizationEndPayLine":"7万","PolicyLink":"","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"一级75%；二级60%；三级45%","OutpatientStartPayLineTwo":"800元","OutpatientEndPayLineTwo":"","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"(城乡居民)","ReimbursementTreatmentThree":"","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"甘肃省","City":"兰州市","ReimbursementRatio":"\"住院：职工：先自付20%后纳入乙类，自付10%，再按照医保报销政策报销；居民：直接按乙类自付10%后报销70%；\n门诊（药店）：职工自付10%后，报销75%；居民自付10%报销70%\"","InsuranceType":"(职工)","ReimbursementTreatment":"\"住院：先自付20%后纳入乙类，自付10%，再按照医保报销政策报销，职工（退休）个人自付比例：三级医院：起付标准以上至1万元12%（9%），1万以上至2万元8%（6%），2万以上至6万4%（3%）\n门诊（药店）：职工自付10%后，报销75%；\"","OutpatientStartPayLine":"无","OutpatientEndPayLine":"无","HospitalizationStartPayLine":"三级甲等：1400，三级乙等：1000；二级：400元，一级和社区卫生机构200元","HospitalizationEndPayLine":"基本医疗保险封顶线6万，超过进入大额医疗保险，上不封顶","PolicyLink":"关于执行2021版药品目录谈判药品的通知","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"\"住院：直接按乙类自付10%后报销70%；\n门诊（药店）：居民自付10%报销70%\"","OutpatientStartPayLineTwo":"无","OutpatientEndPayLineTwo":"无","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"基本医疗保险封顶4万，超出进入大病保险，上不封顶","PolicyLinkTwo":"关于执行2021版药品目录谈判药品的通知","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"","ReimbursementTreatmentThree":"","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"贵州","City":"贵阳","ReimbursementRatio":"","InsuranceType":"(职工)","ReimbursementTreatment":"\"在职：\n省医、贵医、省肿瘤1500\n其它三级医院850/900/950\n二级医院700\n一级医院300/500\n省医、贵医、省肿瘤84%\n其它三级医院89%\n二级医院94%\n一级医院95%\n退休：\n省医、贵医、省肿瘤1200\n其它三级医院650/700/750\n二级医院500\n一级医院200/300\n省医、贵医、省肿瘤92%\n其它三级医院94.5%\n二级医院97%\n一级医院97.5%\n\"","OutpatientStartPayLine":"普通门诊统筹基金不支付，使用个人账户","OutpatientEndPayLine":"普通门诊统筹基金不支付，使用个人账户","HospitalizationStartPayLine":"无起付线","HospitalizationEndPayLine":"基本医保15万；大额封顶线 :  25万","PolicyLink":"贵州基本医保政策","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"\"起付标准：\n县三级800；县以上三级1000；贵医、省医、省肿瘤、贵医口腔1400\n二级400\n一级及以下100\n报销比例：\n三级60%\n二级75%\n一级及以下77%\n限额25万\n大病：\n起付标准7000\n报销比例7000-6万报60%\n6-9万报65%\n9万以上70%\n限额20万\n乙类先行自付比例15%\"","OutpatientStartPayLineTwo":"二级及以下起付线0元；报销比例一级二级50%，乡镇卫生院（社区）60%；村卫生室70%","OutpatientEndPayLineTwo":"最高支付限额400","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"25+20","PolicyLinkTwo":"贵阳市城镇居民基本医疗保险试点实施办法","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"","ReimbursementTreatmentThree":"","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"贵州","City":"遵义","ReimbursementRatio":"","InsuranceType":"(职工)","ReimbursementTreatment":"\"住院职工：\n起付标准：乡镇/社区医院50，县级医院100-300，市级医院400，省级医院450；支付比例：在职：社区医院88%，县级医院87%，市级医院83%，省级医院82%；退休：社区医院91%，县级医院90%，市级医院86%，省级医院85%；基本医疗保险支付限额4万；大额保险支付比例92%，限额25万。\n门诊双通道城镇职工92%\"","OutpatientStartPayLine":"普通门诊统筹基金不支付，使用个人账户","OutpatientEndPayLine":"普通门诊统筹基金不支付，使用个人账户","HospitalizationStartPayLine":"\"\n乡镇/社区医院50，县级医院100-300，市级医院400，省级医院450\"","HospitalizationEndPayLine":"基本医保4万；大额封顶线 :  25万","PolicyLink":"《遵义市城镇职工 基本医疗保险实施办法的通知》遵府发〔2010〕28号","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"\"住院居民：\n起付标准：一级医院100，二级400，市三级800，省三级1200；报销比例：一级85%，二级80%，市三级70%，省三级60%，基本医疗保险支付限额25万；大病起付线6000，报销比例：6000-6万报60%，6万-10万报70%，10万以上80%；最高支付限额50万，先行自付比例10%\n门诊双通道75%\"","OutpatientStartPayLineTwo":"0","OutpatientEndPayLineTwo":"60","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"最高统筹支付限额25万元+50万（大病）","PolicyLinkTwo":"关于调整城镇居民基本医疗保险待遇 有关问题的通知2015","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工、城镇居民","ReimbursementTreatmentThree":"\"职工门慢起付线0元，报销比例80%，支付限额按病种限定；门诊大病起付线0元，报销比例92%，支付限额视同住院\n居民门慢起付线0元，报销比例60%，支付限额按病种定；门诊大病起付线0元，报销比例及限额视同住院\"","OutpatientStartPayLineThree":"0","OutpatientEndPayLineThree":"2400","PolicyLinkThree":"《遵义市城镇职工 基本医疗保险实施办法的通知》遵府发〔2010〕28号;关于调整城镇居民基本医疗保险待遇 有关问题的通知2018","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"重庆","City":"重庆","ReimbursementRatio":"","InsuranceType":"(职工)","ReimbursementTreatment":"\"退休：95%；在职，分医院级别一级90%;二级87%;三级85%。补充：统筹基金支付超过4.7万元以上的，符合大额医疗费互助基金报销规定的，最多50万元，报销比例100%。\n门槛费：一级二级社区医院160/400元；一二三级医院200/440/880元\"","OutpatientStartPayLine":"个人账户支付普通门诊，统筹基金不支付","OutpatientEndPayLine":"个人账户支付普通门诊，统筹基金不支付","HospitalizationStartPayLine":"一级二级社区医院160/400元；一二三级医院200/440/880元","HospitalizationEndPayLine":"4.7+50万","PolicyLink":"重庆市城镇职工医疗保险政策解读","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"\"参保人员住院发生的政策范围内医疗费用，按以下标准报销：一档：一级医疗机构80%，二级60%，三级40%。二档：在一档的基础上提高5个百分点。未成年人在同档参保成年人的基础上提高5个百分点。\n起付线：一级医疗机构100元/次，二级300元/次，三级800元/次\"","OutpatientStartPayLineTwo":"不设起付标准","OutpatientEndPayLineTwo":"年度居民医保的门诊定额包干标准为150元/人","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"28（一档）/32（二档）万","PolicyLinkTwo":"\"重庆市城乡居民合作医疗保险市级统筹实施办法的通知；渝北区2016年城乡居民医保市级统筹政策宣传资料\n\"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工、城乡居民","ReimbursementTreatmentThree":"职工：肿瘤统筹基金按90％支付；其他特殊病种统筹基金按80％支付。特病支付限额与住院合并计算。限额以上，由大额医疗费互助基金支付报销比例100% 支付限额 50万元 。城乡居民：特殊疾病中的慢性疾病门诊（糖尿病，精神病）医药费不设报销起付线，实行按比例、限额的办法。每次报销比例为一级医疗机构80%、二级60%、三级40%，年报销限额为1000元/年、人。重大疾病门诊（肿瘤）实行与住院相同的报销比例和起付线，其起付线一年计算1次（一年内到不同等级医疗机构就医的以最高等级计算），封顶线与住院合并计算，直至当年的成年人报销封顶线；儿童重大疾病住院和门诊的累加封顶线一档10万元，二档15万元。大病医疗保险：参加我区城乡居民合作医疗保险的居民住院和特殊疾病中的重大疾病门诊发生属于居民医保基金报销范围的医疗费用，由居民医保基金按规定比例支付后的自付费用首次或累计超过起付标准（2019年9月1日起，起付标准调整为13193元）以上的，报销比例提高至60%，最高报销金额20万元。对于建档贫困人员9月3日起全面取消大病保险封顶线。","OutpatientStartPayLineThree":"职工：一级医院200元，二级440元，三级882元。居民：不设报销起付线","OutpatientEndPayLineThree":"职工：54.7万；居民：28（一档）/32（二档）万","PolicyLinkThree":"\"关于做好重庆市2019年城乡居民基本医疗保障工作的通知 渝医保发【2019】65号；\n重庆市城镇职工医疗保险政策解读；重庆市城乡居民合作医疗保险特殊疾病管理暂行办法\"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"陕西","City":"西安","ReimbursementRatio":"：先自付4%。职工报76%，居民报60%","InsuranceType":"(职工)","ReimbursementTreatment":"：先自付4%。报销76%，","OutpatientStartPayLine":"无","OutpatientEndPayLine":"无","HospitalizationStartPayLine":"无","HospitalizationEndPayLine":"封顶40万；40万以上进入大额补助医疗保险，自付5%，无封顶","PolicyLink":"关于做好国家基本医疗保险，工伤保险和生育保险药品目录（2019年版）执行落实工作的通知","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"先自付5%。报销60%，","OutpatientStartPayLineTwo":"无","OutpatientEndPayLineTwo":"无","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"20万，20万以上进入大病二次报销，无封顶线","PolicyLinkTwo":"关于做好国家基本医疗保险，工伤保险和生育保险药品目录（2019年版）执行落实工作的通知","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"","ReimbursementTreatmentThree":"","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"","PolicyLinkThree":"关于调整我市基本医疗保险特殊药品范围的通知","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"青海","City":"西宁","ReimbursementRatio":"三级定点医疗机构50%；二级及以下定点医疗机构70%。","InsuranceType":"(职工)","ReimbursementTreatment":"自付35%，其余按照乙类报销。一级85%；二级80%；三级75%","OutpatientStartPayLine":"200","OutpatientEndPayLine":"10000","HospitalizationStartPayLine":"一级医疗机构350元，二级医疗机构550元，三级医疗机构750元","HospitalizationEndPayLine":"25万/年","PolicyLink":"西宁本市职工基本医疗保险","InsuranceTypeTwo":"(居民)","ReimbursementTreatmentTwo":"卫生院60%，二级医院40%，三级医院30%","OutpatientStartPayLineTwo":"10万以下的三级医院659元、二级医院300元、一级医院不设起付线","OutpatientEndPayLineTwo":"2000","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"10万","PolicyLinkTwo":"西宁市城镇居民基本医疗保险","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"年度个人自付费用超过7000元以上的部分，纳入大病保险范围，按照85%比例报销","OutpatientStartPayLineThree":"","OutpatientEndPayLineThree":"10000","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"江苏","City":"无锡","ReimbursementRatio":"0.7","InsuranceType":"(职工)","ReimbursementTreatment":"\"1.门诊，个人账户用完后，在约定社区卫生服务中心（站）或经批准转至其他定点医疗机构就医发生的符合规定的门诊医疗费由统筹基金分别按在职和退休（职）人员70%和85%的比例支付。\n2.住院，在职职工在三级医疗机构出院结算，医疗费用在1万元（含1万元）以下，统筹基金支付84%，个人自付比例为16%；医疗费用在1万元至4万元（含4万元），统筹基金支付88%，个人自付比例为12%；医疗费用在4万元至12万元（含12万元），统筹基金支付92%，个人自付比例8%。在职职工在二级及以下医疗机构出院结算，医疗费用在1万元（含1万元）以下，统筹基金支付88%，个人自付比例为12%；医疗费用在1万元至4万元（含4万元），统筹基金支付90%，个人自付比例为10%；医疗费用在4万元至12万元（含12万元），统筹基金支付92%，个人自付比例8%。在职职工在一级医疗机构出院结算，医疗费用在1万元（含1万元）以下，统筹基金支付96.4%，个人自付比例为3.6%；医疗费用在1万元至4万元（含4万元），统筹基金支付97%，个人自付比例3%；医疗费用在4万元至12万元（含12万元），统筹基金支付92%，个人自付比例8%。在职职工在社区服务机构出院结算，医疗费用在12万元（含12万元）以下，统筹基金支付92%，个人自付比例为8%。退休人员在上述个人自付比例基础上减半执行，建国前参加革命工作的老工人个人自付比例为在职职工的30%。\n医疗费用在4万元至30万元，不分医疗机构级别和人员类别个人均支付8%，基本医疗保险统筹基金支付92%。\"","OutpatientStartPayLine":"参保人员个人帐户用完","OutpatientEndPayLine":"在职5000；退休6000","HospitalizationStartPayLine":"社区300；一级400；二级在职750，退休600；三级在职950，退休750","HospitalizationEndPayLine":"30万","PolicyLink":"无锡医疗职工保险常见问题","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"\"1.门诊：800以内，社区报销50%，其他医院40%；\n2.住院：在社区卫生服务中心就医为90％；在市内和市外医院就医，办理转诊手续的分别为65％和55％，未办理转诊手续的分别按上述比例的50％执行。\"","OutpatientStartPayLineTwo":"不设起付标准","OutpatientEndPayLineTwo":"800元","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"20万，缴费满5年增加5万","PolicyLinkTwo":"无锡\\无锡居民医保政策解读（一二三四）.docx","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"\"1.职工门诊特殊病种（恶性肿瘤化疗、放疗（含核素治疗）、肾透析、器官移植排异、血友病、生物治疗（CIK/DC)）在不同等级医疗机构进行治疗时，其医疗费用合并计算，个人不再支付统筹基金起付费，且统筹段的个人自付比例统一按一级医疗机构的标准执行。1万元以内，在职88%，退休94%；1-4万元，在职90%，退休95%；4-30万元，在职92%，退休96%；30万元以上，在职和退休均为92%\n2.居民医保基金支付比例：1.8万-5万元，50%；5-10万元，60%；10万元以上，80%。未办理转诊手续的分别按上述比例的50％执行。\"","OutpatientStartPayLineThree":"不设起付标准","OutpatientEndPayLineThree":"与住院报销共享最高支付限额职工30万；居民20万。","PolicyLinkThree":"无锡居民医保政策，职工医保政策问答","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"江苏","City":"南通","ReimbursementRatio":"85%-60%","InsuranceType":"(职工)","ReimbursementTreatment":"职工门诊统筹待遇在职70%，退休80%","OutpatientStartPayLine":"600元","OutpatientEndPayLine":"在职和退休：3500元","HospitalizationStartPayLine":"社会医疗统筹基金，对参保人员住院医疗费用起付标准以上， 0 元至 2 万元（含）部分，在一级定点医疗机构在职人员和退休 人员（下同）分别支付 90%、94%，在二级定点医疗机构分别支 付 85%、89%，在三级定点医疗机构分别支付 83%、87%；2 万 元至 10 万元（含）部分，在一级定点医疗机构分别支付 94%、 98%，在二级定点医疗机构分别支付 90%、94%，在三级定点医 疗机构分别支付 88%、92%。 将 10 万元至 20 万元（含）部分，由大额医疗救助资金支付 部分比例调整为在一级定点医疗机构支付 90%、二级定点医疗机构支付 87%、在三级定点医疗机构支付85%。取消原“连续缴纳 大额医疗救助费 5 年以上的分别提高 5 个百分点”的规定。","HospitalizationEndPayLine":"20万元","PolicyLink":"通医保发【2019】23号","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"居民门诊统筹50%","OutpatientStartPayLineTwo":"","OutpatientEndPayLineTwo":"600元","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"20万元","PolicyLinkTwo":"通医保发【2019】23号","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"门慢患者每年补助2000元。","OutpatientStartPayLineThree":"\"职工和居民起付线10000元；\n大病保险起付标准以上 0 元5万元（含）的部分，职工医保和居民医保大病保险资金支付比例50%；5万至10 万元（含）的部分，职工医保和居民医保大病保险资金支付比例调整为 60%；10 万元至 20 万元（含）的部分，职工医保和居民医保大病保险资金支付比例调整为 80%；20 万元以上部分，职工医保和居民医保大病保险资金支付比例调整为 90%\"","OutpatientEndPayLineThree":"","PolicyLinkThree":"通医保发【2019】23号","MedicalAssurancePolicyDetails":[]},{"TreatmentArea":"Autoimmune","ChemicalName":"依奇珠单抗注射液","ProductName":"拓咨","DosageForm":"注射剂","Specification":"是","ApprovaledText":"80mg/ml","NRDLStatus":"","ProductionEnterpriseName":"","Indications":"治疗适合系统治疗或光疗的中度至中度斑块型银屑病成人患者","Province":"江苏","City":"扬州","ReimbursementRatio":"0.7","InsuranceType":"(职工)","ReimbursementTreatment":"\"普通门诊：在职35岁到退休，按照本人缴费基数的2.6-3.5%划入个人账户，退休按退休金总额4.5%划入。\n住院：一级医院，报销92%；二级医院，报销88%，三级医院报销86%\"","OutpatientStartPayLine":"","OutpatientEndPayLine":"","HospitalizationStartPayLine":"一级：400元，二级：600元，三级800元","HospitalizationEndPayLine":"23万元","PolicyLink":"","InsuranceTypeTwo":"(城乡居民)","ReimbursementTreatmentTwo":"定点医疗机构报销50%","OutpatientStartPayLineTwo":"100-600元","OutpatientEndPayLineTwo":"500","HospitalizationStartPayLineTwo":"-","HospitalizationEndPayLineTwo":"全石城镇居民年人均可支配收入的6倍","PolicyLinkTwo":"","InsuranceTypeThree":"(门特门慢门诊大病特病）","CrowdType":"职工/居民","ReimbursementTreatmentThree":"\"职工：一类：恶性肿瘤、血透、血友病及肝、肾移植；起付线500，报销同住院。二类：糖尿病（合并感染或有心、脑、肾、眼、神经并发症之一者）；慢性肝炎和肝硬化(失代偿期)；精神分裂症、情感性精神障碍；慢性肾功能不全；再生障碍性贫血；系统性红斑狼疮；类风湿性关节炎；帕金森氏病及综合征；肺结核。慢性肝炎和肝硬化（失代偿期）；冠心病；阿尔茨海默症（病）；中风后遗症。起付线500，报销同住院，年度上限2500。\n居民：门特同职工报销，年度结算1500-2000元\"","OutpatientStartPayLineThree":"500元","OutpatientEndPayLineThree":"2500元","PolicyLinkThree":"","MedicalAssurancePolicyDetails":[]}]